TY  - JOUR
AU  - Pendeliuk, V.S.
AU  - Melnick, I.V.
TI  - Excitatory synchronization of rat hippocampal interneurons during network activation in vitro
JF  - FRONTIERS IN CELLULAR NEUROSCIENCE
J2  - FRONT CELL NEUROSCI
VL  - 17
PY  - 2023
SN  - 1662-5102
DO  - 10.3389/fncel.2023.1129991
UR  - https://m2.mtmt.hu/api/publication/33759452
ID  - 33759452
N1  - Export Date: 19 April 2023            
            Correspondence Address: Melnick, I.V.; Department of Biophysics of Ion Channels, Ukraine; email: igorm@biph.kiev.ua            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; tetrodotoxin, 4368-28-9, 4664-41-9            
            Funding details: National Academy of Sciences of Ukraine, NASU            
            Funding text 1: This work was funded on a regular basis by the National Academy of Sciences of Ukraine.
AB  - Introduction: Hippocampal interneurons (INs) are known to synchronize their electrical activity via mechanisms, which are poorly defined due to immense complexity of neural tissue but seem to depend on local cell interactions and intensity of network activity. Methods: Here, synchronization of INs was studied using paired patch-clamp recordings in a simplified culture model with intact glutamate transmission. The level of network activity was moderately elevated by field electric stimulation, which is probably an analogue of afferent processing in situ. Results: Even in baseline conditions, ∼45% of spontaneous inhibitory postsynaptic currents (sIPSCs) resulting from firing of individual presynaptic INs coincided between cells within ±1 ms due to simple divergence of inhibitory axons. Brief network activation induced an appearance of ‘hypersynchronous’ (∼80%) population sIPSCs occurring in response to coherent discharges of several INs with jitter ±4 ms. Notably, population sIPSCs were preceded by transient inward currents (TICs). Those were excitatory events capable to synchronize firing of INs, in this respect being reminiscent of so-called fast prepotentials observed in studies on pyramidal neurons. TICs also had network properties consisting of heterogeneous components: glutamate currents, local axonal and dendritic spikelets, and coupling electrotonic currents likely via gap junctions; putative excitatory action of synaptic gamma-aminobutyric acid (GABA) was not involved. The appearance of population excitatory-inhibitory sequences could be initiated and reproduced by firing of a single excitatory cell reciprocally connected with one IN. Discussion: Our data demonstrate that synchronization of INs is initiated and dominated by glutamatergic mechanisms, which recruit, in a whole-sale manner, into supporting action other excitatory means existing in a given neural system. Copyright © 2023 Pendeliuk and Melnick.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Attili, S.M.
AU  - Moradi, K.
AU  - Wheeler, D.W.
AU  - Ascoli, G.A.
TI  - Quantification of neuron types in the rodent hippocampal formation by data mining and numerical optimization
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 55
PY  - 2022
IS  - 7
SP  - 1724
EP  - 1741
PG  - 18
SN  - 0953-816X
DO  - 10.1111/ejn.15639
UR  - https://m2.mtmt.hu/api/publication/32821007
ID  - 32821007
N1  - Center for Neural Informatics, Structures, and Plasticity, Interdisciplinary Neuroscience Program, Krasnow Institute for Advanced Study, Fairfax, VA, United States            
            Bioengineering Department and Volgenau School of Engineering, George Mason University, FairfaxVA, United States            
            Export Date: 13 May 2022            
            CODEN: EJONE            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: George Mason University, GMU            
            Funding text 1: This project is supported in parts by National Institutes of Health, grants R01NS39600 and U01MH114829. We are grateful to Drs. Padmanabhan Seshaiyer (Professor of Mathematical Sciences, George Mason University), Siva Venkadesh (from the authors' lab) and Sean Mackesey (University of California at Berkeley) for critical discussions.            
            Funding text 2: This project is supported in parts by National Institutes of Health, grants R01NS39600 and U01MH114829. We are grateful to Drs. Padmanabhan Seshaiyer (Professor of Mathematical Sciences, George Mason University), Siva Venkadesh (from the authors' lab) and Sean Mackesey (University of California at Berkeley) for critical discussions.
AB  - Quantifying the population sizes of distinct neuron types in different anatomical regions is an essential step towards establishing a brain cell census. Although estimates exist for the total neuronal populations in different species, the number and definition of each specific neuron type are still intensively investigated. Hippocampome.org is an open-source knowledge base with morphological, physiological and molecular information for 122 neuron types in the rodent hippocampal formation. While such framework identifies all known neuron types in this system, their relative abundances remain largely unknown. This work quantitatively estimates the counts of all Hippocampome.org neuron types by literature mining and numerical optimization. We report the number of neurons in each type identified by main neurotransmitter (glutamate or GABA) and axonal-dendritic patterns throughout 26 subregions and layers of the dentate gyrus, Ammon's horn, subiculum and entorhinal cortex. We produce by sensitivity analysis reliable numerical ranges for each type and summarize the amounts across broad neuronal families defined by biomarkers expression and firing dynamics. Study of density distributions indicates that the number of dendritic-targeting interneurons, but not of other neuronal classes, is independent of anatomical volumes. All extracted values, experimental evidence and related software code are released on Hippocampome.org. © 2022 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Kaplanian, Ani
AU  - Vinos, Michael
AU  - Skaliora, Irini
TI  - GABA(B)- and GABA(A)-receptor-mediated regulation of Up and Down states across development
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 600
PY  - 2022
IS  - 10
SP  - 2401
EP  - 2427
PG  - 27
SN  - 0022-3751
DO  - 10.1113/JP282736
UR  - https://m2.mtmt.hu/api/publication/32882089
ID  - 32882089
N1  - Export Date: 18 October 2022            
            CODEN: JPHYA            
            Correspondence Address: Kaplanian, A.; Center for Basic Research, Greece; email: anikaplanian@gmail.com            
            Correspondence Address: Skaliora, I.; Center for Basic Research, Greece; email: iskaliora@bioacademy.gr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; diazepam, 439-14-5; Diazepam; gamma-Aminobutyric Acid; Receptors, GABA-A; Receptors, GABA-B            
            Funding details: European Commission, EC            
            Funding details: Volkswagen Foundation            
            Funding details: European Regional Development Fund, ERDF            
            Funding details: Hellenic Foundation for Research and Innovation, ΕΛ.ΙΔ.Ε.Κ, 81025, NSRF 2014‐2020            
            Funding text 1: This work was supported by a Fondation Sante research grant to I.S., a Volkswagen Foundation research grant to I.S., and a private donation by Periklis and Clio Moustakas. A.K. was supported by the Hellenic Foundation for Research and Innovation (HFRI) under the HFRI PhD Fellowship grant (no. 81025). M.V. and A.K. were supported by BIOIMAGING.GR (MIS 5002755) implemented under ‘Action for Strengthening Research and Innovation Infrastructures’, funded by the Operational Programme ‘Competitiveness, Entrepreneurship and Innovation’ (NSRF 2014‐2020) and co‐financed by Greece and the European Union (European Regional Development Fund).
AB  - Slow oscillations, the hallmark of non-REM sleep, and their cellular counterpart, Up and Down states (UDSs), are considered a signature of cortical dynamics that reflect the intrinsic network organization. Although previous studies have explored the role of inhibition in regulating UDSs, little is known about whether this role changes with maturation. This is surprising since both slow oscillations and UDSs exhibit significant age-dependent alterations. To elucidate the developmental impact of GABA(B) and GABA(A) receptors on UDS activity, we conducted simultaneous local field potentials and intracellular recordings ex vivo, in brain slices of young and adult male mice, using selective blockers, CGP55845 and a non-saturating concentration of gabazine, respectively. Blockade of both GABA(B) and GABA(A) signalling showed age-differentiated functions. CGP55845 caused an increase in Down state duration in young animals, but a decrease in adults. Gabazine evoked spike and wave discharges in both ages; however, while young networks became completely epileptic, adults maintained the ability to generate UDSs. Furthermore, voltage clamp recordings of miniature inhibitory postsynaptic currents revealed that gabazine selectively blocks phasic currents, particularly involving postsynaptic mechanisms. The latter exhibit clear maturational changes, suggesting a different subunit composition of GABA(A) receptors in young vs. adult animals. Indeed, subsequent local field potential recordings under diazepam (nanomolar or micromolar concentrations) revealed that mechanisms engaging the drug's classical binding site, mediated by alpha 1-subunit-containing GABA(A) receptors, make a bigger contribution to Up state initiation in young networks compared to adults. Taken together, these findings help clarify the mechanisms that underlie the maturation of cortical network activity and enhance our understanding regarding the emergence of neurodevelopmental disorders. Key points Slow oscillations, the EEG hallmark of non-REM sleep, and their cellular counterpart, Up and Down states (UDSs), are considered the default activity of the cerebral cortex and reflect the underlying neural connectivity. GABA(B)- and GABA(A)-receptor-mediated inhibition play a major role in regulating UDS activity. Although slow oscillations and UDSs exhibit significant alterations as a function of age, it is unknown how developmental changes in inhibition contribute to the developmental profile of this activity. In this study, we reveal for the first time age-dependent effects of GABA(B) and GABA(A) signalling on UDSs. We also document the differential subunit composition of postsynaptic GABA(A) receptors in young and adult animals, highlighting the alpha 1-subunit as a major component of the age-differentiated regulation of UDSs. These findings help clarify the mechanisms that underlie the maturation of cortical network activity, and enhance our understanding regarding the emergence of neurodevelopmental disorders.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Sumser, A.
AU  - Joesch, M.
AU  - Jonas, P.
AU  - Ben-Simon, Y.
TI  - Fast, high-throughput production of improved rabies viral vectors for specific, efficient and versatile transsynaptic retrograde labelling
JF  - ELIFE
J2  - ELIFE
VL  - 11
PY  - 2022
SN  - 2050-084X
DO  - 10.7554/eLife.79848
UR  - https://m2.mtmt.hu/api/publication/33646037
ID  - 33646037
N1  - Institute of Science and Technology Austria (ISTA), Klosterneuburg, Austria            
            Department of Neurophysiology and Neuropharmacology, Vienna Medical University, Vienna, Austria            
            Allen Institute for Brain Science, Seattle, WA, United States            
            Cited By :1            
            Export Date: 18 February 2023            
            Correspondence Address: Ben-Simon, Y.; Institute of Science and Technology Austria (ISTA)Austria; email: yoav.ben-simon@alleninstitute.org            
            Funding details: Z 312-B27            
            Funding details: European Molecular Biology Organization, EMBO, ALTF 1098-2017            
            Funding details: Horizon 2020 Framework Programme, H2020, 692692, 756502            
            Funding details: European Research Council, ERC            
            Funding details: Human Frontier Science Program, HFSP, LT000256/2018-L            
            Funding text 1: We thank F Marr for technical assistance, A Murray for RVdG-CVS-N2c viruses and Neuro2A packaging cell-lines and J Watson for reading the manuscript. This research was supported by the Scientific Service Units (SSU) of IST-Austria through resources provided by the Imaging and Optics Facility (IOF) and the Preclinical Facility (PCF). This project was funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (ERC advanced grant No 692692, PJ, ERC starting grant No 756502, MJ), the Fond zur Förderung der Wissen-schaftlichen Forschung (Z 312-B27, Wittgenstein award, PJ), the Human Frontier Science Program (LT000256/2018-L, AS) and EMBO (ALTF 1098-2017, AS).
AB  - To understand the function of neuronal circuits, it is crucial to disentangle the connectivity patterns within the network. However, most tools currently used to explore connectivity have low throughput, low selectivity, or limited accessibility. Here, we report the development of an improved packaging system for the production of the highly neurotropic RVdGenvA-CVS-N2c rabies viral vectors, yielding titers orders of magnitude higher with no background contamination, at a fraction of the production time, while preserving the efficiency of transsynaptic labeling. Along with the production pipeline, we developed suites of ‘starter’ AAV and bicistronic RVdG-CVS-N2c vectors, enabling retrograde labeling from a wide range of neuronal populations, tailored for diverse experimental requirements. We demonstrate the power and flexibility of the new system by uncovering hidden local and distal inhibitory connections in the mouse hippocampal formation and by imaging the functional properties of a cortical microcircuit across weeks. Our novel production pipeline provides a convenient approach to generate new rabies vectors, while our toolkit flexibly and efficiently expands the current capacity to label, manipulate and image the neuronal activity of interconnected neuronal circuits in vitro and in vivo. © Sumser et al.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Tecuatl, C.
AU  - Wheeler, D.W.
AU  - Sutton, N.
AU  - Ascoli, G.A.
TI  - Comprehensive estimates of potential synaptic connections in local circuits of the rodent hippocampal formation by axonal-dendritic overlap
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 41
PY  - 2021
IS  - 8
SP  - 1665
EP  - 1683
PG  - 19
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.1193-20.2020
UR  - https://m2.mtmt.hu/api/publication/31939787
ID  - 31939787
N1  - Export Date: 31 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 7 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 9 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu
Export Date: 12 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 14 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 20 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 22 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 23 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
Export Date: 6 May 2021            
            CODEN: JNRSD            
            Correspondence Address: Ascoli, G.A.; Krasnow Institute for Advanced Study; and Bioengineering Department, United States; email: ascoli@gmu.edu            
            Funding details: National Institutes of Health, NIH, R01NS39600, U01MH114829            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, 253060            
            Funding text 1: This work was supported in part by National Institutes of Health Grants R01NS39600 and U01MH114829. C.T. was supported by Consejo Nacional de Ciencia y Tecnología, México Fellowship 253060 (allowing this project to start during her PhD training). We thank Keivan Moradi, Siva Venkadesh, Jeffrey D. Kopsick, and Nikhil Koneru for help and feedback. The authors declare no competing financial interests. Correspondence should be addressed to Giorgio A. Ascoli at ascoli@gmu.edu. https://doi.org/10.1523/JNEUROSCI.1193-20.2020 Copyright © 2021 the authors
AB  - A quantitative description of the hippocampal formation synaptic architecture is essential for understanding the neural mechanisms of episodic memory. Yet the existing knowledge of connectivity statistics between different neuron types in the rodent hippocampus only captures a mere 5% of this circuitry. We present a systematic pipeline to produce first-approximation estimates for most of the missing information. Leveraging the www.Hippocampome.org knowledge base, we derive local connection parameters between distinct pairs of morphologically identified neuron types based on their axonal-dendritic overlap within every layer and subregion of the hippocampal formation. Specifically, we adapt modern image analysis technology to determine the parcel-specific neurite lengths of every neuron type from representative morphologic reconstructions obtained from either sex. We then compute the average number of synapses per neuron pair using relevant anatomic volumes from the mouse brain atlas and ultrastructurally established interaction distances. Hence, we estimate connection probabilities and number of contacts for .1900 neuron type pairs, increasing the available quantitative assessments more than 11-fold. Connectivity statistics thus remain unknown for only a minority of potential synapses in the hippocampal formation, including those involving long-range (23%) or perisomatic (6%) connections and neuron types without morphologic tracings (7%). The described approach also yields approximate measurements of synaptic distances from the soma along the dendritic and axonal paths, which may affect signal attenuation and delay. Overall, this dataset fills a substantial gap in quantitatively describing hippocampal circuits and provides useful model specifications for biologically realistic neural network simulations, until further direct experimental data become available. © 2021 Society for Neuroscience. All rights reserved.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Zhang, M.
AU  - Weiland, H.
AU  - Schöfbänker, M.
AU  - Zhang, W.
TI  - Estrogen receptors alpha and beta mediate synaptic transmission in the pfc and hippocampus of mice
JF  - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
J2  - INT J MOL SCI
VL  - 22
PY  - 2021
IS  - 3
PG  - 15
SN  - 1661-6596
DO  - 10.3390/ijms22031485
UR  - https://m2.mtmt.hu/api/publication/31941703
ID  - 31941703
N1  - Export Date: 1 April 2021            
            Correspondence Address: Zhang, M.; Lab for Molecular Neuroscience, Germany; email: mingyue.zhang@ukmuenster.de            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, ZH34/3-1            
            Funding text 1: Funding: This work was supported by the Deutsche Forschungsgemeinschaft (ZH34/3-1).
Export Date: 13 April 2021            
            Correspondence Address: Zhang, M.; Lab for Molecular Neuroscience, Germany; email: mingyue.zhang@ukmuenster.de            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, ZH34/3-1            
            Funding text 1: Funding: This work was supported by the Deutsche Forschungsgemeinschaft (ZH34/3-1).
Export Date: 20 April 2021            
            Correspondence Address: Zhang, M.; Lab for Molecular Neuroscience, Germany; email: mingyue.zhang@ukmuenster.de            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, ZH34/3-1            
            Funding text 1: Funding: This work was supported by the Deutsche Forschungsgemeinschaft (ZH34/3-1).
Export Date: 17 May 2021            
            Correspondence Address: Zhang, M.; Lab for Molecular Neuroscience, Germany; email: mingyue.zhang@ukmuenster.de            
            Chemicals/CAS: estradiol, 50-28-2; diarylpropionitrile; Estradiol; Estrogen Receptor alpha; Excitatory Amino Acid Agents; GABA Agents; Nitriles; Propionates            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, ZH34/3-1            
            Funding text 1: Funding: This work was supported by the Deutsche Forschungsgemeinschaft (ZH34/3-1).
Cited By :1            
            Export Date: 10 August 2021            
            Correspondence Address: Zhang, M.; Lab for Molecular Neuroscience, Germany; email: mingyue.zhang@ukmuenster.de            
            Chemicals/CAS: estradiol, 50-28-2; diarylpropionitrile; Estradiol; Estrogen Receptor alpha; Excitatory Amino Acid Agents; GABA Agents; Nitriles; Propionates            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, ZH34/3-1            
            Funding text 1: Funding: This work was supported by the Deutsche Forschungsgemeinschaft (ZH34/3-1).
AB  - Distinct from ovarian estradiol, the steroid hormone 17ß-estradiol (E2) is produced in the brain and is involved in numerous functions, particularly acting as a neurosteroid. However, the physiological role of E2 and the mechanism of its effects are not well known. In hippocampal slices, 17ß-estradiol has been found to cause a modest increase in fast glutamatergic transmission; because some of these effects are rapid and acute, they might be mediated by membrane-associated receptors via nongenomic action. Moreover, activation of membrane estrogen receptors can rapidly modulate neuron function in a sex-specific manner. To further investigate the neurological role of E2, we examined the effect of E2, as an estrogen receptor (ER) agonist, on synaptic transmission in slices of the prefrontal cortex (PFC) and hippocampus in both male and female mice. Whole-cell recordings of spontaneous excitatory postsynaptic currents (sEPSC) in the PFC showed that E2 acts as a neuromodulator in glutamatergic transmission in the PFC in both sexes, but often in a cell-specific manner. The sEPSC amplitude and/or frequency responded to E2 in three ways, namely by significantly increasing, decreasing or having no response. Additional experiments using an agonist selective for ERß, diarylpropionitrile (DPN) showed that in males the sEPSC and spontaneous inhibitory postsynaptic currents sIPSC responses were similar to their E2 responses, but in females the estrogen receptor ß (ERß) agonist DPN did not influence excitatory transmission in the PFC. In contrast, in the hippocampus of both sexes E2 potentiated the gluatmatergic synaptic transmission in a subset of hippocampal cells. These data indicate that activation of E2 targeting probably a estrogen subtypes or different downstream signaling affect synaptic transmission in the brain PFC and hippocampus between males versus females mice. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Goaillard, J.-M.
AU  - Moubarak, E.
AU  - Tapia, M.
AU  - Tell, F.
TI  - Diversity of Axonal and Dendritic Contributions to Neuronal Output
JF  - FRONTIERS IN CELLULAR NEUROSCIENCE
J2  - FRONT CELL NEUROSCI
VL  - 13
PY  - 2020
PG  - 21
SN  - 1662-5102
DO  - 10.3389/fncel.2019.00570
UR  - https://m2.mtmt.hu/api/publication/31190263
ID  - 31190263
N1  - Export Date: 20 May 2020            
            Correspondence Address: Goaillard, J.-M.; UMR_S 1072, Aix Marseille Université, INSERM, Faculté de Médecine Secteur NordFrance; email: jean-marc.goaillard@univ-amu.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; dopamine, 51-61-6, 62-31-7; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; oxytocin, 50-56-6, 54577-94-5; parvalbumin, 56094-12-3, 83667-75-8; tyrosine 3 monooxygenase, 9036-22-0; vasopressin, 11000-17-2            
            Funding details: European Research Council, ERC            
            Funding details: European Research Council, ERC, 616827            
            Funding text 1: Funding. This work was funded by the European Research Council (ERC CoG grant 616827 CanaloHmics to J-MG; supporting MT).
Export Date: 23 May 2020            
            Correspondence Address: Goaillard, J.-M.; UMR_S 1072, Aix Marseille Université, INSERM, Faculté de Médecine Secteur NordFrance; email: jean-marc.goaillard@univ-amu.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; dopamine, 51-61-6, 62-31-7; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; oxytocin, 50-56-6, 54577-94-5; parvalbumin, 56094-12-3, 83667-75-8; tyrosine 3 monooxygenase, 9036-22-0; vasopressin, 11000-17-2            
            Funding details: European Research Council, ERC            
            Funding details: European Research Council, ERC, 616827            
            Funding text 1: Funding. This work was funded by the European Research Council (ERC CoG grant 616827 CanaloHmics to J-MG; supporting MT).
Cited By :1            
            Export Date: 30 December 2020            
            Correspondence Address: Goaillard, J.-M.; UMR_S 1072, Aix Marseille Université, INSERM, Faculté de Médecine Secteur NordFrance; email: jean-marc.goaillard@univ-amu.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; dopamine, 51-61-6, 62-31-7; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; oxytocin, 50-56-6, 54577-94-5; parvalbumin, 56094-12-3, 83667-75-8; tyrosine 3 monooxygenase, 9036-22-0; vasopressin, 11000-17-2            
            Funding details: European Research Council, ERC            
            Funding details: European Research Council, ERC, 616827            
            Funding text 1: Funding. This work was funded by the European Research Council (ERC CoG grant 616827 CanaloHmics to J-MG; supporting MT).
Cited By :1            
            Export Date: 25 January 2021
Cited By :1            
            Export Date: 19 March 2021            
            Correspondence Address: Goaillard, J.-M.; UMR_S 1072, France; email: jean-marc.goaillard@univ-amu.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; dopamine, 51-61-6, 62-31-7; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; oxytocin, 50-56-6, 54577-94-5; parvalbumin, 56094-12-3, 83667-75-8; tyrosine 3 monooxygenase, 9036-22-0; vasopressin, 11000-17-2            
            Funding details: European Research Council, ERC, 616827            
            Funding text 1: Funding. This work was funded by the European Research Council (ERC CoG grant 616827 CanaloHmics to J-MG; supporting MT).
Cited By :1            
            Export Date: 13 April 2021            
            Correspondence Address: Goaillard, J.-M.; UMR_S 1072, France; email: jean-marc.goaillard@univ-amu.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; dopamine, 51-61-6, 62-31-7; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; oxytocin, 50-56-6, 54577-94-5; parvalbumin, 56094-12-3, 83667-75-8; tyrosine 3 monooxygenase, 9036-22-0; vasopressin, 11000-17-2            
            Funding details: European Research Council, ERC, 616827            
            Funding text 1: Funding. This work was funded by the European Research Council (ERC CoG grant 616827 CanaloHmics to J-MG; supporting MT).
Cited By :1            
            Export Date: 20 April 2021            
            Correspondence Address: Goaillard, J.-M.; UMR_S 1072, France; email: jean-marc.goaillard@univ-amu.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; dopamine, 51-61-6, 62-31-7; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; oxytocin, 50-56-6, 54577-94-5; parvalbumin, 56094-12-3, 83667-75-8; tyrosine 3 monooxygenase, 9036-22-0; vasopressin, 11000-17-2            
            Funding details: European Research Council, ERC, 616827            
            Funding text 1: Funding. This work was funded by the European Research Council (ERC CoG grant 616827 CanaloHmics to J-MG; supporting MT).
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Vu, Thyna
AU  - Gugustea, Radu
AU  - Leung, L. Stan
TI  - Long-term potentiation of the nucleus reuniens and entorhinal cortex to CA1 distal dendritic synapses in mice
JF  - BRAIN STRUCTURE & FUNCTION
J2  - BRAIN STRUCT FUNC
VL  - 225
PY  - 2020
IS  - 6
SP  - 1817
EP  - 1838
PG  - 22
SN  - 1863-2653
DO  - 10.1007/s00429-020-02095-6
UR  - https://m2.mtmt.hu/api/publication/31411701
ID  - 31411701
N1  - Funding Agency and Grant Number: Canadian Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada [1037-2013]; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MOP-15685]
            Funding text: Funded by operating Grants from the Canadian Natural Sciences and Engineering Research Council (1037-2013) and Canadian Institutes of Health Research (CIHR) MOP-15685 (to LSL).
Graduate Program in Neuroscience, The University of Western Ontario, London, ON N6A5C1, Canada            
            Department of Physiology and Pharmacology, The University of Western Ontario, London, ON N6A5C1, Canada            
            Export Date: 4 February 2021            
            Correspondence Address: Leung, L.S.; Graduate Program in Neuroscience, Canada; email: sleung@uwo.ca
Graduate Program in Neuroscience, The University of Western Ontario, London, ON N6A5C1, Canada            
            Department of Physiology and Pharmacology, The University of Western Ontario, London, ON N6A5C1, Canada            
            Cited By :2            
            Export Date: 13 April 2021            
            Correspondence Address: Leung, L.S.; Graduate Program in Neuroscience, Canada; email: sleung@uwo.ca            
            Funding details: Canadian Institutes of Health Research, CIHR, MOP-15685            
            Funding details: Natural Sciences and Engineering Research Council of Canada, NSERC, 1037-2013            
            Funding text 1: Funded by operating Grants from the Canadian Natural Sciences and Engineering Research Council (1037-2013) and Canadian Institutes of Health Research (CIHR) MOP-15685 (to LSL). Acknowledgements
Graduate Program in Neuroscience, The University of Western Ontario, London, ON N6A5C1, Canada            
            Department of Physiology and Pharmacology, The University of Western Ontario, London, ON N6A5C1, Canada            
            Cited By :3            
            Export Date: 20 April 2021            
            Correspondence Address: Leung, L.S.; Graduate Program in Neuroscience, Canada; email: sleung@uwo.ca            
            Funding details: Canadian Institutes of Health Research, CIHR, MOP-15685            
            Funding details: Natural Sciences and Engineering Research Council of Canada, NSERC, 1037-2013            
            Funding text 1: Funded by operating Grants from the Canadian Natural Sciences and Engineering Research Council (1037-2013) and Canadian Institutes of Health Research (CIHR) MOP-15685 (to LSL). Acknowledgements
AB  - The present study investigated the short-term and long-term synaptic plasticity of excitatory synapses formed by the nucleus reuniens (RE) and entorhinal cortex (EC) on the distal apical dendrites of CA1 pyramidal cells. RE-CA1 synapses are implicated in memory involving the hippocampus and medial prefrontal cortex. Current source density (CSD) analysis was used to identify excitatory and inhibitory currents following stimulation of RE or medial perforant path (MPP) in urethane-anesthetized mice in vivo. At the distal apical dendrites, RE evoked an initial excitatory sink followed by inhibitory sources at short (similar to 30 ms) and long (150-200 ms) latencies, and often showing gamma (25-40 Hz) oscillations. Both RE-evoked and spontaneous gamma-frequency local field potentials displayed the same CSD depth profile. Paired-pulse facilitation (PPF) of the distal excitatory sink at 20-200 ms interpulse intervals was observed following RE stimulation, generally higher than that following MPP stimulation. Theta-frequency burst stimulation (TBS) of RE induced input-specific long-term potentiation (LTP) at the distal dendritic CA1 synapses, accompanied by reduction of PPF. After TBS of the MPP, the MPP-CA1 distal dendritic synapse could manifest LTP or long-term depression, but the non-tetanized RE-CA1 synapse was typically potentiated. Heterosynaptic potentiation of the RE to CA1 distal synapses may occur after repeated activity of EC afferents, or spread of MPP stimulus currents to coursing RE afferents. The results indicate a propensity of RE-CA1 distal excitatory synapses to show PPF, LTP and gamma oscillations, all of which may participate in memory processing by RE and EC.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - German, Allison L.
AU  - Pierce, Spencer R.
AU  - Senneff, Thomas C.
AU  - Burbridge, Ariel B.
AU  - Steinbach, Joe Henry
AU  - Akk, Gustav
TI  - Steady-state activation and modulation of the synaptic-type alpha 1 beta 2 gamma 2L GABA(A) receptor by combinations of physiological and clinical ligands
JF  - PHYSIOLOGICAL REPORTS
J2  - PHYSIOL REPORTS
VL  - 7
PY  - 2019
IS  - 18
PG  - 13
SN  - 2051-817X
DO  - 10.14814/phy2.14230
UR  - https://m2.mtmt.hu/api/publication/30894033
ID  - 30894033
N1  - Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, United States            
            Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, United States            
            Cited By :2            
            Export Date: 20 May 2020            
            Correspondence Address: Akk, G.; Department of Anesthesiology, Washington University School of MedicineUnited States; email: akk@morpheus.wustl.edu            
            Chemicals/CAS: brexanolone, 516-54-1; pregnenolone sulfate, 1247-64-9; propofol, 2078-54-8; taurine, 107-35-7
Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, United States            
            Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, United States            
            Cited By :5            
            Export Date: 13 April 2021            
            Correspondence Address: Akk, G.; Department of Anesthesiology, United States; email: akk@morpheus.wustl.edu            
            Chemicals/CAS: brexanolone, 516-54-1; pregnenolone sulfate, 1247-64-9; propofol, 2078-54-8; taurine, 107-35-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; pregnenolone, 145-13-1; Anesthetics, Intravenous; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Ligands; Pregnenolone; pregnenolone sulfate; Propofol; Receptors, GABA-A            
            Funding details: National Institute of General Medical Sciences, NIGMS, R01GM108580            
            Funding details: Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis            
            Funding text 1: Funding information This work was supported by the National Institutes of Health National Institute of General Medical Sciences [Grant GM108580]; and funds from the Taylor Family Institute for Innovative Psychiatric Research.
Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, United States            
            Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO, United States            
            Cited By :5            
            Export Date: 20 April 2021            
            Correspondence Address: Akk, G.; Department of Anesthesiology, United States; email: akk@morpheus.wustl.edu            
            Chemicals/CAS: brexanolone, 516-54-1; pregnenolone sulfate, 1247-64-9; propofol, 2078-54-8; taurine, 107-35-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; pregnenolone, 145-13-1; Anesthetics, Intravenous; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Ligands; Pregnenolone; pregnenolone sulfate; Propofol; Receptors, GABA-A            
            Funding details: National Institute of General Medical Sciences, NIGMS, R01GM108580            
            Funding details: Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine in St. Louis            
            Funding text 1: Funding information This work was supported by the National Institutes of Health National Institute of General Medical Sciences [Grant GM108580]; and funds from the Taylor Family Institute for Innovative Psychiatric Research.
AB  - The synaptic alpha 1 beta 2 gamma 2 GABA(A) receptor is activated phasically by presynaptically released GABA. The receptor is considered to be inactive between synaptic events when exposed to ambient GABA because of its low resting affinity to the transmitter. We tested the hypothesis that a combination of physiological and/or clinical positive allosteric modulators of the GABA(A) receptor with ambient GABA generates measurable steady-state activity. Recombinant alpha 1 beta 2 gamma 2L GABA(A) receptors were expressed in Xenopus oocytes and activated by combinations of low concentrations of orthosteric (GABA, taurine) and allosteric (the steroid allopregnanolone, the anesthetic propofol) agonists, in the absence and presence of the inhibitory steroid pregnenolone sulfate. Steady-state activity was analyzed using the three-state cyclic Resting-Active-Desensitized model. We estimate that the steady-state open probability of the synaptic alpha 1 beta 2 gamma 2L GABA(A) receptor in the presence of ambient GABA (1 mu mol/L), taurine (10 mu mol/L), and physiological levels of allopregnanolone (0.01 mu mol/L) and pregnenolone sulfate (0.1 mu mol/L) is 0.008. Coapplication of a clinical concentration of propofol (1 mu mol/L) increases the steady-state open probability to 0.03. Comparison of total charge transfer for phasic and tonic activity indicates that steady-state activity can contribute strongly (similar to 20 to >99%) to integrated activity from the synaptic GABA(A) receptor.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Nie, H.
AU  - Bai, Z.
AU  - Li, Z.
AU  - Yan, L.
AU  - Chen, X.-X.
TI  - Intravenous lipid emulsion modifies synaptic transmission in hippocampal CA1 pyramidal neurons after bupivacaine-induced central nervous system toxicity
JF  - JOURNAL OF NEUROCHEMISTRY
J2  - J NEUROCHEM
VL  - 154
PY  - 2019
IS  - 2
SP  - 144
EP  - 157
PG  - 14
SN  - 0022-3042
DO  - 10.1111/jnc.14924
UR  - https://m2.mtmt.hu/api/publication/31318277
ID  - 31318277
N1  - Department of Anesthesiology, General Hospital of Ning Xia Medical University, Yin Chuan, China            
            Institute of Brain Sciences, YICHUANG Institute of Bio-Industry, Beijing, China            
            Export Date: 20 May 2020            
            CODEN: JONRA            
            Correspondence Address: Chen, X.-X.; Department of Anesthesiology, General Hospital of Ning Xia Medical UniversityChina; email: nh.6@qq.com            
            Funding details: 81560305            
            Funding text 1: This study was supported by grants from the National Natural Science Foundation (China; 81560305). The authors thank Li Yan PhD and ICE Bioscience Inc (Beijing, China) for providing experimental equipment and technology.
Department of Anesthesiology, General Hospital of Ning Xia Medical University, Yin Chuan, China            
            Institute of Brain Sciences, YICHUANG Institute of Bio-Industry, Beijing, China            
            Export Date: 13 April 2021            
            CODEN: JONRA            
            Correspondence Address: Chen, X.-X.; Department of Anesthesiology, China; email: nh.6@qq.com            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; bupivacaine, 18010-40-7, 2180-92-9, 55750-21-5, 38396-39-3; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; Anesthetics, Local; Bupivacaine; Fat Emulsions, Intravenous            
            Manufacturers: Kelun, China            
            Funding details: National Natural Science Foundation of China, NSFC, 81560305            
            Funding text 1: This study was supported by grants from the National Natural Science Foundation (China; 81560305). The authors thank Li Yan PhD and ICE Bioscience Inc (Beijing, China) for providing experimental equipment and technology. All experiments were conducted in compliance with the ARRIVE guidelines.            
            Funding text 2: This study was supported by grants from the National Natural Science Foundation (China; 81560305). The authors thank Li Yan PhD and ICE Bioscience Inc (Beijing, China) for providing experimental equipment and technology.
Department of Anesthesiology, General Hospital of Ning Xia Medical University, Yin Chuan, China            
            Institute of Brain Sciences, YICHUANG Institute of Bio-Industry, Beijing, China            
            Export Date: 20 April 2021            
            CODEN: JONRA            
            Correspondence Address: Chen, X.-X.; Department of Anesthesiology, China; email: nh.6@qq.com            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; bupivacaine, 18010-40-7, 2180-92-9, 55750-21-5, 38396-39-3; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; Anesthetics, Local; Bupivacaine; Fat Emulsions, Intravenous            
            Manufacturers: Kelun, China            
            Funding details: National Natural Science Foundation of China, NSFC, 81560305            
            Funding text 1: This study was supported by grants from the National Natural Science Foundation (China; 81560305). The authors thank Li Yan PhD and ICE Bioscience Inc (Beijing, China) for providing experimental equipment and technology. All experiments were conducted in compliance with the ARRIVE guidelines.            
            Funding text 2: This study was supported by grants from the National Natural Science Foundation (China; 81560305). The authors thank Li Yan PhD and ICE Bioscience Inc (Beijing, China) for providing experimental equipment and technology.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Booker, SA
AU  - Vida, I
TI  - Morphological diversity and connectivity of hippocampal interneurons
JF  - CELL AND TISSUE RESEARCH
J2  - CELL TISSUE RES
VL  - 373
PY  - 2018
IS  - 3
SP  - 619
EP  - 641
PG  - 23
SN  - 0302-766X
DO  - 10.1007/s00441-018-2882-2
UR  - https://m2.mtmt.hu/api/publication/27658357
ID  - 27658357
N1  - \n Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany \n Cited By :2 \n Export Date: 13 November 2018 \n CODEN: CTSRC \n Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk \n Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8 \n Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143 \n Funding details: SAB \n Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
\n Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany \n Cited By :2 \n Export Date: 18 November 2018 \n CODEN: CTSRC \n Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk \n Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8 \n Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143 \n Funding details: SAB \n Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
\n Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany \n Cited By :2 \n Export Date: 19 November 2018 \n CODEN: CTSRC \n Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk \n Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8 \n Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143 \n Funding details: SAB \n Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
\n Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom \n Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany \n Cited By :2 \n Export Date: 25 November 2018 \n CODEN: CTSRC \n Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk \n Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8 \n Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143 \n Funding details: SAB \n Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Funding Agency and Grant Number: Deutsche Forschungsgemeinschaft (IV) [FOR 2143]; Simons Initiative for the Developing Brain (SAB)
            Funding text: This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :2            
            Export Date: 9 January 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :2            
            Export Date: 24 May 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 25 July 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 29 July 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 3 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 4 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 17 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 20 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 21 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 23 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 24 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 28 August 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :3            
            Export Date: 3 September 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :5            
            Export Date: 15 October 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :5            
            Export Date: 14 November 2019            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :9            
            Export Date: 24 February 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :9            
            Export Date: 6 March 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :9            
            Export Date: 12 March 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :12            
            Export Date: 15 April 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :12            
            Export Date: 24 April 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :13            
            Export Date: 11 May 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :13            
            Export Date: 15 May 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :14            
            Export Date: 20 May 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :14            
            Export Date: 22 May 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :14            
            Export Date: 24 May 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :14            
            Export Date: 25 May 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :14            
            Export Date: 30 May 2020            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :26            
            Export Date: 1 January 2021            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, University of EdinburghUnited Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :30            
            Export Date: 18 March 2021            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, United Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding details: Simons Initiative for the Developing Brain, SIDB            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :30            
            Export Date: 19 March 2021            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, United Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding details: Simons Initiative for the Developing Brain, SIDB            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :30            
            Export Date: 23 March 2021            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, United Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding details: Simons Initiative for the Developing Brain, SIDB            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :30            
            Export Date: 24 March 2021            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, United Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; gamma-Aminobutyric Acid; Glutamic Acid            
            Funding details: Deutsche Forschungsgemeinschaft, DFG, FOR 2143            
            Funding details: Simons Initiative for the Developing Brain, SIDB            
            Funding text 1: Funding This study was funded by Deutsche Forschungsgemeinschaft (IV; FOR 2143) and the Simons Initiative for the Developing Brain (SAB).
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Simons Initiative for the Developing Brain, University of Edinburgh, Edinburgh, EH8 9XD, United Kingdom            
            Institute for Integrative Neuroanatomy, Charité - Universitätmedizin Berlin, Berlin, Germany            
            Cited By :32            
            Export Date: 31 March 2021            
            CODEN: CTSRC            
            Correspondence Address: Booker, S.A.; Centre for Discovery Brain Sciences, United Kingdom; email: sbooker@exseed.ed.ac.uk            
            Chemicals/CAS: cholecystok
AB  - The mammalian forebrain is constructed from ensembles of neurons that form local microcircuits giving rise to the exquisite cognitive tasks the mammalian brain can perform. Hippocampal neuronal circuits comprise populations of relatively homogenous excitatory neurons, principal cells and exceedingly heterogeneous inhibitory neurons, the interneurons. Interneurons release GABA from their axon terminals and are capable of controlling excitability in every cellular compartment of principal cells and interneurons alike; thus, they provide a brake on excess activity, control the timing of neuronal discharge and provide modulation of synaptic transmission. The dendritic and axonal morphology of interneurons, as well as their afferent and efferent connections within hippocampal circuits, is central to their ability to differentially control excitability, in a cell-type- and compartment-specific manner. This review aims to provide an up-to-date compendium of described hippocampal interneuron subtypes, with respect to their morphology, connectivity, neurochemistry and physiology, a full understanding of which will in time help to explain the rich diversity of neuronal function. © 2018, The Author(s).
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Hamilton, DJ
AU  - Wheeler, DW
AU  - White, CM
AU  - Rees, CL
AU  - Komendantov, AO
AU  - Bergamino, M
AU  - Ascoli, GA
TI  - Name-calling in the hippocampus (and beyond): coming to terms with neuron types and properties
JF  - BRAIN INFORMATICS
J2  - BRAIN INFORMATICS
VL  - 4
PY  - 2017
IS  - 1
SN  - 2198-4018
DO  - 10.1007/s40708-016-0053-3
UR  - https://m2.mtmt.hu/api/publication/27660903
ID  - 27660903
N1  - Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :6            
            Export Date: 29 July 2019            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :6            
            Export Date: 17 August 2019            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :6            
            Export Date: 20 August 2019            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :6            
            Export Date: 21 August 2019            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :6            
            Export Date: 24 August 2019            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :6            
            Export Date: 28 August 2019            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :7            
            Export Date: 14 November 2019            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :8            
            Export Date: 12 March 2020            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :10            
            Export Date: 15 April 2020            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :10            
            Export Date: 18 May 2020            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :10            
            Export Date: 20 May 2020            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :10            
            Export Date: 24 May 2020            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :10            
            Export Date: 26 May 2020            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :10            
            Export Date: 30 May 2020            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason UniversityUnited States; email: ascoli@gmu.edu
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :12            
            Export Date: 18 March 2021            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Funding details: National Science Foundation, NSF, 1302256
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :12            
            Export Date: 23 March 2021            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Funding details: National Science Foundation, NSF, 1302256
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :13            
            Export Date: 31 March 2021            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Funding details: National Science Foundation, NSF, 1302256
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :13            
            Export Date: 6 April 2021            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Funding details: National Science Foundation, NSF, 1302256
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :13            
            Export Date: 7 April 2021            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Funding details: National Science Foundation, NSF, 1302256
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :13            
            Export Date: 13 April 2021            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Funding details: National Science Foundation, NSF, 1302256
Center for Neural Informatics, Structure, & Plasticity, Molecular Neuroscience Dept., Krasnow Institute for Advanced Study, MS2A1, George Mason University, Fairfax, VA 22030-4444, United States            
            Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136, United States            
            Cited By :13            
            Export Date: 20 April 2021            
            Correspondence Address: Ascoli, G.A.; Center for Neural Informatics, United States; email: ascoli@gmu.edu            
            Funding details: National Science Foundation, NSF, 1302256
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Pelkey, Kenneth A
AU  - Chittajallu, Ramesh
AU  - Craig, Michael T
AU  - Tricoire, Ludovic
AU  - Wester, Jason C
AU  - McBain, Chris J
TI  - HIPPOCAMPAL GABAERGIC INHIBITORY INTERNEURONS
JF  - PHYSIOLOGICAL REVIEWS
J2  - PHYSIOL REV
VL  - 97
PY  - 2017
IS  - 4
SP  - 1619
EP  - 1747
PG  - 129
SN  - 0031-9333
DO  - 10.1152/physrev.00007.2017
UR  - https://m2.mtmt.hu/api/publication/27352373
ID  - 27352373
N1  - Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :42            
            Export Date: 24 May 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :48            
            Export Date: 25 July 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :48            
            Export Date: 26 July 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :48            
            Export Date: 29 July 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :48            
            Export Date: 1 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :48            
            Export Date: 3 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 4 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 10 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 11 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 14 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 16 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 17 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 18 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 20 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :49            
            Export Date: 21 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :50            
            Export Date: 23 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :50            
            Export Date: 24 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Funding text 2: The work was supported by a National Institute of Child Health and Human Development Intramural Research Award (to C. J. McBain).
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States            
            Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom            
            Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France            
            Cited By :50            
            Export Date: 27 August 2019            
            CODEN: PHREA            
            Correspondence Address: McBain, C.J.; Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of HealthUnited States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid; Receptors, GABA            
            Funding details: National Institutes of Health            
            Funding details: University of Exeter            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development            
            Funding details: Institut National de la Santé et de la Recherche Médicale            
            Funding details: College of Natural Resources and Sciences, Humboldt State University            
            Funding details: National Institute of Child Health and Human Development            
            Funding text 1: Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland; Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Hatherly Laboratories, University of Exeter, Exeter, United Kingdom; and Sorbonne Universités, UPMC University of Paris, INSERM, CNRS, Neurosciences Paris Seine-Institut de Biologie Paris Seine, Paris, France
Porter Neuroscience Center, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of He
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Szabo, GG
AU  - Du, X
AU  - Oijala, M
AU  - Varga, Csaba
AU  - Parent, JM
AU  - Soltesz, I
TI  - Extended Interneuronal Network of the Dentate Gyrus
JF  - CELL REPORTS
J2  - CELL REP
VL  - 20
PY  - 2017
IS  - 6
SP  - 1262
EP  - 1268
PG  - 7
SN  - 2211-1247
DO  - 10.1016/j.celrep.2017.07.042
UR  - https://m2.mtmt.hu/api/publication/3255790
ID  - 3255790
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Yang, Zhilai
AU  - Chen, Na
AU  - Ge, Rongjing
AU  - Qian, Hao
AU  - Wang, Jin-Hui
TI  - Functional compatibility between Purkinje cell axon branches and their target neurons in the cerebellum
JF  - ONCOTARGET
J2  - ONCOTARGET
VL  - 8
PY  - 2017
IS  - 42
SP  - 72424
EP  - 72437
PG  - 14
SN  - 1949-2553
DO  - 10.18632/oncotarget.19770
UR  - https://m2.mtmt.hu/api/publication/26937496
ID  - 26937496
N1  - Cited By :7            
            Export Date: 20 March 2021            
            Correspondence Address: Wang, J.-H.; Institute of Biophysics, China; email: jhw@sun5.ibp.ac.cn            
            Funding details: National Key Research and Development Program of China, NKRDPC            
            Funding text 1: We thank Dr. David Linden’s critical reading and suggestions before submission. This study is funded by the grants from National Basic Research Program
Cited By :7            
            Export Date: 6 April 2021            
            Correspondence Address: Wang, J.-H.; Institute of Biophysics, China; email: jhw@sun5.ibp.ac.cn            
            Funding details: National Key Research and Development Program of China, NKRDPC            
            Funding text 1: We thank Dr. David Linden’s critical reading and suggestions before submission. This study is funded by the grants from National Basic Research Program
Cited By :7            
            Export Date: 13 April 2021            
            Correspondence Address: Wang, J.-H.; Institute of Biophysics, China; email: jhw@sun5.ibp.ac.cn            
            Funding details: National Key Research and Development Program of China, NKRDPC            
            Funding text 1: We thank Dr. David Linden’s critical reading and suggestions before submission. This study is funded by the grants from National Basic Research Program
Cited By :7            
            Export Date: 20 April 2021            
            Correspondence Address: Wang, J.-H.; Institute of Biophysics, China; email: jhw@sun5.ibp.ac.cn            
            Funding details: National Key Research and Development Program of China, NKRDPC            
            Funding text 1: We thank Dr. David Linden’s critical reading and suggestions before submission. This study is funded by the grants from National Basic Research Program
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bezaire, Marianne J
AU  - Raikov, Ivan
AU  - Burk, Kelly
AU  - Vyas, Dhrumil
AU  - Soltesz, Ivan
TI  - Interneuronal mechanisms of hippocampal theta oscillations in a full-scale model of the rodent CA1 circuit
JF  - ELIFE
J2  - ELIFE
VL  - 5
PY  - 2016
PG  - 106
SN  - 2050-084X
DO  - 10.7554/eLife.18566
UR  - https://m2.mtmt.hu/api/publication/27029396
ID  - 27029396
N1  - Megjegyzés-27031739
OA gold
Megjegyzés-27196780
N1 Funding details: 1458495
N1 Funding details: ACI-1053575, NSF, National Science Foundation
N1 Funding details: NMCSD, Naval Medical Center San Diego
N1 Funding details: NIH, National Institutes of Health
N1 Funding details: 1146949
N1 Funding details: ACI-1238993, University of Texas at Austin
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: UIUC, University of Illinois at Urbana-Champaign
N1 Funding details: NSF, National Science Foundation
N1 Funding text: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Megjegyzés-27433083
N1 Funding details: UofI, University of Illinois
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: R01-NS11613
N1 Funding details: 1458495
N1 Funding details: MH
N1 Funding details: UC, University of California
N1 Funding details: ACI-1053575, NSF, National Science Foundation
N1 Funding details: 1458840
N1 Funding details: 1146949
N1 Funding details: OCI-0725070, University of Texas at Austin
N1 Funding details: ACI-1238993, University of Texas at Austin
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: UIUC, University of Illinois at Urbana-Champaign
N1 Funding text: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Megjegyzés-27479390
N1 Funding details: UofI, University of Illinois
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: R01-NS11613
N1 Funding details: 1458495
N1 Funding details: MH
N1 Funding details: UC, University of California
N1 Funding details: ACI-1053575, NSF, National Science Foundation
N1 Funding details: 1458840
N1 Funding details: 1146949
N1 Funding details: OCI-0725070, University of Texas at Austin
N1 Funding details: ACI-1238993, University of Texas at Austin
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: UIUC, University of Illinois at Urbana-Champaign
N1 Funding text: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Megjegyzés-27612997
N1 Funding details: UofI, University of Illinois
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: R01-NS11613
N1 Funding details: 1458495
N1 Funding details: MH
N1 Funding details: UC, University of California
N1 Funding details: ACI-1053575, NSF, National Science Foundation
N1 Funding details: 1458840
N1 Funding details: 1146949
N1 Funding details: OCI-0725070, University of Texas at Austin
N1 Funding details: ACI-1238993, University of Texas at Austin
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: UIUC, University of Illinois at Urbana-Champaign
N1 Funding text: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Megjegyzés-27637622
N1 Funding details: UofI, University of Illinois
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: R01-NS11613
N1 Funding details: 1458495
N1 Funding details: MH
N1 Funding details: UC, University of California
N1 Funding details: ACI-1053575, NSF, National Science Foundation
N1 Funding details: 1458840
N1 Funding details: 1146949
N1 Funding details: OCI-0725070, University of Texas at Austin
N1 Funding details: ACI-1238993, University of Texas at Austin
N1 Funding details: NCSA, National Centre for Supercomputing Applications
N1 Funding details: UIUC, University of Illinois at Urbana-Champaign
N1 Funding text: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :23            
            Export Date: 3 August 2019            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com            
            Funding details: 1458840, 1146949            
            Funding details: University of Illinois            
            Funding details: Harry Mangalam            
            Funding details: R01-NS11613, 1458495, MH, TC            
            Funding details: University of Texas at Austin, OCI-0725070, ACI-1238993            
            Funding details: University of California            
            Funding details: National Science Foundation, ACI-1053575            
            Funding details: National Institutes of Health            
            Funding details: National Centre for Supercomputing Applications, NCSA            
            Funding details: National Science Foundation            
            Funding details: University of Illinois at Urbana-Champaign            
            Funding text 1: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :25            
            Export Date: 24 August 2019            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com            
            Funding details: 1458840, 1146949            
            Funding details: University of Illinois            
            Funding details: Harry Mangalam            
            Funding details: R01-NS11613, 1458495, MH, TC            
            Funding details: University of Texas at Austin, OCI-0725070, ACI-1238993            
            Funding details: University of California            
            Funding details: National Science Foundation, ACI-1053575            
            Funding details: National Institutes of Health            
            Funding details: National Centre for Supercomputing Applications, NCSA            
            Funding details: National Science Foundation            
            Funding details: University of Illinois at Urbana-Champaign            
            Funding text 1: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :25            
            Export Date: 3 September 2019            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :32            
            Export Date: 14 November 2019            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com            
            Funding details: 1458840, 1146949            
            Funding details: University of Illinois            
            Funding details: Harry Mangalam            
            Funding details: R01-NS11613, 1458495, MH, TC            
            Funding details: University of Texas at Austin, OCI-0725070, ACI-1238993            
            Funding details: University of California            
            Funding details: National Science Foundation, ACI-1053575            
            Funding details: National Institutes of Health            
            Funding details: National Centre for Supercomputing Applications, NCSA            
            Funding details: National Science Foundation            
            Funding details: University of Illinois at Urbana-Champaign            
            Funding text 1: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :36            
            Export Date: 24 February 2020            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com            
            Funding details: 1458840, 1146949            
            Funding details: National Science Foundation, NSF, ACI-1053575            
            Funding details: University of Illinois, UofI            
            Funding details: National Centre for Supercomputing Applications, NCSA            
            Funding details: National Institutes of Health, NIH            
            Funding details: R01-NS11613, 1458495            
            Funding details: University of Texas at Austin, OCI-0725070, ACI-1238993            
            Funding details: University of Illinois at Urbana-Champaign, UIUC            
            Funding details: National Science Foundation, NSF            
            Funding text 1: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :37            
            Export Date: 12 March 2020            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com            
            Funding details: 1458840, 1146949            
            Funding details: National Science Foundation, NSF, ACI-1053575            
            Funding details: University of Illinois, UofI            
            Funding details: National Centre for Supercomputing Applications, NCSA            
            Funding details: National Institutes of Health, NIH            
            Funding details: R01-NS11613, 1458495            
            Funding details: University of Texas at Austin, OCI-0725070, ACI-1238993            
            Funding details: University of Illinois at Urbana-Champaign, UIUC            
            Funding details: National Science Foundation, NSF            
            Funding text 1: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :40            
            Export Date: 15 April 2020            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com            
            Funding details: 1458840, 1146949            
            Funding details: National Science Foundation, NSF, ACI-1053575            
            Funding details: University of Illinois, UofI            
            Funding details: National Centre for Supercomputing Applications, NCSA            
            Funding details: National Institutes of Health, NIH            
            Funding details: R01-NS11613, 1458495            
            Funding details: University of Texas at Austin, OCI-0725070, ACI-1238993            
            Funding details: University of Illinois at Urbana-Champaign, UIUC            
            Funding details: National Science Foundation, NSF            
            Funding text 1: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers and programs operating under their own grants to make this work possible. Immeasurable support was provided by NEURON developers Michael Hines and Ted Carnevale under NIH NINDS grant R01-NS11613 (to MH) and NSF grant 1458495 (to TC). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1053575; the project was supported by XSEDE Research and Startup Allocations to the authors (see funding information listed separately) and via the Neuroscience Gateway with the support of NSF grants 1458840 and 1146949 (to Majumdar et al.). The authors acknowledge the Texas Advanced Computing Center (TACC) at The University of Texas at Austin for providing high performance computing resources that have contributed to the research results reported within this paper (http://www.tacc.utexas.edu). Additionally, this research is part of the Blue Waters sustained-petascale computing project, which is supported by the National Science Foundation (awards OCI-0725070 and ACI-1238993) and the state of Illinois. Blue Waters is a joint effort of the University of Illinois at Urbana-Champaign and its National Center for Supercomputing Applications (NCSA). Parallel supercomputers used in this work include: Blue Waters, owned by the University of Illinois and NCSA; Stampede and the retired Ranger, owned by the University of Texas? Texas Advanced Computing Center (TACC); Trestles and Comet, owned by the San Diego Supercomputing Center; University of California at Irvine?s High Performance Computer and the retired Broadcom Distributed Unified Cluster. We would like to thank the University of Texas? Texas Advanced Computing Center team, the San Diego Supercomputing Center and Neuroscience Gateway teams (especially Glenn Lockwood, Amitava Majumdar, Subhashini Sivagnanam, Mahidhar Tatineni, and Kenneth Yoshimoto), and UC Irvine?s HPC team (especially Joseph Farran and Harry Mangalam) for their excellent technical support throughout this work. We would also like to thank Padraig Gleeson, Andras Ecker, Tom Morse, and Jeff Teeters for assistance making our code and model results public, and Jesse Jackson and Sylvain Williams for the use of their spectrogram analysis script.
Department of Anatomy and Neurobiology, University of California, Irvine, United States            
            Department of Neurosurgery, Stanford University, Stanford, United States            
            Department of Psychological and Brain Sciences, Boston University, Boston, United States            
            Cited By :41            
            Export Date: 11 May 2020            
            Correspondence Address: Bezaire, M.J.; Department of Anatomy and Neurobiology, University of CaliforniaUnited States; email: marianne.bezaire@gmail.com            
            Funding details: 1458840, 1146949            
            Funding details: National Science Foundation, NSF, ACI-1053575            
            Funding details: University of Illinois, UofI            
            Funding details: National Centre for Supercomputing Applications, NCSA            
            Funding details: National Institutes of Health, NIH            
            Funding details: R01-NS11613, 1458495            
            Funding details: University of Texas at Austin, OCI-0725070, ACI-1238993            
            Funding details: University of Illinois at Urbana-Champaign, UIUC            
            Funding details: National Science Foundation, NSF            
            Funding text 1: In addition to the direct funding provided to the authors from NIH and NSF (listed separately), the authors wish to thank several researchers a
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Kohus, Zsolt
AU  - Káli, Szabolcs
AU  - Rovira Esteban, Laura
AU  - Schlingloff, Dániel
AU  - Papp, Orsolya
AU  - Freund, Tamás
AU  - Hájos, Norbert
AU  - Gulyás, Attila
TI  - Properties and dynamics of inhibitory synaptic communication within the CA3 microcircuits of pyramidal cells and interneurons expressing parvalbumin or cholecystokinin
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 594
PY  - 2016
IS  - 13
SP  - 3745
EP  - 3774
PG  - 30
SN  - 0022-3751
DO  - 10.1113/JP272231
UR  - https://m2.mtmt.hu/api/publication/3078169
ID  - 3078169
N1  - Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            János Szentágothai, PhD Program of Semmelweis University, Budapest, Hungary            
            Péter Pázmány Catholic University, Faculty of Information Technology, Budapest, Hungary            
            Cited By :31            
            Export Date: 19 May 2022            
            CODEN: JPHYA            
            Correspondence Address: Gulyás, A.I.; Institute of Experimental Medicine, Hungary; email: gulyas@koki.hu            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8            
            Funding details: Horizon 2020 Framework Programme, H2020, 720270
AB  - Different hippocampal activity patterns are determined primarily by the interaction of excitatory cells and different types of interneurons. To understand the mechanisms underlying the generation of different network dynamics the properties of synaptic transmission need to be uncovered. Perisomatic inhibition has been shown to be critical for the generation of sharp wave-ripples, gamma oscillations as well as pathological epileptic activities. Therefore, we decided to quantitatively and systematically characterize the temporal properties of the synaptic transmission between perisomatic inhibitory neurons and pyramidal cells in the CA3 area of mouse hippocampal slices, using action potential patterns recorded during physiological and pathological network states. PV+ and CCK+ interneurons had distinct intrinsic physiological features. Interneurons of the same type formed reciprocally connected subnetworks, while the connectivity between interneuron classes was sparse. The characteristics of unitary interactions depended on the identity of both synaptic partners, while the short-term plasticity of synaptic transmission depended mainly on the presynaptic cell type. PV+ interneurons showed frequency-dependent depression, while more complex dynamics characterized the output of CCK+ interneurons. We quantitatively captured the dynamics of transmission at these different types of connection with simple mathematical models, and described in detail the response to physiological and pathological discharge patterns. Our data suggest that the temporal propeties of PV+ interneuron transmission may contribute to sharp wave-ripple generation. These findings support the view that intrinsic and synaptic features of PV+ cells make them ideally suited for the generation of physiological network oscillations, while CCK+ cells implement more subtle, graded control in the hippocampus. This article is protected by copyright. All rights reserved.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Jahnke, Sven
AU  - Timme, Marc
AU  - Memmesheimer, Raoul-Martin
TI  - A Unified Dynamic Model for Learning, Replay, and Sharp-Wave/Ripples
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 35
PY  - 2015
IS  - 49
SP  - 16236
EP  - 16258
PG  - 23
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.3977-14.2015
UR  - https://m2.mtmt.hu/api/publication/26832257
ID  - 26832257
N1  - Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :20            
            Export Date: 23 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :20            
            Export Date: 28 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :21            
            Export Date: 14 November 2019            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :24            
            Export Date: 15 February 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :25            
            Export Date: 6 March 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :26            
            Export Date: 22 April 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :26            
            Export Date: 13 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :26            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :27            
            Export Date: 23 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :27            
            Export Date: 26 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :27            
            Export Date: 30 December 2020            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, Columbia University, Kolb Research Annex, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :28            
            Export Date: 17 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :28            
            Export Date: 19 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :28            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :28            
            Export Date: 30 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :28            
            Export Date: 7 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :28            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
Network Dynamics, Max Planck Institute for Dynamics and Self-Organization, Göttingen, 37077, Germany            
            Bernstein Center for Computational Neuroscience, Göttingen, 37077, Germany            
            Institute for Nonlinear Dynamics, Georg August University, Göttingen, 37077, Germany            
            Center for Theoretical Neuroscience, Columbia University, New York, NY 10032-2695, United States            
            Donders Institute for Brain, Cognition, and Behavior, Radboud University, Nijmegen, 6500, Netherlands            
            Cited By :28            
            Export Date: 20 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Memmesheimer, R.-M.; Center for Theoretical Neuroscience, 1051 Riverside Drive, United States; email: rm3354@cumc.columbia.edu
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Rubinstein, Moran
AU  - Westenbroek, Ruth E
AU  - Yu, Frank H
AU  - Jones, Christina J
AU  - Scheuer, Todd
AU  - Catterall, William A
TI  - Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome
JF  - NEUROBIOLOGY OF DISEASE
J2  - NEUROBIOL DIS
VL  - 73
PY  - 2015
SP  - 106
EP  - 117
PG  - 12
SN  - 0969-9961
DO  - 10.1016/j.nbd.2014.09.017
UR  - https://m2.mtmt.hu/api/publication/25863140
ID  - 25863140
N1  - Cited By :32            
            Export Date: 20 May 2020            
            CODEN: NUDIE            
            Correspondence Address: Catterall, W.A.; University of Washington, School of Medicine, Department of Pharmacology, Box 357280, United States            
            Chemicals/CAS: lidocaine, 137-58-6, 24847-67-4, 56934-02-2, 73-78-9; Lidocaine; NAV1.1 Voltage-Gated Sodium Channel; QX-314; Scn1a protein, mouse; Sodium Channel Blockers            
            Funding details: National Institutes of Health, NIH, R01NS25704            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS            
            Funding details: Simons Foundation, SF, 240243            
            Funding text 1: Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS25704 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also supported by the Simons Foundation under award number 240243 .
Cited By :40            
            Export Date: 6 April 2021            
            CODEN: NUDIE            
            Correspondence Address: Catterall, W.A.; University of Washington, School of Medicine, Department of Pharmacology, Box 357280, United States            
            Chemicals/CAS: lidocaine, 137-58-6, 24847-67-4, 56934-02-2, 73-78-9; Lidocaine; NAV1.1 Voltage-Gated Sodium Channel; QX-314; Scn1a protein, mouse; Sodium Channel Blockers            
            Funding details: National Institutes of Health, NIH            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025704            
            Funding details: Simons Foundation, SF, 240243            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, U54HD083091            
            Funding text 1: Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS25704 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also supported by the Simons Foundation under award number 240243 .
Cited By :40            
            Export Date: 13 April 2021            
            CODEN: NUDIE            
            Correspondence Address: Catterall, W.A.; University of Washington, School of Medicine, Department of Pharmacology, Box 357280, United States            
            Chemicals/CAS: lidocaine, 137-58-6, 24847-67-4, 56934-02-2, 73-78-9; Lidocaine; NAV1.1 Voltage-Gated Sodium Channel; QX-314; Scn1a protein, mouse; Sodium Channel Blockers            
            Funding details: National Institutes of Health, NIH            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025704            
            Funding details: Simons Foundation, SF, 240243            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, U54HD083091            
            Funding text 1: Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01NS25704 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also supported by the Simons Foundation under award number 240243 .
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Roy, Birbickram
AU  - Ali, Declan W
TI  - Multiple types of GABAA responses identified from zebrafish Mauthner cells
JF  - NEUROREPORT
J2  - NEUROREPORT
VL  - 25
PY  - 2014
IS  - 15
SP  - 1232
EP  - 1236
PG  - 5
SN  - 0959-4965
DO  - 10.1097/WNR.0000000000000258
UR  - https://m2.mtmt.hu/api/publication/25712723
ID  - 25712723
N1  - Cited By :6            
            Export Date: 20 May 2020            
            CODEN: NERPE            
            Correspondence Address: Ali, D.W.; Department of Biological Sciences, Biological Sciences Building, University of AlbertaCanada; email: declan.ali@ualberta.ca            
            Chemicals/CAS: Receptors, GABA-A; Zebrafish Proteins            
            Funding details: Natural Sciences and Engineering Research Council of Canada, NSERC
Cited By :7            
            Export Date: 13 April 2021            
            CODEN: NERPE            
            Correspondence Address: Ali, D.W.; Department of Biological Sciences, Canada; email: declan.ali@ualberta.ca            
            Chemicals/CAS: Receptors, GABA-A; Zebrafish Proteins            
            Funding details: Natural Sciences and Engineering Research Council of Canada, NSERC
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Tyan, Leonid
AU  - Chamberland, Simon
AU  - Magnin, Elise
AU  - Camire, Olivier
AU  - Francavilla, Ruggiero
AU  - David, Linda Suzanne
AU  - Deisseroth, Karl
AU  - Topolnik, Lisa
TI  - Dendritic Inhibition Provided by Interneuron-Specific Cells Controls the Firing Rate and Timing of the Hippocampal Feedback Inhibitory Circuitry
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 34
PY  - 2014
IS  - 13
SP  - 4534
EP  - 4547
PG  - 14
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.3813-13.2014
UR  - https://m2.mtmt.hu/api/publication/25863192
ID  - 25863192
N1  - Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :38            
            Export Date: 17 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :38            
            Export Date: 21 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :38            
            Export Date: 24 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :38            
            Export Date: 28 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :38            
            Export Date: 14 November 2019            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :39            
            Export Date: 24 February 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :39            
            Export Date: 12 March 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :42            
            Export Date: 18 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :42            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :42            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :42            
            Export Date: 25 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :42            
            Export Date: 26 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :42            
            Export Date: 30 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :53            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :55            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :55            
            Export Date: 7 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :55            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
Axis of Cellular and Molecular Neuroscience, Institut Universitaire en Santé Mentale de Québec, Department of Biochemistry, Microbiology and Bio-informatics, Université Laval, QC, G1J 2G3, Canada            
            Department of Bioengineering, Stanford University, Stanford, CA 94305-5444, United States            
            Cited By :56            
            Export Date: 23 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC, PQ, G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: vasoactive intestinal polypeptide, 37221-79-7
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Berzhanskaya, J
AU  - Chernyy, N
AU  - Gluckman, BJ
AU  - Schiff, SJ
AU  - Ascoli, GA
TI  - Modulation of hippocampal rhythms by subthreshold electric fields and network topology
JF  - JOURNAL OF COMPUTATIONAL NEUROSCIENCE
J2  - J COMPUT NEUROSCI
VL  - 34
PY  - 2013
IS  - 3
SP  - 369
EP  - 389
PG  - 21
SN  - 0929-5313
DO  - 10.1007/s10827-012-0426-4
UR  - https://m2.mtmt.hu/api/publication/31269855
ID  - 31269855
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bezaire, MJ
AU  - Soltesz, Ivan
TI  - Quantitative assessment of CA1 local circuits: Knowledge base for interneuron-pyramidal cell connectivity
JF  - HIPPOCAMPUS
J2  - HIPPOCAMPUS
VL  - 23
PY  - 2013
IS  - 9
SP  - 751
EP  - 785
PG  - 35
SN  - 1050-9631
DO  - 10.1002/hipo.22141
UR  - https://m2.mtmt.hu/api/publication/2941489
ID  - 2941489
N1  - Megjegyzés-23456077
FN: Thomson Reuters Web of Knowledge
Megjegyzés-23486321
FN: Thomson Reuters Web of Knowledge
Megjegyzés-23641154
N1 Funding Details: NS35915, NIH, National Institutes of Health
N1 Funding Details: DGE-0808392, NSF, National Science Foundation
Megjegyzés-24488367
N1 Funding Details: NS35915, NIH, National Institutes of Health
N1 Funding Details: DGE-0808392, NSF, National Science Foundation
Megjegyzés-24488472
N1 Funding Details: NS35915, NIH, National Institutes of Health
N1 Funding Details: DGE-0808392, NSF, National Science Foundation
Megjegyzés-25476642
N1 Funding Details: NS35915, NIH, National Institutes of Health
N1 Funding Details: DGE-0808392, NSF, National Science Foundation
Megjegyzés-26303976
N1 Funding details: NS35915, NIH, National Institutes of Health
N1 Funding details: DGE-0808392, NSF, National Science Foundation
AB  - In this work, through a detailed literature review, data-mining, and extensive calculations, we provide a current, quantitative estimate of the cellular and synaptic constituents of the CA1 region of the rat hippocampus. Beyond estimating the cell numbers of GABAergic interneuron types, we calculate their convergence onto CA1 pyramidal cells and compare it with the known input synapses on CA1 pyramidal cells. The convergence calculation and comparison are also made for excitatory inputs to CA1 pyramidal cells. In addition, we provide a summary of the excitatory and inhibitory convergence onto interneurons. The quantitative knowledge base assembled and synthesized here forms the basis for data-driven, large-scale computational modeling efforts. Additionally, this work highlights specific instances where the available data are incomplete, which should inspire targeted experimental projects toward a more complete quantification of the CA1 neurons and their connectivity. (c) 2013 Wiley Periodicals, Inc.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Zemankovics, Rita
AU  - Veres, Judit
AU  - Oren, I
AU  - Hájos, Norbert
TI  - Feedforward Inhibition Underlies the Propagation of Cholinergically Induced Gamma Oscillations from Hippocampal CA3 to CA1.
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 33
PY  - 2013
IS  - 30
SP  - 12337
EP  - 12351
PG  - 15
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.3680-12.2013
UR  - https://m2.mtmt.hu/api/publication/2369864
ID  - 2369864
N1  - Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450, Budapest, Hungary            
            Centre for Cognitive and Neural Systems, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom            
            Cited By :56            
            Export Date: 8 June 2023            
            CODEN: JNRSD            
            Correspondence Address: Hájos, N.; Institute of Experimental Medicine, , Budapest H-1450, Hungary; email: hajos@koki.hu            
            Chemicals/CAS: carbachol, 462-58-8, 51-83-2; Carbachol, 51-83-2; Cholinergic Agonists
AB  - Gamma frequency (30-80 Hz) oscillations are implicated in memory processing. Such rhythmic activity can be generated intrinsically in the CA3 region of the hippocampus from where it can propagate to the CA1 area. To uncover the synaptic mechanisms underlying the intrahippocampal spread of gamma oscillations, we recorded local field potentials, as well as action potentials and synaptic currents in anatomically identified CA1 and CA3 neurons during carbachol-induced gamma oscillations in mouse hippocampal slices. The firing of the vast majority of CA1 neurons and all CA3 neurons was phase-coupled to the oscillations recorded in the stratum pyramidale of the CA1 region. The predominant synaptic input to CA1 interneurons was excitatory, and their discharge followed the firing of CA3 pyramidal cells at a latency indicative of monosynaptic connections. Correlation analysis of the input-output characteristics of the neurons and local pharmacological block of inhibition both agree with a model in which glutamatergic CA3 input controls the firing of CA1 interneurons, with local pyramidal cell activity having a minimal role. The firing of phase-coupled CA1 pyramidal cells was controlled principally by their inhibitory inputs, which dominated over excitation. Our results indicate that the synchronous firing of CA3 pyramidal cells rhythmically recruits CA1 interneurons and that this feedforward inhibition generates the oscillatory activity in CA1. These findings identify distinct synaptic mechanisms underlying the generation of gamma frequency oscillations in neighboring hippocampal subregions.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Chamberland, Simon
AU  - Topolnik, Lisa
TI  - Inhibitory control of hippocampal inhibitory neurons
JF  - FRONTIERS IN NEUROSCIENCE
J2  - FRONT NEUROSCI-SWITZ
VL  - 6
PY  - 2012
PG  - 13
SN  - 1662-4548
DO  - 10.3389/fnins.2012.00165
UR  - https://m2.mtmt.hu/api/publication/25002714
ID  - 25002714
N1  - Cited By :57            
            Export Date: 21 August 2019            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :58            
            Export Date: 14 November 2019            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :61            
            Export Date: 24 February 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :62            
            Export Date: 6 March 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :62            
            Export Date: 12 March 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :63            
            Export Date: 18 May 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :63            
            Export Date: 20 May 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :63            
            Export Date: 24 May 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :63            
            Export Date: 25 May 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :63            
            Export Date: 28 May 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :63            
            Export Date: 30 May 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :71            
            Export Date: 30 December 2020            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :71            
            Export Date: 1 January 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, Microbiology and Bioinformatics at Laval University, Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 19 March 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 23 March 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 24 March 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 31 March 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 1 April 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 6 April 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 7 April 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 13 April 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 14 April 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
Cited By :74            
            Export Date: 26 April 2021            
            Correspondence Address: Topolnik, L.; Biophotonicsat the Department of Biochemistry, , Quebec-city, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Capogna, Marco
AU  - Pearce, Robert A
TI  - GABA(A,slow): causes and consequences
JF  - TRENDS IN NEUROSCIENCES
J2  - TRENDS NEUROSCI
VL  - 34
PY  - 2011
IS  - 2
SP  - 101
EP  - 112
PG  - 12
SN  - 0166-2236
DO  - 10.1016/j.tins.2010.10.005
UR  - https://m2.mtmt.hu/api/publication/25003698
ID  - 25003698
N1  - Megjegyzés-21811585
Z9: 3
Megjegyzés-21898654
Z9: 4
Megjegyzés-21898825
Z9: 4
Megjegyzés-21898989
Z9: 4
Megjegyzés-21899175
Z9: 4
Megjegyzés-21901277
Z9: 4
Megjegyzés-21901390
Z9: 4
Megjegyzés-21904370
Z9: 4
WC: Neurosciences
Megjegyzés-21921792
Z9: 4
WC: Neurosciences
Megjegyzés-21921830
Z9: 4
WC: Neurosciences
Megjegyzés-21921851
Z9: 4
WC: Neurosciences
Megjegyzés-21922037
Z9: 4
WC: Neurosciences
Megjegyzés-22007114
Z9: 7
WC: Neurosciences
Megjegyzés-22076091
Z9: 8
WC: Neurosciences
Megjegyzés-21810857
Z9: 3
Cited By :80            
            Export Date: 15 April 2020            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Cited By :80            
            Export Date: 18 April 2020            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Cited By :81            
            Export Date: 20 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Cited By :81            
            Export Date: 21 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Cited By :81            
            Export Date: 23 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Cited By :81            
            Export Date: 24 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Cited By :81            
            Export Date: 25 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Cited By :85            
            Export Date: 18 March 2021            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :85            
            Export Date: 24 March 2021            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :86            
            Export Date: 6 April 2021            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :86            
            Export Date: 13 April 2021            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :87            
            Export Date: 6 May 2021            
            CODEN: TNSCD            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Protein Subunits; Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Capogna, Marco
TI  - Neurogliaform cells and other interneurons of stratum lacunosum-moleculare gate entorhinal-hippocampal dialogue
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 589
PY  - 2011
IS  - 8
SP  - 1875
EP  - 1883
PG  - 9
SN  - 0022-3751
DO  - 10.1113/jphysiol.2010.201004
UR  - https://m2.mtmt.hu/api/publication/25003696
ID  - 25003696
N1  - Megjegyzés-21811342
Z9: 2
Megjegyzés-21901274
Z9: 2
Megjegyzés-21901381
Z9: 2
Megjegyzés-21921693
Z9: 2
WC: Neurosciences; Physiology
Megjegyzés-21921789
Z9: 2
WC: Neurosciences; Physiology
Megjegyzés-21921801
Z9: 2
WC: Neurosciences; Physiology
Megjegyzés-21921847
Z9: 2
WC: Neurosciences; Physiology
Megjegyzés-21922031
Z9: 2
WC: Neurosciences; Physiology
Megjegyzés-22246154
Z9: 3
Megjegyzés-21811177
Z9: 2
Cited By :34            
            Export Date: 21 August 2019            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2
Cited By :34            
            Export Date: 14 November 2019            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2
Cited By :34            
            Export Date: 15 April 2020            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2
Cited By :34            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2
Cited By :34            
            Export Date: 23 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2
Cited By :34            
            Export Date: 24 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2
Cited By :40            
            Export Date: 18 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :40            
            Export Date: 23 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :40            
            Export Date: 24 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :41            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
Cited By :41            
            Export Date: 6 May 2021            
            CODEN: JPHYA            
            Correspondence Address: Capogna, M.; MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: neuronal nitric oxide synthase, 506430-87-1; neuropeptide Y, 82785-45-3, 83589-17-7; Receptors, GABA-A; Receptors, GABA-B; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197106
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Cea-Del Rio, CA
AU  - Lawrence, JJ
AU  - Erdélyi, Ferenc
AU  - Szabó, Gábor
AU  - McBain, CJ
TI  - Cholinergic modulation amplifies the intrinsic oscillatory properties of CA1 hippocampal cholecystokinin-positive interneurons
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 589
PY  - 2011
IS  - 3
SP  - 609
EP  - 627
PG  - 19
SN  - 0022-3751
DO  - 10.1113/jphysiol.2010.199422
UR  - https://m2.mtmt.hu/api/publication/1433117
ID  - 1433117
N1  - Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :35            
            Export Date: 17 August 2019            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :35            
            Export Date: 21 August 2019            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :35            
            Export Date: 14 November 2019            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 6 March 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 12 March 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 24 April 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 18 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 24 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 25 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :37            
            Export Date: 30 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :40            
            Export Date: 20 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS069689            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :40            
            Export Date: 23 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS069689            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :40            
            Export Date: 31 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS069689            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :40            
            Export Date: 6 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS069689            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :40            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS069689            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver, National Institute of Child Health and Human Development, Bethesda, MA 20892, United States            
            Centre for Structural and Functional Neuroscience, Department of Biomedical and Pharmaceutical Sciences, University of Montana, 385 Skaggs Bldg, Missoula, MT 59801, United States            
            Laboratory of Molecular Biology and Genetics, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Cited By :42            
            Export Date: 7 September 2021            
            CODEN: JPHYA            
            Correspondence Address: Mcbain, C.J.; Porter Neuroscience Center, Bldg 35, Rm 3C903, 35 Lincoln Drive, Bethesda, MD 20892, United States; email: mcbainc@mail.nih.gov            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; muscarine, 300-54-9; Cholecystokinin, 9011-97-6; Glutamate Decarboxylase, 4.1.1.15; Green Fluorescent Proteins, 147336-22-9; Muscarine, 300-54-9; Receptor, Muscarinic M1; Receptor, Muscarinic M3; glutamate decarboxylase 2, 4.1.1.15            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS069689            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
AB  - Non-technical summary In the mammalian hippocampus, the neurotransmitter acetylcholine (ACh) promotes learning and memory storage. During sensory processing and learning, large ACh-dependent electrical oscillatory events are observed, which involve the synchronization of both inhibitory and excitatory neural circuits. While the actions of ACh are known on excitatory hippocampal circuits, its actions on specific inhibitory circuits are poorly understood. We show that two types of cholecystokinin-positive local circuit inhibitory interneuron, the so-called 'basket cells' and 'Schaffer collateral-associated' cells, which innervate separately the cell body and dendritic regions of principal cells, are modulated similarly by cholinergic receptor activation. In both cell types activation of their muscarinic receptors triggers a general increase of excitability and intrinsic oscillatory activity, and a more efficient engagement to slow network oscillations. Knowledge of how cholinergic neuromodulation acts on neurochemically identical but morphologically distinct inhibitory interneurons will allow us to understand the role played by this important neuromodulator during hippocampal-dependent tasks in vivo.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Crawford, LK
AU  - Craige, CP
AU  - Beck, SG
TI  - Glutamatergic input is selectively increased in dorsal raphe subfield 5-HT neurons: role of morphology, topography and selective innervation
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 34
PY  - 2011
IS  - 11
SP  - 1794
EP  - 1806
PG  - 13
SN  - 0953-816X
DO  - 10.1111/j.1460-9568.2011.07882.x
UR  - https://m2.mtmt.hu/api/publication/21901276
ID  - 21901276
N1  - : FN Thomson Reuters Web of Knowledge
Megjegyzés-21828501
: FN Thomson Reuters Web of Knowledge
Cited By :15            
            Export Date: 16 August 2019            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse
Cited By :15            
            Export Date: 13 May 2020            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse
Cited By :15            
            Export Date: 20 May 2020            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse
Cited By :15            
            Export Date: 23 May 2020            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse
Cited By :15            
            Export Date: 24 May 2020            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse
Cited By :15            
            Export Date: 28 May 2020            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse
Cited By :15            
            Export Date: 1 December 2020            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse            
            Funding details: National Institute of Mental Health, NIMH, P01MH048125, R01MH075047, R21MH099488, F31MH082611, RC1MH089800
Cited By :15            
            Export Date: 20 March 2021            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, , Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse            
            Funding details: National Institute of Mental Health, NIMH, F31MH082611, P01MH048125, R01MH075047, R21MH099488, RC1MH089800
Cited By :15            
            Export Date: 31 March 2021            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, , Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse            
            Funding details: National Institute of Mental Health, NIMH, F31MH082611, P01MH048125, R01MH075047, R21MH099488, RC1MH089800
Cited By :15            
            Export Date: 8 April 2021            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, , Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse            
            Funding details: National Institute of Mental Health, NIMH, F31MH082611, P01MH048125, R01MH075047, R21MH099488, RC1MH089800
Cited By :15            
            Export Date: 13 April 2021            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, , Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse            
            Funding details: National Institute of Mental Health, NIMH, F31MH082611, P01MH048125, R01MH075047, R21MH099488, RC1MH089800
Cited By :15            
            Export Date: 14 April 2021            
            CODEN: EJONE            
            Correspondence Address: Beck, S.G.; Anesthesiology, , Philadelphia, PA, United States; email: becks@email.chop.edu            
            Chemicals/CAS: serotonin, 50-67-9; Amino Acid Transport Systems, Acidic; Glutamic Acid, 56-86-0; Serotonin, 50-67-9; Slc17a6 protein, mouse; Slc17a7 protein, mouse; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2; vesicular glutamate transporter 3, mouse            
            Funding details: National Institute of Mental Health, NIMH, F31MH082611, P01MH048125, R01MH075047, R21MH099488, RC1MH089800
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Dietz, SB
AU  - Markopoulos, F
AU  - Murthy, VN
TI  - Postnatal development of dendrodendritic inhibition in the mammalian olfactory bulb
JF  - FRONTIERS IN CELLULAR NEUROSCIENCE
J2  - FRONT CELL NEUROSCI
VL  - 5
PY  - 2011
SN  - 1662-5102
DO  - 10.3389/fncel.2011.00010
UR  - https://m2.mtmt.hu/api/publication/26787890
ID  - 26787890
N1  - Cited By :14            
            Export Date: 8 June 2023            
            Correspondence Address: Murthy, V. N.; Department of Molecular and Cellular Biology, 16 Divinity Avenue, Cambridge, MA 02138, United States; email: vnmurthy@fas.harvard.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Katona, Gergely
AU  - Kaszás, Attila
AU  - Turi, Gergely
AU  - Hájos, Norbert
AU  - Tamás, Gábor
AU  - Vizi, E. Szilveszter
AU  - Rózsa J., Balázs
TI  - Roller Coaster Scanning reveals spontaneous triggering of dendritic spikes in CA1 interneurons
JF  - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
J2  - P NATL ACAD SCI USA
VL  - 108
PY  - 2011
IS  - 5
SP  - 2148
EP  - 2153
PG  - 6
SN  - 0027-8424
DO  - 10.1073/pnas.1009270108
UR  - https://m2.mtmt.hu/api/publication/1424451
ID  - 1424451
N1  - Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1083, Budapest, Hungary            
            Research Group for Cortical Microcircuits of the Hungarian, Academy of Sciences, University of Szeged, H-6726, Szeged, Hungary            
            Pázmány Péter Catholic University, H-1083, Budapest, Hungary            
            Cited By :64            
            Export Date: 30 January 2024            
            CODEN: PNASA            
            Correspondence Address: Rózsa, B.; Institute of Experimental Medicine, , H-1083, Budapest, Hungary; email: rozsabal@koki.hu            
            Chemicals/CAS: n methyl dextro aspartic acid, 6384-92-5
AB  - Inhibitory interneurons are considered to be the controlling units of neural networks, despite their sparse number and unique morphological characteristics compared with excitatory pyramidal cells. Although pyramidal cell dendrites have been shown to display local regenerative events-dendritic spikes (dSpikes)-evoked by artificially patterned stimulation of synaptic inputs, no such studies exist for interneurons or for spontaneous events. In addition, imaging techniques have yet to attain the required spatial and temporal resolution for the detection of spontaneously occurring events that trigger dSpikes. Here we describe a high-resolution 3D two-photon laser scanning method (Roller Coaster Scanning) capable of imaging long dendritic segments resolving individual spines and inputs with a temporal resolution of a few milliseconds. By using this technique, we found that local, NMDA receptor-dependent dSpikes can be observed in hippocampal CA1 stratum radiatum interneurons during spontaneous network activities in vitro. These NMDA spikes appear when approximately 10 spatially clustered inputs arrive synchronously and trigger supralinear integration in dynamic interaction zones. In contrast to the one-to-one relationship between computational subunits and dendritic branches described in pyramidal cells, here we show that interneurons have relatively small ( approximately 14 mum) sliding interaction zones. Our data suggest a unique principle as to how interneurons integrate synaptic information by local dSpikes.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Kispersky, TJ
AU  - Economo, MN
AU  - Randeria, P
AU  - White, JA
TI  - GenNet: A platform for hybrid network experiments
JF  - FRONTIERS IN NEUROINFORMATICS
J2  - FRONT NEUROINFORM
VL  - 5
PY  - 2011
SN  - 1662-5196
DO  - 10.3389/fninf.2011.00011
UR  - https://m2.mtmt.hu/api/publication/26177688
ID  - 26177688
N1  - N1 Funding Details: R01 MH085074, NIH, National Institutes of Health
N1 Funding Details: R01 MH085387, NIH, National Institutes of Health
N1 Funding Details: R01 RR020115, NIH, National Institutes of Health
Boston University, Boston, MA, United States            
            Brain Institute, University of Utah, Salt Lake City, UT, United States            
            Department of Biomedical Engineering, Boston University, Boston, MA, United States            
            Department of Biomedical Engineering, Northwestern University, Evanston, IL, United States            
            Department of Bioengineering, University of Utah, Salt Lake City, UT, United States            
            Cited By :12            
            Export Date: 13 April 2021            
            Correspondence Address: White, J.A.; Department of Bioengineering, 20 South 2030 East, Room 108 BPRB, United States; email: john.white@utah.edu            
            Funding details: National Institutes of Health, NIH, R01 MH085074, R01 MH085387, R01 RR020115            
            Funding text 1: We would like to thank Jonathan Bettencourt for his technical assistance and Dr. Tilman Broicher for helpful comments on the manuscript. Support was provided by NIH grants R01 MH085387, R01 MH085074, and R01 RR020115 (John A. White).            
            Funding text 2: We would like to thank Jonathan Bettencourt for his technical assistance and Dr. Tilman Broicher for helpful comments on the manuscript. Support was provided by NIHNational Institutes of Health grants R01 MH085387, R01 MH085074, and R01 RR020115 (John A. White).
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Salesse, Charleen
AU  - Mueller, Christopher Lacharite
AU  - Chamberland, Simon
AU  - Topolnik, Lisa
TI  - Age-dependent remodelling of inhibitory synapses onto hippocampal CA1 oriens-lacunosum moleculare interneurons
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 589
PY  - 2011
IS  - 20
SP  - 4885
EP  - 4901
PG  - 17
SN  - 0022-3751
DO  - 10.1113/jphysiol.2011.215244
UR  - https://m2.mtmt.hu/api/publication/27029740
ID  - 27029740
N1  - Megjegyzés-21811055
: FN Thomson Reuters Web of Knowledge
Megjegyzés-21828810
: FN Thomson Reuters Web of Knowledge
Megjegyzés-21898656
: FN Thomson Reuters Web of Knowledge
Megjegyzés-22029748
WC: Neurosciences; Physiology
Megjegyzés-21810730
: FN Thomson Reuters Web of Knowledge
Cited By :13            
            Export Date: 21 August 2019            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :16            
            Export Date: 12 March 2020            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :16            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :16            
            Export Date: 21 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :16            
            Export Date: 24 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :16            
            Export Date: 25 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :19            
            Export Date: 1 January 2021            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :20            
            Export Date: 23 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :20            
            Export Date: 31 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :20            
            Export Date: 6 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :20            
            Export Date: 7 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
Cited By :20            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, Québec, PQ, G1J 2G3, Canada; email: lisa.topolnik@crulrg.ulaval.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Gabra5 protein, mouse; Receptors, GABA-A
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Salgado, H
AU  - Garcia-Oscos, F
AU  - Dinh, L
AU  - Atzori, M
TI  - Dynamic modulation of short-term synaptic plasticity in the auditory cortex: The role of norepinephrine
JF  - HEARING RESEARCH
J2  - HEARING RES
VL  - 271
PY  - 2011
IS  - 1-2
SP  - 26
EP  - 36
PG  - 11
SN  - 0378-5955
DO  - 10.1016/j.heares.2010.08.014
UR  - https://m2.mtmt.hu/api/publication/27197322
ID  - 27197322
N1  - Megjegyzés-21811362
Z9: 2
Megjegyzés-21812917
Z9: 2
Megjegyzés-21828886
Z9: 2
Megjegyzés-21901278
Z9: 2
Megjegyzés-21810862
Z9: 2
School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes 490 x 59, Mexico            
            Cited By :13            
            Export Date: 12 March 2020            
            CODEN: HERED            
            Correspondence Address: Atzori, M.; School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: calcium ion, 14127-61-8; noradrenalin, 1407-84-7, 51-41-2; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Consejo Nacional de Ciencia y TecnologÃa, Paraguay, El CONACYT, MOD-ORD-1-09 PCI-047-11-09            
            Funding details: R01DC005986            
            Funding text 1: This study has been funded by NIH/NIDCD R01DC005986 and by a N.A.R.S.A.D. Young Investigator Award to MA; CONACyT ( MOD-ORD-1-09 PCI-047-11-09 to H.S. ). We would like to thank Dr. M. Treviño and Dr. L. Cauller for intellectual contributions and useful discussions during the development of this study.
School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes 490 x 59, Mexico            
            Cited By :13            
            Export Date: 20 May 2020            
            CODEN: HERED            
            Correspondence Address: Atzori, M.; School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: calcium ion, 14127-61-8; noradrenalin, 1407-84-7, 51-41-2; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Consejo Nacional de Ciencia y TecnologÃa, Paraguay, El CONACYT, MOD-ORD-1-09 PCI-047-11-09            
            Funding details: R01DC005986            
            Funding text 1: This study has been funded by NIH/NIDCD R01DC005986 and by a N.A.R.S.A.D. Young Investigator Award to MA; CONACyT ( MOD-ORD-1-09 PCI-047-11-09 to H.S. ). We would like to thank Dr. M. Treviño and Dr. L. Cauller for intellectual contributions and useful discussions during the development of this study.
School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes 490 x 59, Mexico            
            Cited By :13            
            Export Date: 25 May 2020            
            CODEN: HERED            
            Correspondence Address: Atzori, M.; School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: calcium ion, 14127-61-8; noradrenalin, 1407-84-7, 51-41-2; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Consejo Nacional de Ciencia y TecnologÃa, Paraguay, El CONACYT, MOD-ORD-1-09 PCI-047-11-09            
            Funding details: R01DC005986            
            Funding text 1: This study has been funded by NIH/NIDCD R01DC005986 and by a N.A.R.S.A.D. Young Investigator Award to MA; CONACyT ( MOD-ORD-1-09 PCI-047-11-09 to H.S. ). We would like to thank Dr. M. Treviño and Dr. L. Cauller for intellectual contributions and useful discussions during the development of this study.
School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes 490 x 59, Mexico            
            Cited By :14            
            Export Date: 31 March 2021            
            CODEN: HERED            
            Correspondence Address: Atzori, M.; School of Behavioral and Brain Sciences, , Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: calcium ion, 14127-61-8; noradrenalin, 1407-84-7, 51-41-2; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institutes of Health, NIH            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC005986            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, MOD-ORD-1-09 PCI-047-11-09            
            Funding text 1: This study has been funded by NIH/NIDCD R01DC005986 and by a N.A.R.S.A.D. Young Investigator Award to MA; CONACyT ( MOD-ORD-1-09 PCI-047-11-09 to H.S. ). We would like to thank Dr. M. Treviño and Dr. L. Cauller for intellectual contributions and useful discussions during the development of this study.
School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes 490 x 59, Mexico            
            Cited By :14            
            Export Date: 6 April 2021            
            CODEN: HERED            
            Correspondence Address: Atzori, M.; School of Behavioral and Brain Sciences, , Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: calcium ion, 14127-61-8; noradrenalin, 1407-84-7, 51-41-2; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institutes of Health, NIH            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC005986            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, MOD-ORD-1-09 PCI-047-11-09            
            Funding text 1: This study has been funded by NIH/NIDCD R01DC005986 and by a N.A.R.S.A.D. Young Investigator Award to MA; CONACyT ( MOD-ORD-1-09 PCI-047-11-09 to H.S. ). We would like to thank Dr. M. Treviño and Dr. L. Cauller for intellectual contributions and useful discussions during the development of this study.
School of Behavioral and Brain Sciences, Laboratory of Cell and Synaptic Physiology, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes 490 x 59, Mexico            
            Cited By :14            
            Export Date: 13 April 2021            
            CODEN: HERED            
            Correspondence Address: Atzori, M.; School of Behavioral and Brain Sciences, , Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: calcium ion, 14127-61-8; noradrenalin, 1407-84-7, 51-41-2; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institutes of Health, NIH            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC005986            
            Funding details: Consejo Nacional de Ciencia y Tecnología, CONACYT, MOD-ORD-1-09 PCI-047-11-09            
            Funding text 1: This study has been funded by NIH/NIDCD R01DC005986 and by a N.A.R.S.A.D. Young Investigator Award to MA; CONACyT ( MOD-ORD-1-09 PCI-047-11-09 to H.S. ). We would like to thank Dr. M. Treviño and Dr. L. Cauller for intellectual contributions and useful discussions during the development of this study.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Salgado, H
AU  - Garcia-Oscos, F
AU  - Patel, A
AU  - Martinolich, L
AU  - Nichols, JA
AU  - Dinh, L
AU  - Roychowdhury, S
AU  - Tseng, KY
AU  - Atzori, M
TI  - Layer-Specific Noradrenergic Modulation of Inhibition in Cortical Layer II/III
JF  - CEREBRAL CORTEX
J2  - CEREB CORTEX
VL  - 21
PY  - 2011
IS  - 1
SP  - 212
EP  - 221
PG  - 10
SN  - 1047-3211
DO  - 10.1093/cercor/bhq081
UR  - https://m2.mtmt.hu/api/publication/21901275
ID  - 21901275
N1  - Z9: 2
Megjegyzés-21810853
Z9: 1
Megjegyzés-21811361
Z9: 1
Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes, Mérida, Yucatán 97000, Mexico            
            Department of Cellular and Molecular Pharmacology, Rosalind Franklin University, Chicago Medical School, Chicago, IL 60064, United States            
            Cited By :38            
            Export Date: 12 March 2020            
            CODEN: CECOE            
            Correspondence Address: Atzori, M.; Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, GR41, 2601 North Floyd Road, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; zolpidem, 82626-48-0; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Consejo Nacional de Ciencia y Tecnología, MOD-ORD-1-09 PCI-047-11-09            
            Funding details: National Alliance for Research on Schizophrenia and Depression            
            Funding details: National Institute on Deafness and Other Communication Disorders, R01DC005986            
            Funding text 1: National Institutes of Health/National Institute of Deafness and other Communication Disorder (R01DC005986), National Alliance for Research on Schizophrenia And Depression Young Investigator Award to M.A; CONACyT (MOD-ORD-1-09 PCI-047-11-09 to H.S.).
Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes, Mérida, Yucatán 97000, Mexico            
            Department of Cellular and Molecular Pharmacology, Rosalind Franklin University, Chicago Medical School, Chicago, IL 60064, United States            
            Cited By :38            
            Export Date: 20 May 2020            
            CODEN: CECOE            
            Correspondence Address: Atzori, M.; Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, GR41, 2601 North Floyd Road, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; zolpidem, 82626-48-0; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Consejo Nacional de Ciencia y Tecnología, MOD-ORD-1-09 PCI-047-11-09            
            Funding details: National Alliance for Research on Schizophrenia and Depression            
            Funding details: National Institute on Deafness and Other Communication Disorders, R01DC005986            
            Funding text 1: National Institutes of Health/National Institute of Deafness and other Communication Disorder (R01DC005986), National Alliance for Research on Schizophrenia And Depression Young Investigator Award to M.A; CONACyT (MOD-ORD-1-09 PCI-047-11-09 to H.S.).
Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes, Mérida, Yucatán 97000, Mexico            
            Department of Cellular and Molecular Pharmacology, Rosalind Franklin University, Chicago Medical School, Chicago, IL 60064, United States            
            Cited By :38            
            Export Date: 25 May 2020            
            CODEN: CECOE            
            Correspondence Address: Atzori, M.; Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, GR41, 2601 North Floyd Road, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; zolpidem, 82626-48-0; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Consejo Nacional de Ciencia y Tecnología, MOD-ORD-1-09 PCI-047-11-09            
            Funding details: National Alliance for Research on Schizophrenia and Depression            
            Funding details: National Institute on Deafness and Other Communication Disorders, R01DC005986            
            Funding text 1: National Institutes of Health/National Institute of Deafness and other Communication Disorder (R01DC005986), National Alliance for Research on Schizophrenia And Depression Young Investigator Award to M.A; CONACyT (MOD-ORD-1-09 PCI-047-11-09 to H.S.).
Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes, Mérida, Yucatán 97000, Mexico            
            Department of Cellular and Molecular Pharmacology, Rosalind Franklin University, Chicago Medical School, Chicago, IL 60064, United States            
            Cited By :43            
            Export Date: 31 March 2021            
            CODEN: CECOE            
            Correspondence Address: Atzori, M.; Laboratory of Cell and Synaptic Physiology, GR41, 2601 North Floyd Road, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; zolpidem, 82626-48-0; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC005986            
            Funding details: National Alliance for Research on Schizophrenia and Depression            
            Funding details: Consejo Nacional de Ciencia y Tecnología, MOD-ORD-1-09 PCI-047-11-09            
            Funding text 1: National Institutes of Health/National Institute of Deafness and other Communication Disorder (R01DC005986), National Alliance for Research on Schizophrenia And Depression Young Investigator Award to M.A; CONACyT (MOD-ORD-1-09 PCI-047-11-09 to H.S.).
Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes, Mérida, Yucatán 97000, Mexico            
            Department of Cellular and Molecular Pharmacology, Rosalind Franklin University, Chicago Medical School, Chicago, IL 60064, United States            
            Cited By :43            
            Export Date: 6 April 2021            
            CODEN: CECOE            
            Correspondence Address: Atzori, M.; Laboratory of Cell and Synaptic Physiology, GR41, 2601 North Floyd Road, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; zolpidem, 82626-48-0; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC005986            
            Funding details: National Alliance for Research on Schizophrenia and Depression            
            Funding details: Consejo Nacional de Ciencia y Tecnología, MOD-ORD-1-09 PCI-047-11-09            
            Funding text 1: National Institutes of Health/National Institute of Deafness and other Communication Disorder (R01DC005986), National Alliance for Research on Schizophrenia And Depression Young Investigator Award to M.A; CONACyT (MOD-ORD-1-09 PCI-047-11-09 to H.S.).
Laboratory of Cell and Synaptic Physiology, School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, United States            
            Departamento de Neurociencias, Centro de Investigaciones Regionales Hideyo Noguchi, Universidad Autónoma de Yucatán, Avenida Itzáes, Mérida, Yucatán 97000, Mexico            
            Department of Cellular and Molecular Pharmacology, Rosalind Franklin University, Chicago Medical School, Chicago, IL 60064, United States            
            Cited By :43            
            Export Date: 13 April 2021            
            CODEN: CECOE            
            Correspondence Address: Atzori, M.; Laboratory of Cell and Synaptic Physiology, GR41, 2601 North Floyd Road, Richardson, TX 75080, United States; email: marco.atzori@utdallas.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; zolpidem, 82626-48-0; Norepinephrine, 51-41-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC005986            
            Funding details: National Alliance for Research on Schizophrenia and Depression            
            Funding details: Consejo Nacional de Ciencia y Tecnología, MOD-ORD-1-09 PCI-047-11-09            
            Funding text 1: National Institutes of Health/National Institute of Deafness and other Communication Disorder (R01DC005986), National Alliance for Research on Schizophrenia And Depression Young Investigator Award to M.A; CONACyT (MOD-ORD-1-09 PCI-047-11-09 to H.S.).
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Tricoire, Ludovic
AU  - Pelkey, Kenneth A
AU  - Erkkila, Brian E
AU  - Jeffries, Brian W
AU  - Yuan, Xiaoqing
AU  - McBain, Chris J
TI  - A Blueprint for the Spatiotemporal Origins of Mouse Hippocampal Interneuron Diversity
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 31
PY  - 2011
IS  - 30
SP  - 10948
EP  - 10970
PG  - 23
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.0323-11.2011
UR  - https://m2.mtmt.hu/api/publication/27029735
ID  - 27029735
N1  - Megjegyzés-21647470
: FN Thomson Reuters Web of Knowledge
Megjegyzés-21899319
: FN Thomson Reuters Web of Knowledge
Megjegyzés-21984813
: FN Thomson Reuters Web of Knowledge
Megjegyzés-21985573
: FN Thomson Reuters Web of Knowledge
Megjegyzés-22019338
WC: Neurosciences
Megjegyzés-22020071
WC: Neurosciences
Megjegyzés-22246174
Z9: 2
Megjegyzés-22249523
Z9: 2
WC: Neurosciences
Megjegyzés-22338245
Z9: 6
Megjegyzés-22722817
N1 Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :140            
            Export Date: 4 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :140            
            Export Date: 21 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :144            
            Export Date: 14 November 2019            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :158            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :158            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :158            
            Export Date: 25 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :159            
            Export Date: 30 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :172            
            Export Date: 30 December 2020            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :173            
            Export Date: 19 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, , Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :174            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, , Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :175            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, , Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
Program in Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, United States            
            Porter Neuroscience Research Center, 35 Lincoln Drive, MSC 3715, Bethesda, MD 20892-3715, United States            
            Cited By :176            
            Export Date: 23 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Pelkey, K. A.; Program in Developmental Neurobiology, , Bethesda, MD 20892, United States; email: pelkeyk2@mail.nih.gov            
            Molecular Sequence Numbers: GENBANK: NM_007586, NM_008077, NM_008078, NM_008500, NM_008712, NM_008718, NM_009115, NM_009215, NM_009697, NM_009923, NM_010277, NM_010777, NM_011702, NM_013561, NM_013645, NM_013780, NM_023456, NM_031161, NM_139001, NM_182959, NM_182993;            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; nitric oxide synthase, 125978-95-2; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Ascl1 protein, mouse; Basic Helix-Loop-Helix Transcription Factors; Green Fluorescent Proteins, 147336-22-9; Nerve Tissue Proteins; Olig2 protein, mouse; Peptides; RNA, Messenger; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Eunice Kennedy Shriver National Institute of Child Health and Human Development, NICHD, ZIAHD001205
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Chamberland, Simon
AU  - Salesse, Charleen
AU  - Topolnik, Dimitry
AU  - Topolnik, Lisa
TI  - Synapse-specific inhibitory control of hippocampal feedback inhibitory circuit
JF  - FRONTIERS IN CELLULAR NEUROSCIENCE
J2  - FRONT CELL NEUROSCI
VL  - 4
PY  - 2010
PG  - 14
SN  - 1662-5102
DO  - 10.3389/fncel.2010.00130
UR  - https://m2.mtmt.hu/api/publication/27029724
ID  - 27029724
N1  - Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :31            
            Export Date: 16 August 2019            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :31            
            Export Date: 17 August 2019            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :31            
            Export Date: 21 August 2019            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :31            
            Export Date: 23 August 2019            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :32            
            Export Date: 12 March 2020            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :32            
            Export Date: 24 April 2020            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :32            
            Export Date: 13 May 2020            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :32            
            Export Date: 20 May 2020            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :32            
            Export Date: 24 May 2020            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :32            
            Export Date: 25 May 2020            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, CRULRG, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :37            
            Export Date: 23 March 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 31 March 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 1 April 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 6 April 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 7 April 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 8 April 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 13 April 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 14 April 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
Axis of Cellular and Molecular Neuroscience, CRULRG, QC, Canada            
            Department of Biochemistry, Microbiology and Bioinformatics, Laval University, QC, Canada            
            Cited By :38            
            Export Date: 26 April 2021            
            Correspondence Address: Topolnik, L.; Axis of Cellular and Molecular Neuroscience, 2601 Ch. De La Canardière, QC G1J 2G3, Canada; email: Lisa.Topolnik@crulrg.ulaval.ca
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Karayannis, Theofanis
AU  - Elfant, David
AU  - Huerta-Ocampo, Icnelia
AU  - Teki, Sundeep
AU  - Scott, Ricardo S
AU  - Rusakov, Dmitri A
AU  - Jones, Mathew V
AU  - Capogna, Marco
TI  - Slow GABA Transient and Receptor Desensitization Shape Synaptic Responses Evoked by Hippocampal Neurogliaform Cells
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 30
PY  - 2010
IS  - 29
SP  - 9898
EP  - 9909
PG  - 12
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.5883-09.2010
UR  - https://m2.mtmt.hu/api/publication/26269554
ID  - 26269554
N1  - Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom            
            Department of Physiology, University of Wisconsin-Madison, Madison, WI 53706-1510, United States            
            Neuroscience Program, Smilow Research Center, New York University School of Medicine, New York, NY 10016, United States            
            Cited By :54            
            Export Date: 15 April 2020            
            CODEN: JNRSD            
            Correspondence Address: Capogna, M.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom            
            Department of Physiology, University of Wisconsin-Madison, Madison, WI 53706-1510, United States            
            Neuroscience Program, Smilow Research Center, New York University School of Medicine, New York, NY 10016, United States            
            Cited By :55            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Capogna, M.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom            
            Department of Physiology, University of Wisconsin-Madison, Madison, WI 53706-1510, United States            
            Neuroscience Program, Smilow Research Center, New York University School of Medicine, New York, NY 10016, United States            
            Cited By :55            
            Export Date: 23 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Capogna, M.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2
Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom            
            Department of Physiology, University of Wisconsin-Madison, Madison, WI 53706-1510, United States            
            Neuroscience Program, Smilow Research Center, New York University School of Medicine, New York, NY 10016, United States            
            Cited By :60            
            Export Date: 18 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Capogna, M.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, G0802216, G0900613, MC_U138197106
Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom            
            Department of Physiology, University of Wisconsin-Madison, Madison, WI 53706-1510, United States            
            Neuroscience Program, Smilow Research Center, New York University School of Medicine, New York, NY 10016, United States            
            Cited By :60            
            Export Date: 24 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Capogna, M.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, G0802216, G0900613, MC_U138197106
Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom            
            Department of Physiology, University of Wisconsin-Madison, Madison, WI 53706-1510, United States            
            Neuroscience Program, Smilow Research Center, New York University School of Medicine, New York, NY 10016, United States            
            Cited By :61            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Capogna, M.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, G0802216, G0900613, MC_U138197106
Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom            
            Department of Physiology, University of Wisconsin-Madison, Madison, WI 53706-1510, United States            
            Neuroscience Program, Smilow Research Center, New York University School of Medicine, New York, NY 10016, United States            
            Cited By :61            
            Export Date: 6 May 2021            
            CODEN: JNRSD            
            Correspondence Address: Capogna, M.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: marco.capogna@pharm.ox.ac.uk            
            Chemicals/CAS: Receptors, GABA-A; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, G0802216, G0900613, MC_U138197106
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Lee, S-H
AU  - Földy, Csaba
AU  - Soltesz, Ivan
TI  - Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 30
PY  - 2010
IS  - 23
SP  - 7993
EP  - 8000
PG  - 8
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.6238-09.2010
UR  - https://m2.mtmt.hu/api/publication/2833483
ID  - 2833483
N1  - Megjegyzés-21899061
Z9: 7
AB  - Endocannabinoid-mediated retrograde synaptic signaling is a key regulator of GABA release at synapses formed on the perisomatic region of pyramidal cells by basket cells that coexpress the cannabinoid type 1 receptor (CB1R) and cholecystokinin (CCK). However, CB1R and CCK-positive GABAergic terminals are present on pyramidal cell dendrites as well, but the principles of endocannabinoid control of GABA release in dendrites are not understood. We performed paired recordings from CCK-positive perisomatically (basket cells) or dendritically projecting (Schaffer collateral-associated cells) interneurons and postsynaptic CA1 pyramidal cells to determine the properties of endocannabinoid signaling at GABAergic synapses along the somato-dendritic axis. Although several key elements of the currently known molecular machinery for endocannabinoid synthesis are thought be primarily localized in dendrites, our results revealed that the depolarization-induced suppression of inhibition, the endocannabinoid-mediated tonic inhibition of GABA release, and the metabotropic glutamate receptor activation-induced, CB1R-mediated depression of GABA release were all significantly less effective at dendritic compared with perisomatic synapses. In addition, low concentration of exogenous CB1 receptor agonist inhibited GABA release to a lesser extent at dendritic compared with perisomatic synapses, indicating that presynaptic differences are partly responsible for the differential control of GABA release by endocannabinoids in dendrites. Together, these data demonstrate a novel domain-specific regulation of GABA release by endocannabinoid signaling in the hippocampus. Copyright © 2010 the authors.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Poulter, MO
AU  - Du, L
AU  - Zhurov, V
AU  - Palkovits, Miklós
AU  - Faludi, Gábor
AU  - Merali, Z
AU  - Anisman, H
TI  - Altered organization of GABAA receptor mRNA expression in the depressed suicide brain
JF  - FRONTIERS IN MOLECULAR NEUROSCIENCE
J2  - FRONT MOL NEUROSCI
VL  - 3
PY  - 2010
SN  - 1662-5099
DO  - 10.3389/neuro.02.003.2010
UR  - https://m2.mtmt.hu/api/publication/1335858
ID  - 1335858
N1  - Molecular Brain Research Group, Department of Physiology and Pharmacology, Robarts Research Institute, University of Western Ontario, London, ON, Canada            
            Institute of Neuroscience, Department of Psychology, Carleton University, Ottawa, ON, Canada            
            University of Ottawa Institute of Mental Health Research, Royal Ottawa Hospital and Departments of Psychology and Psychiatry, University of Ottawa, Ottawa, ON, Canada            
            Neuromorphological and Neuroendocrine Research Laboratory, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary            
            Department of Clinical and Theoretical Mental Health, Semmelweis University, Budapest, Hungary            
            Cited By :34            
            Export Date: 20 May 2020            
            Correspondence Address: Poulter, M. O.; Molecular Brain Research Group, Department of Physiology and Pharmacology, Robarts Research Institute, University of Western Ontario, 100 Perth Drive Box 5015, London, ON, N6A 5K8, Canada
Molecular Brain Research Group, Department of Physiology and Pharmacology, Robarts Research Institute, University of Western Ontario, London, ON, Canada            
            Institute of Neuroscience, Department of Psychology, Carleton University, Ottawa, ON, Canada            
            University of Ottawa Institute of Mental Health Research, Royal Ottawa Hospital and Departments of Psychology and Psychiatry, University of Ottawa, Ottawa, ON, Canada            
            Neuromorphological and Neuroendocrine Research Laboratory, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary            
            Department of Clinical and Theoretical Mental Health, Semmelweis University, Budapest, Hungary            
            Cited By :37            
            Export Date: 13 April 2021            
            Correspondence Address: Poulter, M. O.; Molecular Brain Research Group, Department of Physiology and Pharmacology, 100 Perth Drive Box 5015, London, ON, N6A 5K8, Canada
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Poulter, MO
AU  - Du, L
AU  - Zhurov, V
AU  - Merali, Z
AU  - Anisman, H
TI  - PLASTICITY OF THE GABA(A) RECEPTOR SUBUNIT CASSETTE IN RESPONSE TO STRESSORS IN REACTIVE VERSUS RESILIENT MICE
JF  - NEUROSCIENCE
J2  - NEUROSCIENCE
VL  - 165
PY  - 2010
IS  - 4
SP  - 1039
EP  - 1051
PG  - 13
SN  - 0306-4522
DO  - 10.1016/j.neuroscience.2009.11.028
UR  - https://m2.mtmt.hu/api/publication/21316153
ID  - 21316153
N1  - Molecular Brain (Research Group), Robarts Research Institute, Department of Physiology and Pharmacology, London, Ont., Canada            
            Institute of Neuroscience, Department of Psychology, Carleton University, Ottawa, Ont., Canada            
            University of Ottawa Institute of Mental Health Research, Royal Ottawa Hospital, Departments of Psychology and Psychiatry, Ottawa, Ont., Canada            
            Cited By :17            
            Export Date: 20 May 2020            
            CODEN: NRSCD            
            Correspondence Address: Poulter, M.O.; Molecular Brain (Research Group), Robarts Research Institute, Department of Physiology and Pharmacology, London, Ont., Canada; email: mpoulter@robarts.ca            
            Chemicals/CAS: sucrose, 122880-25-5, 57-50-1; Dietary Sucrose; RNA, Messenger; Receptors, GABA-A            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding text 1: This research was supported by a CIHR grant to MOP, HA and ZM. A NARSAD Independent researcher Award also supports MOP. HA is a Tier I Canada Research Chair.
Molecular Brain (Research Group), Robarts Research Institute, Department of Physiology and Pharmacology, London, Ont., Canada            
            Institute of Neuroscience, Department of Psychology, Carleton University, Ottawa, Ont., Canada            
            University of Ottawa Institute of Mental Health Research, Royal Ottawa Hospital, Departments of Psychology and Psychiatry, Ottawa, Ont., Canada            
            Cited By :17            
            Export Date: 13 April 2021            
            CODEN: NRSCD            
            Correspondence Address: Poulter, M.O.; Molecular Brain (Research Group), , London, Ont., Canada; email: mpoulter@robarts.ca            
            Chemicals/CAS: sucrose, 122880-25-5, 57-50-1; Dietary Sucrose; RNA, Messenger; Receptors, GABA-A            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding text 1: This research was supported by a CIHR grant to MOP, HA and ZM. A NARSAD Independent researcher Award also supports MOP. HA is a Tier I Canada Research Chair.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Klausberger, Thomas
TI  - GABAergic interneurons targeting dendrites of pyramidal cells in the CA1 area of the hippocampus
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 30
PY  - 2009
IS  - 6
SP  - 947
EP  - 957
PG  - 11
SN  - 0953-816X
DO  - 10.1111/j.1460-9568.2009.06913.x
UR  - https://m2.mtmt.hu/api/publication/27029706
ID  - 27029706
N1  - Megjegyzés-21894448
Z9: 22
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :135            
            Export Date: 17 August 2019            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :135            
            Export Date: 21 August 2019            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :135            
            Export Date: 23 August 2019            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :138            
            Export Date: 14 November 2019            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 6 March 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 12 March 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 15 April 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 24 April 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 13 May 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 20 May 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 23 May 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 24 May 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :140            
            Export Date: 25 May 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :148            
            Export Date: 30 December 2020            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :150            
            Export Date: 18 March 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :150            
            Export Date: 23 March 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :151            
            Export Date: 31 March 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :151            
            Export Date: 1 April 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :151            
            Export Date: 6 April 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :151            
            Export Date: 13 April 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :151            
            Export Date: 14 April 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University Vienna, 1090 Vienna, Austria            
            Cited By :158            
            Export Date: 7 September 2021            
            CODEN: EJONE            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: calcium, 7440-70-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Medical Research Council, MRC, MC_U138197110
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Klausberger, T
AU  - Somogyi, Péter Pál
TI  - Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.
JF  - SCIENCE
J2  - SCIENCE
VL  - 321
PY  - 2008
IS  - 5885
SP  - 53
EP  - 57
PG  - 5
SN  - 0036-8075
DO  - 10.1126/science.1149381
UR  - https://m2.mtmt.hu/api/publication/2086363
ID  - 2086363
N1  - Megjegyzés-27028849
Megjegyzés-10324201
[273006]
Megjegyzés-21921752
Z9: 231
WC: Multidisciplinary Sciences
Cited By :1085            
            Export Date: 21 August 2019            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1106            
            Export Date: 14 November 2019            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1133            
            Export Date: 6 March 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1133            
            Export Date: 12 March 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1140            
            Export Date: 15 April 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1158            
            Export Date: 18 May 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1161            
            Export Date: 20 May 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1162            
            Export Date: 23 May 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1162            
            Export Date: 24 May 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1162            
            Export Date: 25 May 2020            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1235            
            Export Date: 18 March 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1235            
            Export Date: 23 March 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1239            
            Export Date: 31 March 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1239            
            Export Date: 6 April 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1239            
            Export Date: 7 April 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1241            
            Export Date: 13 April 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1241            
            Export Date: 14 April 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1244            
            Export Date: 20 April 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1244            
            Export Date: 26 April 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :1283            
            Export Date: 7 September 2021            
            CODEN: SCIEA            
            Correspondence Address: Klausberger, T.; MRC Anatomical Neuropharmacology Unit, , Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
AB  - In the cerebral cortex, diverse types of neurons form intricate 
circuits and cooperate in time for the processing and storage of 
information. Recent advances reveal a spatiotemporal division 
of labor in cortical circuits, as exemplified in the CA1 
hippocampal area. In particular, distinct GABAergic (gamma-
aminobutyric acid-releasing) cell types subdivide the surface of 
pyramidal cells and act in discrete time windows, either on the 
same or on different subcellular compartments. They also 
interact with glutamatergic pyramidal cell inputs in a domain-
specific manner and support synaptic temporal dynamics, network 
oscillations, selection of cell assemblies, and the 
implementation of brain states. The spatiotemporal 
specializations in cortical circuits reveal that cellular 
diversity and temporal dynamics coemerged during evolution, 
providing a basis for cognitive behavior.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Ogier, R
AU  - Wrobel, LJ
AU  - Raggenbass, M
TI  - ACTION OF TACHYKININS IN THE HIPPOCAMPUS: FACILITATION OF INHIBITORY DRIVE TO GABAergic INTERNEURONS
JF  - NEUROSCIENCE
J2  - NEUROSCIENCE
VL  - 156
PY  - 2008
IS  - 3
SP  - 527
EP  - 536
PG  - 10
SN  - 0306-4522
DO  - 10.1016/j.neuroscience.2008.08.001
UR  - https://m2.mtmt.hu/api/publication/22867993
ID  - 22867993
N1  - Megjegyzés-10030770
FU: Swiss National Science Foundation
FX: This work was supported in part by the Swiss National Science
: Foundation (grant to M. R.). R. O. was supported by the Swiss National
: Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloetta,
: Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthelabo
: Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor
: antagonist. We also thank Ms. D. Machard and A. Dupre for excellent
: technical assistance.
Megjegyzés-10042335
FU: Swiss National Science Foundation
FX: This work was supported in part by the Swiss National Science
: Foundation (grant to M. R.). R. O. was supported by the Swiss National
: Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloetta,
: Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthelabo
: Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor
: antagonist. We also thank Ms. D. Machard and A. Dupre for excellent
: technical assistance.
Megjegyzés-10044111
FU: Swiss National Science Foundation
FX: This work was supported in part by the Swiss National Science
: Foundation (grant to M. R.). R. O. was supported by the Swiss National
: Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloetta,
: Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthelabo
: Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor
: antagonist. We also thank Ms. D. Machard and A. Dupre for excellent
: technical assistance.
Megjegyzés-10059983
FU: Swiss National Science Foundation
FX: This work was supported in part by the Swiss National Science
: Foundation (grant to M. R.). R. O. was supported by the Swiss National
: Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloetta,
: Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthelabo
: Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor
: antagonist. We also thank Ms. D. Machard and A. Dupre for excellent
: technical assistance.
Megjegyzés-10063315
FU: Swiss National Science Foundation
FX: This work was supported in part by the Swiss National Science
: Foundation (grant to M. R.). R. O. was supported by the Swiss National
: Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloetta,
: Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthelabo
: Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor
: antagonist. We also thank Ms. D. Machard and A. Dupre for excellent
: technical assistance.
Megjegyzés-10324200
[273009]
Megjegyzés-10026565
FU: Swiss National Science Foundation
FX: This work was supported in part by the Swiss National Science
: Foundation (grant to M. R.). R. O. was supported by the Swiss National
: Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloetta,
: Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthelabo
: Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor
: antagonist. We also thank Ms. D. Machard and A. Dupre for excellent
: technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 17 August 2019            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 21 August 2019            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 12 March 2020            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNSF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 24 April 2020            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNSF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 20 May 2020            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNSF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 24 May 2020            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNSF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 25 May 2020            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNSF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 23 March 2021            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 31 March 2021            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 1 April 2021            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 6 April 2021            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 13 April 2021            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
Department of Basic Neurosciences, University Medical Center, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland            
            Sanofi-Aventis (Suisse), CH-1217 Meyrin, Geneva, Switzerland            
            Cited By :10            
            Export Date: 14 April 2021            
            CODEN: NRSCD            
            Correspondence Address: Raggenbass, M.; Department of Basic Neurosciences, 1, rue Michel-Servet, CH-1211 Geneva 4, Switzerland; email: mario.raggenbass@medecine.unige.ch            
            Chemicals/CAS: oxytocin, 50-56-6, 54577-94-5; substance P, 33507-63-0; Anesthetics, Local; Lysine, 56-87-1; Oxytocin, 50-56-6; Receptors, Tachykinin; Substance P, 33507-63-0; Tachykinins; Tetrodotoxin, 4368-28-9; biocytin, 576-19-2; gamma-Aminobutyric Acid, 56-12-2            
            Funding details: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, SNF            
            Funding text 1: This work was supported in part by the Swiss National Science Foundation (grant to M.R.). R.O. was supported by the Swiss National Science Foundation MD-PhD program (Foundation Prof. Dr. Max Cloëtta, Zurich, Switzerland). We thank Dr. E. Weinling (Sanofi-Synthélabo Recherche, Chilly-Mazarin, France) for the supply of the NK1 receptor antagonist. We also thank Ms. D. Machard and A. Dupré for excellent technical assistance.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Sceniak, MP
AU  - MacIver, MB
TI  - Slow GABA(A) mediated synaptic transmission in rat visual cortex
JF  - BMC NEUROSCIENCE
J2  - BMC NEUROSCI
VL  - 9
PY  - 2008
SN  - 1471-2202
DO  - 10.1186/1471-2202-9-8
UR  - https://m2.mtmt.hu/api/publication/22890358
ID  - 22890358
N1  - Cited By :25            
            Export Date: 23 August 2019            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A
Cited By :25            
            Export Date: 14 November 2019            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A
Cited By :25            
            Export Date: 12 March 2020            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A
Cited By :25            
            Export Date: 14 May 2020            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A
Cited By :25            
            Export Date: 20 May 2020            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A
Cited By :25            
            Export Date: 23 May 2020            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A
Cited By :27            
            Export Date: 18 March 2021            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, , Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA017884            
            Funding details: National Institute of General Medical Sciences, NIGMS, R01GM054767
Cited By :27            
            Export Date: 31 March 2021            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, , Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA017884            
            Funding details: National Institute of General Medical Sciences, NIGMS, R01GM054767
Cited By :27            
            Export Date: 13 April 2021            
            CODEN: BNMEA            
            Correspondence Address: Sceniak, M.; Department of Pharmacology, , Cleveland, OH 44106, United States; email: michael.sceniak@case.edu            
            Chemicals/CAS: furosemide, 54-31-9; picrotoxin, 124-87-8; Chloride Channels; Furosemide, 54-31-9; GABA Antagonists; Picrotoxin, 124-87-8; Receptors, GABA-A            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA017884            
            Funding details: National Institute of General Medical Sciences, NIGMS, R01GM054767
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Zheng, F
AU  - Khanna, S
TI  - Intra-hippocampal tonic inhibition influences formalin pain-induced pyramidal cell suppression, but not excitation in dorsal field CA1 of rat
JF  - BRAIN RESEARCH BULLETIN
J2  - BRAIN RES BULL
VL  - 77
PY  - 2008
IS  - 6
SP  - 374
EP  - 381
PG  - 8
SN  - 0361-9230
DO  - 10.1016/j.brainresbull.2008.09.004
UR  - https://m2.mtmt.hu/api/publication/21502286
ID  - 21502286
N1  - Megjegyzés-10031683
FU: Academic Research Fund ; National Medical Research Council, Singapore
FX: This work was supported by a research grant from the Academic Research
: Fund and National Medical Research Council, Singapore to SK.
Megjegyzés-10043041
FU: Academic Research Fund ; National Medical Research Council, Singapore
FX: This work was supported by a research grant from the Academic Research
: Fund and National Medical Research Council, Singapore to SK.
Megjegyzés-10044108
FU: Academic Research Fund ; National Medical Research Council, Singapore
FX: This work was supported by a research grant from the Academic Research
: Fund and National Medical Research Council, Singapore to SK.
Megjegyzés-10068606
FU: Academic Research Fund ; National Medical Research Council, Singapore
FX: This work was supported by a research grant from the Academic Research
: Fund and National Medical Research Council, Singapore to SK.
Megjegyzés-10026185
FU: Academic Research Fund ; National Medical Research Council, Singapore
FX: This work was supported by a research grant from the Academic Research
: Fund and National Medical Research Council, Singapore to SK.
Cited By :10            
            Export Date: 14 November 2019            
            CODEN: BRBUD            
            Correspondence Address: Khanna, S.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597, Singapore; email: phsks@nus.edu.sg            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; formaldehyde, 50-00-0; bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; Formaldehyde, 50-00-0            
            Funding details: National Medical Research Council, NMRC            
            Funding text 1: This work was supported by a research grant from the Academic Research Fund and National Medical Research Council, Singapore to SK.
Cited By :10            
            Export Date: 20 May 2020            
            CODEN: BRBUD            
            Correspondence Address: Khanna, S.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597, Singapore; email: phsks@nus.edu.sg            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; formaldehyde, 50-00-0; bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; Formaldehyde, 50-00-0            
            Funding details: National Medical Research Council, NMRC            
            Funding text 1: This work was supported by a research grant from the Academic Research Fund and National Medical Research Council, Singapore to SK.
Cited By :10            
            Export Date: 24 May 2020            
            CODEN: BRBUD            
            Correspondence Address: Khanna, S.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597, Singapore; email: phsks@nus.edu.sg            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; formaldehyde, 50-00-0; bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; Formaldehyde, 50-00-0            
            Funding details: National Medical Research Council, NMRC            
            Funding text 1: This work was supported by a research grant from the Academic Research Fund and National Medical Research Council, Singapore to SK.
Cited By :10            
            Export Date: 25 May 2020            
            CODEN: BRBUD            
            Correspondence Address: Khanna, S.; Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, Singapore 117597, Singapore; email: phsks@nus.edu.sg            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; formaldehyde, 50-00-0; bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; Formaldehyde, 50-00-0            
            Funding details: National Medical Research Council, NMRC            
            Funding text 1: This work was supported by a research grant from the Academic Research Fund and National Medical Research Council, Singapore to SK.
Cited By :10            
            Export Date: 6 April 2021            
            CODEN: BRBUD            
            Correspondence Address: Khanna, S.; Department of Physiology, 2 Medical Drive, Singapore 117597, Singapore; email: phsks@nus.edu.sg            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; formaldehyde, 50-00-0; bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; Formaldehyde, 50-00-0            
            Funding details: National Medical Research Council, NMRC            
            Funding text 1: This work was supported by a research grant from the Academic Research Fund and National Medical Research Council, Singapore to SK.
Cited By :10            
            Export Date: 13 April 2021            
            CODEN: BRBUD            
            Correspondence Address: Khanna, S.; Department of Physiology, 2 Medical Drive, Singapore 117597, Singapore; email: phsks@nus.edu.sg            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; formaldehyde, 50-00-0; bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; Formaldehyde, 50-00-0            
            Funding details: National Medical Research Council, NMRC            
            Funding text 1: This work was supported by a research grant from the Academic Research Fund and National Medical Research Council, Singapore to SK.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Eggers, Erika D
AU  - McCall, Maureen A
AU  - Lukasiewicz, Peter D
TI  - Presynaptic inhibition differentially shapes transmission in distinct circuits in the mouse retina
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 582
PY  - 2007
IS  - 2
SP  - 569
EP  - 582
PG  - 14
SN  - 0022-3751
DO  - 10.1113/jphysiol.2007.131763
UR  - https://m2.mtmt.hu/api/publication/25005231
ID  - 25005231
N1  - Department of Ophthalmology and Visual Sciences, Washington University, St Louis, MO 63110, United States            
            Department of Psychological and Brain Sciences, University of Louisville, Louisville, KY 40292, United States            
            Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY 40292, United States            
            Department of Ophthalmology, Washington University School of Medicine, 660 S. Euclid Avenue, St Louis, MO 63110, United States            
            Cited By :65            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Lukasiewicz, P.D.; Department of Ophthalmology, Washington University School of Medicine, 660 S. Euclid Avenue, St Louis, MO 63110, United States; email: lukasiewicz@vision.wustl.edu            
            Chemicals/CAS: GABA-C receptor; Receptors, GABA; Receptors, GABA-A; Receptors, Glycine
Department of Ophthalmology and Visual Sciences, Washington University, St Louis, MO 63110, United States            
            Department of Psychological and Brain Sciences, University of Louisville, Louisville, KY 40292, United States            
            Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY 40292, United States            
            Department of Ophthalmology, Washington University School of Medicine, 660 S. Euclid Avenue, St Louis, MO 63110, United States            
            Cited By :68            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Lukasiewicz, P.D.; Department of Ophthalmology, 660 S. Euclid Avenue, St Louis, MO 63110, United States; email: lukasiewicz@vision.wustl.edu            
            Chemicals/CAS: GABA-C receptor; Receptors, GABA; Receptors, GABA-A; Receptors, Glycine            
            Funding details: National Eye Institute, NEI, F32EY015629, R01EY008922, R01EY014701, T32EY013360
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Labyt, Etienne
AU  - Wending, Fabrice
TI  - Role of the hippocampus-entorhinal cortex loop in the temporal lobe epilepsy
JF  - EPILEPSIES
J2  - EPILEPSIES
VL  - 19
PY  - 2007
IS  - 1
SP  - 11
EP  - 22
PG  - 12
SN  - 1149-6576
DO  - 10.1684/epi.2007.0047
UR  - https://m2.mtmt.hu/api/publication/25003084
ID  - 25003084
N1  - Export Date: 21 August 2019            
            CODEN: EPILE            
            Correspondence Address: Wendling, F.; Inserm U642, Université de Rennes 1, Laboratoire Traitement du Signal et de l'Image, 35042 Rennes Cedex, France; email: fabrice.wendling@univ-rennes1.fr
Export Date: 20 May 2020            
            CODEN: EPILE            
            Correspondence Address: Wendling, F.; Inserm U642, Université de Rennes 1, Laboratoire Traitement du Signal et de l'Image, 35042 Rennes Cedex, France; email: fabrice.wendling@univ-rennes1.fr
Export Date: 25 May 2020            
            CODEN: EPILE            
            Correspondence Address: Wendling, F.; Inserm U642, Université de Rennes 1, Laboratoire Traitement du Signal et de l'Image, 35042 Rennes Cedex, France; email: fabrice.wendling@univ-rennes1.fr
Export Date: 28 May 2020            
            CODEN: EPILE            
            Correspondence Address: Wendling, F.; Inserm U642, Université de Rennes 1, Laboratoire Traitement du Signal et de l'Image, 35042 Rennes Cedex, France; email: fabrice.wendling@univ-rennes1.fr
Export Date: 13 April 2021            
            CODEN: EPILE            
            Correspondence Address: Wendling, F.; Inserm U642, , 35042 Rennes Cedex, France; email: fabrice.wendling@univ-rennes1.fr
LA  - French
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Spampanato, J
AU  - Mody, I
TI  - Spike timing of lacunosom-moleculare targeting interneurons and CA3 pyramidal cells during high-frequency network oscillations in vitro
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 98
PY  - 2007
IS  - 1
SP  - 96
EP  - 104
PG  - 9
SN  - 0022-3077
DO  - 10.1152/jn.00188.2007
UR  - https://m2.mtmt.hu/api/publication/22882509
ID  - 22882509
N1  - Megjegyzés-21894489
Z9: 14
Megjegyzés-21381166
Chemicals/CAS: Green Fluorescent Proteins, 147336-22-9
Cited By :24            
            Export Date: 18 May 2020            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; UCLA, Neurology NRB1, 635 Charles E. Young Dr. South, Los Angeles, CA 90095-7335, United States; email: Mody@ucla.edu            
            Chemicals/CAS: Green Fluorescent Proteins, 147336-22-9
Cited By :24            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; UCLA, Neurology NRB1, 635 Charles E. Young Dr. South, Los Angeles, CA 90095-7335, United States; email: Mody@ucla.edu            
            Chemicals/CAS: Green Fluorescent Proteins, 147336-22-9
Cited By :24            
            Export Date: 31 March 2021            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; UCLA, 635 Charles E. Young Dr. South, Los Angeles, CA 90095-7335, United States; email: Mody@ucla.edu            
            Chemicals/CAS: Green Fluorescent Proteins, 147336-22-9
Cited By :24            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; UCLA, 635 Charles E. Young Dr. South, Los Angeles, CA 90095-7335, United States; email: Mody@ucla.edu            
            Chemicals/CAS: Green Fluorescent Proteins, 147336-22-9
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Andrásfalvy, Bertalan
AU  - Mody, I
TI  - Differences between the scaling of miniature IPSCs and EPSCs recorded in the dendrites of CA1 mouse pyramidal neurons
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 576
PY  - 2006
IS  - Pt 1
SP  - 191
EP  - 196
PG  - 6
SN  - 0022-3751
DO  - 10.1113/jphysiol.2006.115428
UR  - https://m2.mtmt.hu/api/publication/1616467
ID  - 1616467
AB  - Anatomical studies have described inhibitory synaptic contacts on apical dendrites, and an abundant number of GABAergic synapses on the somata and proximal dendrites of CA1 pyramidal cells of the hippocampus. The number of inhibitory contacts decreases dramatically with distance from the soma, but the local electrophysiological characterization of these synapses at their site of origin in the dendrites is missing. We directly recorded dendritic GABA receptor-mediated inhibitory synaptic events in adult mouse hippocampal CA1 pyramidal neurons and compared them to excitatory synaptic currents recorded at the same sites. Miniature GABAergic events were evoked using localized application of a hyperosmotic solution to the apical dendrites in the vicinity of the dendritic whole-cell recording pipette. Glutamatergic synaptic events were blocked by kynurenic acid, leaving picrotoxin-sensitive IPSCs. We measured the amplitude and kinetic properties of mIPSCs at the soma and at three different dendritic locations. The amplitude of mIPSCs recorded at the various sites was similar along the somato-dendritic axis. The rise- and decay-times of local mIPSCs were also independent of the location of the synapses. The frequency of mIPSCs was 5 Hz at the soma, in contrast to < 0.5 Hz at dendritic sites, which could be increased to 10-20 Hz and 6-10 Hz, respectively, by our hyperosmotic stimulation protocol. Miniature glutamatergic events were evoked with the same protocol after blocking inhibitory synapses by bicucculine. The measured amplitudes increased along the somato-dendritic axis proportionally with their distance from the soma. The measured kinetic properties were independent of location. Consistent with the idea that IPSCs may have a restricted local effect in the dendrites, our data show a lack of distance-dependent scaling of miniature inhibitory synaptic events, in contrast to the scaling of excitatory events recorded at the same sites.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Cossart, R
AU  - Petanjek, Z
AU  - Dumitriu, D
AU  - Hirsch, JC
AU  - Ben-Ari, Y
AU  - Esclapez, M
AU  - Bernard, C
TI  - Interneurons targeting similar layers receive synaptic inputs with similar kinetics
JF  - HIPPOCAMPUS
J2  - HIPPOCAMPUS
VL  - 16
PY  - 2006
IS  - 4
SP  - 408
EP  - 420
PG  - 13
SN  - 1050-9631
DO  - 10.1002/hipo.20169
UR  - https://m2.mtmt.hu/api/publication/27029657
ID  - 27029657
N1  - INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :28            
            Export Date: 17 August 2019            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 12 March 2020            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 24 April 2020            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 18 May 2020            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 20 May 2020            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 21 May 2020            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 22 May 2020            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 25 May 2020            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 18 March 2021            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 31 March 2021            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 1 April 2021            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 6 April 2021            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
INMED, INSERM U29, Parc Scientifique de Luminy, B.P. 13, 13673 Marseille, Cédex 9, France            
            Croatian Institute for Brain Research, University of Zagreb, 10000 Zagreb, Croatia            
            Department of Biological Sciences, Columbia University, 1212 Amsterdam Avenue, 10027 New York, NY, United States            
            INSERM U 751, Faculté de Médecine Timone, 27 Bd Jean Moulin, 13385 Marseille Cedex 5, France            
            Cited By :30            
            Export Date: 13 April 2021            
            CODEN: HIPPE            
            Correspondence Address: Bernard, C.; INMED, B.P. 13, 13673 Marseille, Cédex 9, France; email: cbernard@inmed.univ-mrs.fr            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Eggers, Erika D
AU  - Lukasiewicz, Peter D
TI  - Receptor and transmitter release properties set the time course of retinal inhibition
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 26
PY  - 2006
IS  - 37
SP  - 9413
EP  - 9425
PG  - 13
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.2591-06.2006
UR  - https://m2.mtmt.hu/api/publication/25005236
ID  - 25005236
N1  - Cited By :58            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Lukasiewicz, P.D.; Department of Ophthalmology, Campus Box 8096, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, United States; email: lukasiewicz@vision.wustl.edu            
            Chemicals/CAS: glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; Glutamic Acid, 56-86-0; Neurotransmitter Agents; Receptors, GABA; Receptors, Glycine; Receptors, Neurotransmitter
Cited By :60            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Lukasiewicz, P.D.; Department of Ophthalmology, 660 South Euclid Avenue, St. Louis, MO 63110, United States; email: lukasiewicz@vision.wustl.edu            
            Chemicals/CAS: glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; Glutamic Acid, 56-86-0; Neurotransmitter Agents; Receptors, GABA; Receptors, Glycine; Receptors, Neurotransmitter            
            Funding details: National Eye Institute, NEI, F32EY015629, P30EY002687, R01EY008922, T32EY013360
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Orbán, Gergő
AU  - Kiss, Tamás
AU  - Érdi, Péter
TI  - Intrinsic and synaptic mechanisms determining the timing of neuron population activity during hippocampal theta oscillation
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 96
PY  - 2006
IS  - 6
SP  - 2889
EP  - 2904
PG  - 16
SN  - 0022-3077
DO  - 10.1152/jn.01233.2005
UR  - https://m2.mtmt.hu/api/publication/1290344
ID  - 1290344
AB  - Hippocampal theta (3-8 Hz) is a major electrophysiological activity in rodents, which can be found in primates and humans as well. During theta activity, pyramidal cells and different classes of interneurons were shown to discharge at different phases of the extracellular theta. A recent in vitro study has shown that theta-frequency oscillation can be elicited in a hippocampal CA1 slice by the activation of metabotropic glutamate receptors with similar pharmacological and physiological profile that was found in vivo. We constructed a conductance based three-population network model of the hippocampal CA1 region to study the specific roles of neuron types in the generation of the in vitro theta oscillation and the emergent network properties. Interactions between pairs of neuron populations were studied systematically to assess synchronization and delay properties. We showed that the circuitry consisting of pyramidal cells and two types of hippocampal interneurons [basket and oriens lacunosum-moleculare (O-LM) neurons] was able to generate coherent theta-frequency population oscillation. Furthermore, we found that hyperpolarization-activated nonspecific cation current in pyramidal cells, but not in O-LM neurons, plays an important role in the timing of spike generation, and thus synchronization of pyramidal cells. The model was shown to exhibit the same phase differences between neuron population activities found in vivo, supporting the idea that these patterns of activity are determined internal to the hippocampus.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Pervouchine, DD
AU  - Netoff, TI
AU  - Rotstein, HG
AU  - White, JA
AU  - Cunningham, MO
AU  - Whittington, MA
AU  - Kopell, NJ
TI  - Low-dimensional maps encoding dynamics in entorhinal cortex and hippocampus
JF  - NEURAL COMPUTATION
J2  - NEURAL COMPUT
VL  - 18
PY  - 2006
SP  - 2617
EP  - 2650
PG  - 34
SN  - 0899-7667
DO  - 10.1162/neco.2006.18.11.2617
UR  - https://m2.mtmt.hu/api/publication/10044118
ID  - 10044118
N1  - Department of Mathematics and Statistics, Center for BioDynamics, Boston University, Boston, MA 02215, United States            
            Department of Biomedical Engineering, Center for BioDynamics, Boston University, Boston, MA 02215, United States            
            School of Neurology, Neurobiology and Psychiatry, University of Newcastle, Newcastle upon Tyne, NE2 4HH, United Kingdom            
            Cited By :33            
            Export Date: 20 May 2020            
            Correspondence Address: Pervouchine, D.D.; Department of Mathematics and Statistics, Center for BioDynamics, Boston University, Boston, MA 02215, United States; email: dp@math.bu.edu
Department of Mathematics and Statistics, Center for BioDynamics, Boston University, Boston, MA 02215, United States            
            Department of Biomedical Engineering, Center for BioDynamics, Boston University, Boston, MA 02215, United States            
            School of Neurology, Neurobiology and Psychiatry, University of Newcastle, Newcastle upon Tyne, NE2 4HH, United Kingdom            
            Cited By :33            
            Export Date: 13 April 2021            
            Correspondence Address: Pervouchine, D.D.; Department of Mathematics and Statistics, , Boston, MA 02215, United States; email: dp@math.bu.edu            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS046058
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Buldakova, SL
AU  - Tikhonov, DB
AU  - Magazanik, LG
TI  - Analysis of the excitatory and inhibitory components of postsynaptic currents recorded in pyramidal neurons and interneurons in the rat hippocampus
JF  - NEUROSCIENCE AND BEHAVIORAL PHYSIOLOGY
J2  - NEUROSCI BEHAV PHYSIOL
VL  - 35
PY  - 2005
IS  - 8
SP  - 835
EP  - 843
PG  - 9
SN  - 0097-0549
DO  - 10.1007/s11055-005-0133-y
UR  - https://m2.mtmt.hu/api/publication/25466669
ID  - 25466669
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Gloveli, T
AU  - Dugladze, T
AU  - Rotstein, HG
AU  - Traub, RD
AU  - Monyer, H
AU  - Heinemann, U
AU  - Whittington, MA
AU  - Kopell, NJ
TI  - Orthogonal arrangement of rhythm-generating microcircuits in the hippocampus
JF  - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
J2  - P NATL ACAD SCI USA
VL  - 102
PY  - 2005
IS  - 37
SP  - 13295
EP  - 13300
PG  - 6
SN  - 0027-8424
DO  - 10.1073/pnas.0506259102
UR  - https://m2.mtmt.hu/api/publication/27029651
ID  - 27029651
N1  - Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Tucholskystrasse 2, 10117 Berlin, Germany            
            Department of Mathematics, Center for Biodynamics, Boston University, 111 Cummington Street, Boston, MA 02215, United States            
            Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, NY 11203, United States            
            Department of Clinical Neurobiology, University Hospital of Neurology, Im Neuenheimerfeld 364, Heidelberg D-69120, Germany            
            School of Neurology, Neurobiology and Psychiatry, University of Newcastle, Newcastle upon Tyne NE2 4HH, United Kingdom            
            Cited By :125            
            Export Date: 20 May 2020            
            CODEN: PNASA            
            Correspondence Address: Gloveli, T.; Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Tucholskystrasse 2, 10117 Berlin, Germany; email: tengis.gloveli@charite.de            
            Chemicals/CAS: kainic acid, 487-79-6
Institute of Neurophysiology, Charité-Universitätsmedizin Berlin, Tucholskystrasse 2, 10117 Berlin, Germany            
            Department of Mathematics, Center for Biodynamics, Boston University, 111 Cummington Street, Boston, MA 02215, United States            
            Department of Physiology and Pharmacology, State University of New York Health Science Center, Brooklyn, NY 11203, United States            
            Department of Clinical Neurobiology, University Hospital of Neurology, Im Neuenheimerfeld 364, Heidelberg D-69120, Germany            
            School of Neurology, Neurobiology and Psychiatry, University of Newcastle, Newcastle upon Tyne NE2 4HH, United Kingdom            
            Cited By :134            
            Export Date: 13 April 2021            
            CODEN: PNASA            
            Correspondence Address: Gloveli, T.; Institute of Neurophysiology, Tucholskystrasse 2, 10117 Berlin, Germany; email: tengis.gloveli@charite.de            
            Chemicals/CAS: kainic acid, 487-79-6            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS046058
LA  - English
DB  - MTMT
ER  - 

TY  - BOOK
AU  - Soltesz, Ivan
TI  - Diversity in the Neuronal Machine: Order and Variability in Interneuronal Microcircuits
ET  - 0
PB  - Oxford University Press
CY  - Oxford
PY  - 2005
SP  - 264
SN  - 9780199864713
DO  - 10.1093/acprof:oso/9780195177015.001.1
UR  - https://m2.mtmt.hu/api/publication/2979897
ID  - 2979897
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Jang, IS
AU  - Ito, Y
AU  - Akaike, N
TI  - Feed-forward facilitation of glutamate release by presynaptic GAB(A) receptors
JF  - NEUROSCIENCE
J2  - NEUROSCIENCE
VL  - 135
PY  - 2005
IS  - 3
SP  - 737
EP  - 748
PG  - 12
SN  - 0306-4522
DO  - 10.1016/j.neuroscience.2005.06.030
UR  - https://m2.mtmt.hu/api/publication/23827988
ID  - 23827988
N1  - Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan            
            Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan            
            Cited By :26            
            Export Date: 20 May 2020            
            CODEN: NRSCD            
            Correspondence Address: Akaike, N.; Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan; email: akaike@kumamoto-hsu.ac.jp            
            Chemicals/CAS: 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 104104-50-9; calcium ion, 14127-61-8; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; muscimol, 2763-96-4; GABA Agonists; gabazine, 104104-50-9; Glutamic Acid, 56-86-0; Muscimol, 2763-96-4; Pyridazines; Receptors, GABA-A; Receptors, Presynaptic            
            Funding details: Japan Society for the Promotion of Science, JSPS            
            Funding text 1: We thank Dr. A. Moorhouse for his valuable comments and critically reading this manuscript. This work is supported by Grants-in-Aid for Scientific Research (14002235) from the Japan Society for the Promotion of Science for Y.I. and Project for Promoting Industry-Academic Collaborative Research for N.A. I.-S. Jang is a postdoctoral fellow (P02235) of the Japan Society for the Promotion of Science.
Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan            
            Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan            
            Cited By :26            
            Export Date: 25 May 2020            
            CODEN: NRSCD            
            Correspondence Address: Akaike, N.; Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan; email: akaike@kumamoto-hsu.ac.jp            
            Chemicals/CAS: 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 104104-50-9; calcium ion, 14127-61-8; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; muscimol, 2763-96-4; GABA Agonists; gabazine, 104104-50-9; Glutamic Acid, 56-86-0; Muscimol, 2763-96-4; Pyridazines; Receptors, GABA-A; Receptors, Presynaptic            
            Funding details: Japan Society for the Promotion of Science, JSPS            
            Funding text 1: We thank Dr. A. Moorhouse for his valuable comments and critically reading this manuscript. This work is supported by Grants-in-Aid for Scientific Research (14002235) from the Japan Society for the Promotion of Science for Y.I. and Project for Promoting Industry-Academic Collaborative Research for N.A. I.-S. Jang is a postdoctoral fellow (P02235) of the Japan Society for the Promotion of Science.
Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan            
            Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan            
            Cited By :26            
            Export Date: 28 May 2020            
            CODEN: NRSCD            
            Correspondence Address: Akaike, N.; Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan; email: akaike@kumamoto-hsu.ac.jp            
            Chemicals/CAS: 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 104104-50-9; calcium ion, 14127-61-8; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; muscimol, 2763-96-4; GABA Agonists; gabazine, 104104-50-9; Glutamic Acid, 56-86-0; Muscimol, 2763-96-4; Pyridazines; Receptors, GABA-A; Receptors, Presynaptic            
            Funding details: Japan Society for the Promotion of Science, JSPS            
            Funding text 1: We thank Dr. A. Moorhouse for his valuable comments and critically reading this manuscript. This work is supported by Grants-in-Aid for Scientific Research (14002235) from the Japan Society for the Promotion of Science for Y.I. and Project for Promoting Industry-Academic Collaborative Research for N.A. I.-S. Jang is a postdoctoral fellow (P02235) of the Japan Society for the Promotion of Science.
Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan            
            Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan            
            Cited By :26            
            Export Date: 6 April 2021            
            CODEN: NRSCD            
            Correspondence Address: Akaike, N.; Research Division for Life Sciences, Izumi-machi 325, Kumamoto 861-5598, Japan; email: akaike@kumamoto-hsu.ac.jp            
            Chemicals/CAS: 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 104104-50-9; calcium ion, 14127-61-8; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; muscimol, 2763-96-4; GABA Agonists; gabazine, 104104-50-9; Glutamic Acid, 56-86-0; Muscimol, 2763-96-4; Pyridazines; Receptors, GABA-A; Receptors, Presynaptic            
            Funding details: Japan Society for the Promotion of Science, KAKEN            
            Funding text 1: We thank Dr. A. Moorhouse for his valuable comments and critically reading this manuscript. This work is supported by Grants-in-Aid for Scientific Research (14002235) from the Japan Society for the Promotion of Science for Y.I. and Project for Promoting Industry-Academic Collaborative Research for N.A. I.-S. Jang is a postdoctoral fellow (P02235) of the Japan Society for the Promotion of Science.
Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan            
            Research Division for Life Sciences, Kumamoto Health Science University, Izumi-machi 325, Kumamoto 861-5598, Japan            
            Cited By :26            
            Export Date: 13 April 2021            
            CODEN: NRSCD            
            Correspondence Address: Akaike, N.; Research Division for Life Sciences, Izumi-machi 325, Kumamoto 861-5598, Japan; email: akaike@kumamoto-hsu.ac.jp            
            Chemicals/CAS: 3 amino 2 (3 carboxypropyl) 6 (4 methoxyphenyl)pyridazinium bromide, 104104-50-9; calcium ion, 14127-61-8; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; muscimol, 2763-96-4; GABA Agonists; gabazine, 104104-50-9; Glutamic Acid, 56-86-0; Muscimol, 2763-96-4; Pyridazines; Receptors, GABA-A; Receptors, Presynaptic            
            Funding details: Japan Society for the Promotion of Science, KAKEN            
            Funding text 1: We thank Dr. A. Moorhouse for his valuable comments and critically reading this manuscript. This work is supported by Grants-in-Aid for Scientific Research (14002235) from the Japan Society for the Promotion of Science for Y.I. and Project for Promoting Industry-Academic Collaborative Research for N.A. I.-S. Jang is a postdoctoral fellow (P02235) of the Japan Society for the Promotion of Science.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Klausberger, T
AU  - Marton, LF
AU  - O, Neill J
AU  - Huck, JH
AU  - Dalezios, Y
AU  - Fuentealba, P
AU  - Suen, WY
AU  - Papp, Edit
AU  - Kaneko, T
AU  - Watanabe, M
AU  - Csicsvari, J
AU  - Somogyi, Péter Pál
TI  - Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 25
PY  - 2005
IS  - 42
SP  - 9782
EP  - 9793
PG  - 12
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.3269-05.2005
UR  - https://m2.mtmt.hu/api/publication/109559
ID  - 109559
N1  - Megjegyzés-25003763
Megjegyzés-21899100
Z9: 111
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :266            
            Export Date: 21 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :271            
            Export Date: 12 March 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :273            
            Export Date: 11 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :274            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :274            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :274            
            Export Date: 25 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :295            
            Export Date: 19 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :295            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :296            
            Export Date: 31 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :296            
            Export Date: 1 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :296            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :296            
            Export Date: 14 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :296            
            Export Date: 26 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Oxford OX1 3TH, United Kingdom            
            Center for Brain Research, Medical University, 1090 Vienna, Austria            
            Department of Morphological Brain Science, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan            
            Department of Anatomy, Hokkaido University School of Medicine, 060-3638 Sapporo, Japan            
            Medical Research Council Anatomical Neuropharmacology Unit, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :301            
            Export Date: 7 September 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA
AB  - In the hippocampal CA1 area, a relatively homogenous population of pyramidal cells is accompanied by a diversity of GABAergic interneurons. Previously, we found that parvalbumin-expressing basket, axo-axonic, bistratified, and oriens-lacunosum moleculare cells, innervating different domains of pyramidal cells, have distinct firing patterns during network oscillations in vivo. A second family of interneurons, expressing cholecystokinin but not parvalbumin, is known to target the same domains of pyramidal cells as do the parvalbumin cells. To test the temporal activity of these independent and parallel GABAergic inputs, we recorded the precise spike timing of identified cholecystokinin interneurons during hippocampal network oscillations in anesthetized rats and determined their molecular expression profiles and synaptic targets. The cells were cannabinoid receptor type 1 immunopositive. Contrary to the stereotyped firing of parvalbumin interneurons, cholecystokinin-expressing basket and dendrite-innervating cells discharge, on average, with 1.7 +/- 2.0 Hz during high-frequency ripple oscillations in an episode- dependent manner. During theta oscillations, cholecystokinin-expressing interneurons fire with 8.8 +/- 3.3 Hz at a characteristic time on the ascending phase of theta waves (155 +/- 81), when place cells start firing in freely moving animals. The firing patterns of some interneurons recorded in drug- free behaving rats were similar to cholecystokinin cells in anesthetized animals. Our results demonstrate that cholecystokinin- and parvalbumin- expressing interneurons make different contributions to network oscillations and play distinct roles in different brain states. We suggest that the specific spike timing of cholecystokinin interneurons and their sensitivity to endocannabinoids might contribute to differentiate subgroups of pyramidal cells forming neuronal assemblies, whereas parvalbumin interneurons contribute to synchronizing the entire network.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Maccaferri, G
TI  - Stratum oriens horizontal interneurone diversity and hippocampal network dynamics
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 562
PY  - 2005
IS  - Leeds
SP  - 73
EP  - 80
PG  - 8
SN  - 0022-3751
DO  - 10.1113/jphysiol.2004.077081
UR  - https://m2.mtmt.hu/api/publication/27029647
ID  - 27029647
N1  - Megjegyzés-21894539
Z9: 33
Cited By :69            
            Export Date: 17 August 2019            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :69            
            Export Date: 21 August 2019            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :71            
            Export Date: 12 March 2020            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :71            
            Export Date: 24 April 2020            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :72            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :72            
            Export Date: 24 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2
Cited By :77            
            Export Date: 30 December 2020            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :78            
            Export Date: 23 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :79            
            Export Date: 1 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :79            
            Export Date: 6 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :79            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :79            
            Export Date: 20 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 E Chicago Ave., Tarry Bldg., Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Moskalyuk, AA
AU  - Koval', OM
AU  - Fedulova, SA
AU  - Veselovskii, NS
TI  - Evoked electrical activity and immunocytochemical peculiarities of cultured excitatory and inhibitory neurons of the rat hippocampus
JF  - NEUROPHYSIOLOGY
J2  - NEUROPHYSIOLOGY+
VL  - 37
PY  - 2005
IS  - 3
SP  - 178
EP  - 187
PG  - 10
SN  - 0090-2977
DO  - 10.1007/s11062-005-0063-x
UR  - https://m2.mtmt.hu/api/publication/27660916
ID  - 27660916
N1  - International Center for Molecular Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine            
            Bogomolets Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine            
            Export Date: 20 May 2020            
            CODEN: NPHYB            
            Correspondence Address: Moskalyuk, A.A.; International Center for Molecular Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine; email: nast@biph.kiev.ua            
            Chemicals/CAS: somatostatin, 38916-34-6, 51110-01-1
International Center for Molecular Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine            
            Bogomolets Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine            
            Export Date: 6 April 2021            
            CODEN: NPHYB            
            Correspondence Address: Moskalyuk, A.A.; International Center for Molecular Physiology, , Kyiv, Ukraine; email: nast@biph.kiev.ua            
            Chemicals/CAS: somatostatin, 38916-34-6, 51110-01-1
International Center for Molecular Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine            
            Bogomolets Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv, Ukraine            
            Export Date: 13 April 2021            
            CODEN: NPHYB            
            Correspondence Address: Moskalyuk, A.A.; International Center for Molecular Physiology, , Kyiv, Ukraine; email: nast@biph.kiev.ua            
            Chemicals/CAS: somatostatin, 38916-34-6, 51110-01-1
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Patenaude, C
AU  - Massicotte, G
AU  - Lacaille, JC
TI  - Cell-type specific GABA synaptic transmission and activity-dependent plasticity in rat hippocampal stratum radiatum interneurons
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 22
PY  - 2005
IS  - 1
SP  - 179
EP  - 188
PG  - 10
SN  - 0953-816X
DO  - 10.1111/j.1460-9568.2005.04207.x
UR  - https://m2.mtmt.hu/api/publication/22867961
ID  - 22867961
N1  - Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :20            
            Export Date: 21 August 2019            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 20 May 2020            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 21 May 2020            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 24 May 2020            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 25 May 2020            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 1 January 2021            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 23 March 2021            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 6 April 2021            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 13 April 2021            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Université de Montréal, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada            
            Département de Chimie-Biologie, Université du Québec à Trois-Rivières, Quebec, Que., Canada            
            Cited By :21            
            Export Date: 7 September 2021            
            CODEN: EJONE            
            Correspondence Address: Lacaille, J.-C.; Centre de Recherche en Sciences Neurologiques, C.P. 6128 Succ. Centre-ville, Montréal, Que. H3C 3J7, Canada; email: jean-claude.lacaille@umontreal.ca            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; gamma-Aminobutyric Acid, 56-12-2; Receptors, GABA-B; Receptors, Metabotropic Glutamate
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Rotstein, HG
AU  - Pervouchine, DD
AU  - Acker, CD
AU  - Gillies, MJ
AU  - White, JA
AU  - Buhl, EH
AU  - Whittington, MA
AU  - Kopell, N
TI  - Slow and fast inhibition and an H-current interact to create a theta rhythm in a model of CA1 interneuron network
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 94
PY  - 2005
IS  - 2
SP  - 1509
EP  - 1518
PG  - 10
SN  - 0022-3077
DO  - 10.1152/jn.00957.2004
UR  - https://m2.mtmt.hu/api/publication/27029259
ID  - 27029259
N1  - Department of Mathematics and Statistics, Center for Biodynamics, Boston University, Boston, MA 02215, United States            
            Department of Biomedical Engineering, Center for Biodynamics, Boston University, Boston, MA, United States            
            School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom            
            Cited By :99            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Rotstein, H.G.; Department of Mathematics and Statistics, Center for Biodynamics, Boston University, Boston, MA 02215, United States; email: horacio@math.bu.edu            
            Chemicals/CAS: 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline, 118876-58-7; dihydroxyphenylethylene glycol, 3343-19-9; Excitatory Amino Acid Antagonists; Ion Channels; Methoxyhydroxyphenylglycol, 534-82-7; Quinoxalines
Department of Mathematics and Statistics, Center for Biodynamics, Boston University, Boston, MA 02215, United States            
            Department of Biomedical Engineering, Center for Biodynamics, Boston University, Boston, MA, United States            
            School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom            
            Cited By :99            
            Export Date: 24 May 2020            
            CODEN: JONEA            
            Correspondence Address: Rotstein, H.G.; Department of Mathematics and Statistics, Center for Biodynamics, Boston University, Boston, MA 02215, United States; email: horacio@math.bu.edu            
            Chemicals/CAS: 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline, 118876-58-7; dihydroxyphenylethylene glycol, 3343-19-9; Excitatory Amino Acid Antagonists; Ion Channels; Methoxyhydroxyphenylglycol, 534-82-7; Quinoxalines
Department of Mathematics and Statistics, Center for Biodynamics, Boston University, Boston, MA 02215, United States            
            Department of Biomedical Engineering, Center for Biodynamics, Boston University, Boston, MA, United States            
            School of Biomedical Sciences, University of Leeds, Leeds, United Kingdom            
            Cited By :105            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Rotstein, H.G.; Department of Mathematics and Statistics, , Boston, MA 02215, United States; email: horacio@math.bu.edu            
            Chemicals/CAS: 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline, 118876-58-7; dihydroxyphenylethylene glycol, 3343-19-9; Excitatory Amino Acid Antagonists; Ion Channels; Methoxyhydroxyphenylglycol, 534-82-7; Quinoxalines
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Shao, LR
AU  - Dudek, FE
TI  - Changes in mIPSCs and sIPSCs after kainate treatment: Evidence for loss of inhibitory input to dentate granule cells and possible compensatory responses
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 94
PY  - 2005
IS  - 2
SP  - 952
EP  - 960
PG  - 9
SN  - 0022-3077
DO  - 10.1152/jn.01342.2004
UR  - https://m2.mtmt.hu/api/publication/21884847
ID  - 21884847
N1  - Z9: 36
WC: Neurosciences; Physiology
Cited By :64            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Dudek, F.E.; Dept. of Biomedical Sciences, Anatomy and Neurobiology, Colorado State University, Fort Collins, CO 80523, United States; email: ed.dudek@colostate.edu            
            Chemicals/CAS: 2 amino 5 phosphonovaleric acid, 76726-92-6; 6,7 dinitro 2,3 quinoxalinedione, 2379-57-9; kainic acid, 487-79-6; sodium chloride, 7647-14-5; Anesthetics, Local; Bicuculline, 485-49-4; Excitatory Amino Acid Agonists; GABA Antagonists; Kainic Acid, 487-79-6; Tetrodotoxin, 4368-28-9
Cited By :65            
            Export Date: 30 December 2020            
            CODEN: JONEA            
            Correspondence Address: Dudek, F.E.; Dept. of Biomedical Sciences, Anatomy and Neurobiology, Colorado State University, Fort Collins, CO 80523, United States; email: ed.dudek@colostate.edu            
            Chemicals/CAS: 2 amino 5 phosphonovaleric acid, 76726-92-6; 6,7 dinitro 2,3 quinoxalinedione, 2379-57-9; kainic acid, 487-79-6; sodium chloride, 7647-14-5; Anesthetics, Local; Bicuculline, 485-49-4; Excitatory Amino Acid Agonists; GABA Antagonists; Kainic Acid, 487-79-6; Tetrodotoxin, 4368-28-9            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS016683
Cited By :65            
            Export Date: 1 January 2021            
            CODEN: JONEA            
            Correspondence Address: Dudek, F.E.; Dept. of Biomedical Sciences, Anatomy and Neurobiology, Colorado State University, Fort Collins, CO 80523, United States; email: ed.dudek@colostate.edu            
            Chemicals/CAS: 2 amino 5 phosphonovaleric acid, 76726-92-6; 6,7 dinitro 2,3 quinoxalinedione, 2379-57-9; kainic acid, 487-79-6; sodium chloride, 7647-14-5; Anesthetics, Local; Bicuculline, 485-49-4; Excitatory Amino Acid Agonists; GABA Antagonists; Kainic Acid, 487-79-6; Tetrodotoxin, 4368-28-9            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS016683
Cited By :65            
            Export Date: 19 March 2021            
            CODEN: JONEA            
            Correspondence Address: Dudek, F.E.; Dept. of Biomedical Sciences, Anatomy and Neurobiology, , Fort Collins, CO 80523, United States; email: ed.dudek@colostate.edu            
            Chemicals/CAS: 2 amino 5 phosphonovaleric acid, 76726-92-6; 6,7 dinitro 2,3 quinoxalinedione, 2379-57-9; kainic acid, 487-79-6; sodium chloride, 7647-14-5; Anesthetics, Local; Bicuculline, 485-49-4; Excitatory Amino Acid Agonists; GABA Antagonists; Kainic Acid, 487-79-6; Tetrodotoxin, 4368-28-9            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS016683
Cited By :65            
            Export Date: 1 April 2021            
            CODEN: JONEA            
            Correspondence Address: Dudek, F.E.; Dept. of Biomedical Sciences, Anatomy and Neurobiology, , Fort Collins, CO 80523, United States; email: ed.dudek@colostate.edu            
            Chemicals/CAS: 2 amino 5 phosphonovaleric acid, 76726-92-6; 6,7 dinitro 2,3 quinoxalinedione, 2379-57-9; kainic acid, 487-79-6; sodium chloride, 7647-14-5; Anesthetics, Local; Bicuculline, 485-49-4; Excitatory Amino Acid Agonists; GABA Antagonists; Kainic Acid, 487-79-6; Tetrodotoxin, 4368-28-9            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS016683
Cited By :65            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Dudek, F.E.; Dept. of Biomedical Sciences, Anatomy and Neurobiology, , Fort Collins, CO 80523, United States; email: ed.dudek@colostate.edu            
            Chemicals/CAS: 2 amino 5 phosphonovaleric acid, 76726-92-6; 6,7 dinitro 2,3 quinoxalinedione, 2379-57-9; kainic acid, 487-79-6; sodium chloride, 7647-14-5; Anesthetics, Local; Bicuculline, 485-49-4; Excitatory Amino Acid Agonists; GABA Antagonists; Kainic Acid, 487-79-6; Tetrodotoxin, 4368-28-9            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS016683
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Somogyi, Péter Pál
AU  - Klausberger, T
TI  - Defined types of cortical interneurone structure space and spike timing in the hippocampus.
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 562
PY  - 2005
IS  - 1
SP  - 9
EP  - 26
PG  - 18
SN  - 0022-3751
DO  - 10.1113/jphysiol.2004.078915
UR  - https://m2.mtmt.hu/api/publication/2086378
ID  - 2086378
N1  - Megjegyzés-27029648
Megjegyzés-21894553
Z9: 316
Cited By :646            
            Export Date: 6 March 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :646            
            Export Date: 12 March 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :647            
            Export Date: 24 April 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :648            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :648            
            Export Date: 22 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :648            
            Export Date: 23 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :648            
            Export Date: 24 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :648            
            Export Date: 25 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :664            
            Export Date: 30 December 2020            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :664            
            Export Date: 1 January 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :667            
            Export Date: 18 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :667            
            Export Date: 23 March 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :669            
            Export Date: 1 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :669            
            Export Date: 6 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :669            
            Export Date: 7 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :669            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :669            
            Export Date: 14 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
Cited By :677            
            Export Date: 7 September 2021            
            CODEN: JPHYA            
            Correspondence Address: Somogyi, P.; MRC Anatomical Neuropharmacol. Unit, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; parvalbumin, 56094-12-3, 83667-75-8; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7
AB  - The cerebral cortex encodes, stores and combines information about the internal and external environment in rhythmic activity of multiple frequency ranges. Neurones of the cortex can be defined, recognized and compared on the comprehensive application of the following measures: (i) brain area- and cell domain-specific distribution of input and output synapses, (ii) expression of molecules involved in cell signalling, (iii) membrane and synaptic properties reflecting the expression of membrane proteins, (iv) temporal structure of firing in vivo, resulting from (i)-(iii). Spatial and temporal measures of neurones in the network reflect an indivisible unity of evolutionary design, i.e. neurones do not have separate structure or function. The blueprint of this design is most easily accessible in the CA1 area of the hippocampus, where a relatively uniform population of pyramidal cells and their inputs follow an instantly recognizable laminated pattern and act within stereotyped network activity patterns. Reviewing the cell types and their spatio-temporal interactions, we suggest that CA1 pyramidal cells are supported by at least 16 distinct types of GABAergic neurone. During a given behaviour-contingent network oscillation, interneurones of a given type exhibit similar firing patterns. During different network oscillations representing two distinct brain states, interneurones of the same class show different firing patterns modulating their postsynaptic target-domain in a brain-state-dependent manner. These results suggest roles for specific interneurone types in structuring the activity of pyramidal cells via their respective target domains, and accurately timing and synchronizing pyramidal cell discharge, rather than providing generalized inhibition. Finally, interneurones belonging to different classes may fire preferentially at distinct time points during a given oscillation. As different interneurones innervate distinct domains of the pyramidal cells, the different compartments will receive GABAergic input differentiated in time. Such a dynamic, spatio-temporal, GABAergic control, which evolves distinct patterns during different brain states, is ideally suited to regulating the input integration of individual pyramidal cells contributing to the formation of cell assemblies and representations in the hippocampus and, probably, throughout the cerebral cortex.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Aradi, I
AU  - Maccaferri, G
TI  - Cell type-specific synaptic dynamics of synchronized bursting in the juvenile CA3 rat hippocampus
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 24
PY  - 2004
IS  - 43
SP  - 9681
EP  - 9692
PG  - 12
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.2800-04.2004
UR  - https://m2.mtmt.hu/api/publication/25006528
ID  - 25006528
N1  - Cited By :41            
            Export Date: 21 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, NW University Medical School, Tarry Building, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A
Cited By :41            
            Export Date: 6 March 2020            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, NW University Medical School, Tarry Building, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A
Cited By :41            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, NW University Medical School, Tarry Building, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A
Cited By :41            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, NW University Medical School, Tarry Building, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A
Cited By :42            
            Export Date: 1 January 2021            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, NW University Medical School, Tarry Building, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :42            
            Export Date: 22 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :42            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
Cited By :42            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Maccaferri, G.; Department of Physiology, 303 East Chicago Avenue, Chicago, IL 60611, United States; email: g-macaferri@northwestern.edu            
            Chemicals/CAS: Chlorides; gabazine, 104104-50-9; gamma-Aminobutyric Acid, 56-12-2; Pyridazines; Receptors, GABA-A            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Karnup, SV
TI  - Membrane and network theta-rhythm generation in hippocampal slices
JF  - ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA
J2  - ZH VYSSH NERV DEYAT+
VL  - 54
PY  - 2004
IS  - 1
SP  - 32
EP  - 43
PG  - 12
SN  - 0044-4677
UR  - https://m2.mtmt.hu/api/publication/27029231
ID  - 27029231
N1  - Megjegyzés-20998535
PubMed ID: 15069814
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Russian Federation            
            University of Maryland Medical School, Department of Anatomy and Neurobiology, Baltimore, United States            
            Export Date: 20 May 2020            
            CODEN: ZVNDA            
            Correspondence Address: Karnup, S. V.; Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Russian Federation; email: skarn001@umaryland.edu
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Russian Federation            
            University of Maryland Medical School, Department of Anatomy and Neurobiology, Baltimore, United States            
            Export Date: 6 April 2021            
            CODEN: ZVNDA            
            Correspondence Address: Karnup, S. V.; Institute of Theoretical and Experimental Biophysics, , Pushchino, Russian Federation; email: skarn001@umaryland.edu            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC002588, R01DC005676
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Russian Federation            
            University of Maryland Medical School, Department of Anatomy and Neurobiology, Baltimore, United States            
            Export Date: 13 April 2021            
            CODEN: ZVNDA            
            Correspondence Address: Karnup, S. V.; Institute of Theoretical and Experimental Biophysics, , Pushchino, Russian Federation; email: skarn001@umaryland.edu            
            Funding details: National Institute on Deafness and Other Communication Disorders, NIDCD, R01DC002588, R01DC005676
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Kogo, N
AU  - Dalezios, Y
AU  - Capogna, M
AU  - Ferraguti, F
AU  - Shigemoto, R
AU  - Somogyi, Péter Pál
TI  - Depression of GABAergic input to identified hippocampal neurons by group III metabotropic glutamate receptors in the rat.
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 19
PY  - 2004
IS  - 10
SP  - 2727
EP  - 2740
PG  - 14
SN  - 0953-816X
DO  - 10.1111/j.0953-816X.2004.03394.x
UR  - https://m2.mtmt.hu/api/publication/2086376
ID  - 2086376
N1  - Megjegyzés-27029633
Megjegyzés-21894586
Z9: 26
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :43            
            Export Date: 31 July 2019            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :43            
            Export Date: 11 August 2019            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :43            
            Export Date: 17 August 2019            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :43            
            Export Date: 21 August 2019            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :45            
            Export Date: 19 April 2020            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :45            
            Export Date: 20 April 2020            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :45            
            Export Date: 24 April 2020            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :45            
            Export Date: 20 May 2020            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :45            
            Export Date: 24 May 2020            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :46            
            Export Date: 30 December 2020            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :46            
            Export Date: 1 January 2021            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :46            
            Export Date: 19 March 2021            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :46            
            Export Date: 23 March 2021            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :46            
            Export Date: 1 April 2021            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :46            
            Export Date: 6 April 2021            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
Medical Research Council, Anatomical Neuropharmacology Unit, Univ. Department of Pharmacology, Mansfield Road, Oxford, United Kingdom            
            Dept. of Basic Sciences, Faculty of Medicine, University of Crete, GR-71003 Heraklion, Greece            
            Division of Cerebral Structure, Natl. Inst. for Physiological Sci., Okazaki, Japan            
            CREST, Japan Sci. and Technol. Corporation, Kawaguchi, Japan            
            Department of Pharmacology, University Innsbruck, A-6020 Innsbruck, Austria            
            Cited By :46            
            Export Date: 13 April 2021            
            CODEN: EJONE            
            Correspondence Address: Somogyi, P.; Medical Research Council, Mansfield Road, Oxford, United Kingdom; email: peter.somogyi@pharm.ox.ac.uk            
            Chemicals/CAS: 2 amino 2 (2 carboxycyclopropyl) 3 (xanthen 9 yl)propionic acid, 201943-63-7; biocytin, 576-19-2; somatostatin, 38916-34-6, 51110-01-1; 2-amino-4-phosphono-propinate; 2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acids; biocytin, 576-19-2; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Horseradish Peroxidase, EC 1.11.1.-; LY 341495; Lysine, 56-87-1; metabotropic glutamate receptor 3; Propionic Acids; Receptors, Metabotropic Glutamate; Somatostatin, 51110-01-1; Xanthenes
AB  - The release of GABA in synapses is modulated by presynaptic metabotropic glutamate receptors (mGluRs). We tested whether GABA release to identified hippocampal neurons is influenced by group III mGluR activation using the agonist L-(+)-2-amino-4-phosphonobutyric acid (L-AP4) on inhibitory postsynaptic currents (IPSCs) evoked in CA1 interneurons and pyramidal cells. In interneurons, characterized with biocytin and immunolabelling for somatostatin, evoked IPSCs were depressed by 50 micro m L-AP4 (activating mGluR4 and 8) to 68 +/- 6% of control, but they were rarely depressed in pyramidal cells (96 +/- 4% of control). At 300-500 micro m concentration (activating mGluR4, 7 and 8), L-AP4 depressed IPSCs in both interneurons (to 70 +/- 6%) and pyramidal cells (to 67 +/- 4%). The change in trial-to-trial variability and in paired-pulse depression indicated a presynaptic action. In interneurons, the degree of IPSC depression was variable (to 9-87%), and a third of IPSCs were not affected by L-AP4. The L-AP4-evoked IPSC depression was blocked by LY341495. The depression of IPSCs was similar in O-LM cells and other interneurons. The lack of cell-type selectivity and the similar efficacy of different concentrations of L-AP4 suggest that several group III mGluRs are involved in the depression of IPSCs. Electron microscopic immunocytochemistry confirmed that mGluR4, mGluR7a and mGluR8a occur in the presynaptic active zone of GABAergic terminals on interneurons, but not on those innervating pyramidal cells. The high variability of L-AP4-evoked IPSC suppression is in line with the selective expression of presynaptic mGluRs by several distinct types of GABAergic neuron innervating each interneuron type.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Meguro, R
AU  - Lu, J
AU  - Gavrilovici, C
AU  - Poulter, MO
TI  - Static, transient and permanent organization of GABA(A) receptor expression in calbindin-positive interneurons in response to amygdala kindled seizures
JF  - JOURNAL OF NEUROCHEMISTRY
J2  - J NEUROCHEM
VL  - 91
PY  - 2004
SP  - 144
EP  - 154
PG  - 11
SN  - 0022-3042
DO  - 10.1111/j.1471-4159.2004.02701.x
UR  - https://m2.mtmt.hu/api/publication/10044132
ID  - 10044132
N1  - Neuroscience Research Institute, Carleton University, Ottawa, Ont., Canada            
            Dept. Sensory and Integrative Med., Grad. Sch. of Med. and Dent. Sci., Niigata University, Niigata, Japan            
            Neuroscience Research Institute, Department of Psychology, Carleton University, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada            
            Cited By :13            
            Export Date: 20 May 2020            
            CODEN: JONRA            
            Correspondence Address: Poulter, M.O.; Neuroscience Research Institute, Department of Psychology, Carleton University, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada; email: michael_poulter@carleton.ca            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Parvalbumins; Protein Subunits; Receptors, GABA-A; RNA, Messenger
Neuroscience Research Institute, Carleton University, Ottawa, Ont., Canada            
            Dept. Sensory and Integrative Med., Grad. Sch. of Med. and Dent. Sci., Niigata University, Niigata, Japan            
            Neuroscience Research Institute, Department of Psychology, Carleton University, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada            
            Cited By :13            
            Export Date: 30 December 2020            
            CODEN: JONRA            
            Correspondence Address: Poulter, M.O.; Neuroscience Research Institute, Department of Psychology, Carleton University, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada; email: michael_poulter@carleton.ca            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Parvalbumins; Protein Subunits; Receptors, GABA-A; RNA, Messenger
Neuroscience Research Institute, Carleton University, Ottawa, Ont., Canada            
            Dept. Sensory and Integrative Med., Grad. Sch. of Med. and Dent. Sci., Niigata University, Niigata, Japan            
            Neuroscience Research Institute, Department of Psychology, Carleton University, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada            
            Cited By :13            
            Export Date: 19 March 2021            
            CODEN: JONRA            
            Correspondence Address: Poulter, M.O.; Neuroscience Research Institute, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada; email: michael_poulter@carleton.ca            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Parvalbumins; Protein Subunits; Receptors, GABA-A; RNA, Messenger
Neuroscience Research Institute, Carleton University, Ottawa, Ont., Canada            
            Dept. Sensory and Integrative Med., Grad. Sch. of Med. and Dent. Sci., Niigata University, Niigata, Japan            
            Neuroscience Research Institute, Department of Psychology, Carleton University, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada            
            Cited By :13            
            Export Date: 13 April 2021            
            CODEN: JONRA            
            Correspondence Address: Poulter, M.O.; Neuroscience Research Institute, 1125 Colonel By Drive, Ottawa, Ont. K1S 5B6, Canada; email: michael_poulter@carleton.ca            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Parvalbumins; Protein Subunits; Receptors, GABA-A; RNA, Messenger
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Ratzliff, ADH
AU  - Howard, AL
AU  - Santhakumar, V
AU  - Osapay, I
AU  - Soltesz, Ivan
TI  - Rapid deletion of mossy cells does not result in a hyperexcitable dentate gyrus: Implications for epileptogenesis
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 24
PY  - 2004
IS  - 9
SP  - 2259
EP  - 2269
PG  - 11
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.5191-03.2004
UR  - https://m2.mtmt.hu/api/publication/2941536
ID  - 2941536
AB  - Loss of cells from the hilus of the dentate gyrus is a major histological hallmark of human temporal lobe epilepsy. Hilar mossy cells, in particular, are thought to show dramatic numerical reductions in pathological conditions, and one prominent theory of epileptogenesis is based on the assumption that mossy cell loss directly results in granule cell hyperexcitability. However, whether it is the disappearance of hilar mossy cells from the dentate gyrus circuitry after various insults or the subsequent synaptic - cellular alterations ( e. g., reactive axonal sprouting) that lead to dentate hyperexcitability has not been rigorously tested, because of the lack of available techniques to rapidly remove specific classes of nonprincipal cells from neuronal networks. We developed a fast, cell-specific ablation technique that allowed the targeted lesioning of either mossy cells or GABAergic interneurons in horizontal as well as axial ( longitudinal) slices of the hippocampus. The results demonstrate that mossy cell deletion consistently decreased the excitability of granule cells to perforant path stimulation both within and outside of the lamella where the mossy cell ablation took place. In contrast, ablation of interneurons caused the expected increase in excitability, and control aspirations of the hilar neuropil or of interneurons in the presence of GABA receptor blockers caused no alteration in granule cell excitability. These data do not support the hypothesis that loss of mossy cells from the dentate hilus after seizures or traumatic brain injury directly results in hyperexcitability.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bacci, A
AU  - Rudolph, U
AU  - Huguenard, JR
AU  - Prince, DA
TI  - Major differences in inhibitory synaptic transmission onto two neocortical interneuron subclasses
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 23
PY  - 2003
IS  - 29
SP  - 9664
EP  - 9674
PG  - 11
SN  - 0270-6474
DO  - 10.1523/jneurosci.23-29-09664.2003
UR  - https://m2.mtmt.hu/api/publication/25005890
ID  - 25005890
N1  - Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :109            
            Export Date: 15 April 2020            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :109            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :109            
            Export Date: 21 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :109            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :109            
            Export Date: 25 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :114            
            Export Date: 18 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, P50NS012151, R01NS039579
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :114            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, P50NS012151, R01NS039579
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :114            
            Export Date: 7 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, P50NS012151, R01NS039579
Dept. of Neurol. and Neurol. Sci., Stanford Univ. School of Medicine, Stanford, CA 94305, United States            
            Inst. of Pharmacology and Toxicology, University of Zürich, CH-8057 Zürich, Switzerland            
            Dept. of Neurol. and Neurol. Sci., Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, United States            
            Cited By :114            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Prince, D.A.; Dept. of Neurol. and Neurol. Sci., 300 Pasteur Drive, Stanford, CA 94305, United States; email: daprince@stanford.edu            
            Chemicals/CAS: loreclezole, 117857-45-1; zolpidem, 82626-48-0; 4 aminobutyric acid, 28805-76-7, 56-12-2; GABA Agonists; gamma-Aminobutyric Acid, 56-12-2; loreclezole, 117857-45-1; Protein Subunits; Pyridines; Receptors, GABA-A; Triazoles; zolpidem, 82626-48-0            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, P50NS012151, R01NS039579
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Hoffman, AF
AU  - Riegel, AC
AU  - Lupica, CR
TI  - Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 18
PY  - 2003
IS  - 3
SP  - 524
EP  - 534
PG  - 11
SN  - 0953-816X
DO  - 10.1046/j.1460-9568.2003.02773.x
UR  - https://m2.mtmt.hu/api/publication/25005684
ID  - 25005684
N1  - Cited By :58            
            Export Date: 21 August 2019            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, National Institutes of Health, US Dept. of Hlth. and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6
Cited By :59            
            Export Date: 12 March 2020            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, National Institutes of Health, US Dept. of Hlth. and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6
Cited By :59            
            Export Date: 20 May 2020            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, National Institutes of Health, US Dept. of Hlth. and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6
Cited By :59            
            Export Date: 24 May 2020            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, National Institutes of Health, US Dept. of Hlth. and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6
Cited By :59            
            Export Date: 25 May 2020            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, National Institutes of Health, US Dept. of Hlth. and Human Services, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6
Cited By :63            
            Export Date: 23 March 2021            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA014263, Z01DA000456
Cited By :63            
            Export Date: 1 April 2021            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA014263, Z01DA000456
Cited By :63            
            Export Date: 6 April 2021            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA014263, Z01DA000456
Cited By :63            
            Export Date: 13 April 2021            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA014263, Z01DA000456
Cited By :64            
            Export Date: 7 September 2021            
            CODEN: EJONE            
            Correspondence Address: Lupica, C.R.; National Institute on Drug Abuse, 5500 Nathan Shock Drive, Baltimore, MD 21224, United States; email: clupica@intra.nida.nih.gov            
            Chemicals/CAS: 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; carbachol, 462-58-8, 51-83-2; rimonabant, 158681-13-1, 168273-06-1; Cannabinoids; gamma-Aminobutyric Acid, 56-12-2; Glutamic Acid, 56-86-0; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; SR 141716A, 158681-13-1; Win 55212-2, 134959-51-6            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA014263, Z01DA000456
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Hsu, FC
AU  - Waldeck, R
AU  - Faber, DS
AU  - Smith, SS
TI  - Neurosteroid effects on GABAergic synaptic plasticity in hippocampus
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 89
PY  - 2003
SP  - 1929
EP  - 1940
PG  - 12
SN  - 0022-3077
DO  - 10.1152/jn.00780.2002
UR  - https://m2.mtmt.hu/api/publication/10044356
ID  - 10044356
N1  - Department of Neurobiology, Med. Coll. of PA-Hahnemann Univ., Philadelphia, PA 19129, United States            
            Dept. of Physiology, SUNY Downstate Medical Center, 450 Clarkson Ave., Brooklyn, NY 11203, United States            
            Cited By :50            
            Export Date: 18 October 2022            
            CODEN: JONEA            
            Correspondence Address: Smith, S.S.; Dept. of Physiology, 450 Clarkson Ave., Brooklyn, NY 11203, United States; email: sheryl.smith@downstate.edu            
            Chemicals/CAS: 3alpha hydroxy 5alpha pregnan 20 one, 516-54-1; 8 azido 5,6 dihydro 5 methyl 6 oxo 4h imidazo[1,5 a][1,4]benzodiazepine 3 carboxylic acid ethyl ester, 91917-65-6; lorazepam, 846-49-1; tetrodotoxin, 4368-28-9, 4664-41-9; Affinity Labels; Azides; benzodiazepine, 12794-10-4; Benzodiazepines; gamma-Aminobutyric Acid, 56-12-2; Oligonucleotides, Antisense; Pregnanolone, 128-20-1; Receptors, GABA; Ro 15-4513, 91917-65-6            
            Tradenames: ro 15 4513            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA009618            
            Funding details: National Institute on Alcohol Abuse and Alcoholism, NIAAA, R01AA012958            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS021848
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Jensen, K
AU  - Chiu, CS
AU  - Sokolova, I
AU  - Lester, HA
AU  - Mody, I
TI  - GABA transporter-1 (GAT1)-Deficient mice: Differential tonic activation of GABA(A) versus GABA(B) receptors in the hippocampus
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 90
PY  - 2003
SP  - 2690
EP  - 2701
PG  - 12
SN  - 0022-3077
DO  - 10.1152/jn.00240.2003
UR  - https://m2.mtmt.hu/api/publication/10058143
ID  - 10058143
N1  - Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, United States            
            Division of Biology, California Institute of Technology, Pasadena, CA 91125, United States            
            Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States            
            Cited By :162            
            Export Date: 26 August 2019            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; carrier protein, 80700-39-6; glutamate decarboxylase, 9024-58-2; Carrier Proteins; GABA permease, 69913-01-5; GABA Plasma Membrane Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters; Receptors, GABA-A; Receptors, GABA-B; Slc6a1 protein, mouse
Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, United States            
            Division of Biology, California Institute of Technology, Pasadena, CA 91125, United States            
            Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States            
            Cited By :164            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; carrier protein, 80700-39-6; glutamate decarboxylase, 9024-58-2; Carrier Proteins; GABA permease, 69913-01-5; GABA Plasma Membrane Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters; Receptors, GABA-A; Receptors, GABA-B; Slc6a1 protein, mouse
Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, United States            
            Division of Biology, California Institute of Technology, Pasadena, CA 91125, United States            
            Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States            
            Cited By :164            
            Export Date: 24 May 2020            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; carrier protein, 80700-39-6; glutamate decarboxylase, 9024-58-2; Carrier Proteins; GABA permease, 69913-01-5; GABA Plasma Membrane Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters; Receptors, GABA-A; Receptors, GABA-B; Slc6a1 protein, mouse
Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, United States            
            Division of Biology, California Institute of Technology, Pasadena, CA 91125, United States            
            Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States            
            Cited By :167            
            Export Date: 30 December 2020            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; carrier protein, 80700-39-6; glutamate decarboxylase, 9024-58-2; Carrier Proteins; GABA permease, 69913-01-5; GABA Plasma Membrane Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters; Receptors, GABA-A; Receptors, GABA-B; Slc6a1 protein, mouse            
            Funding details: National Institute of Mental Health, NIMH, R01MH061468, P50MH049176            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA014947, R29DA010509, R01DA009121, R01DA010509            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS030549, R37NS030549, R01NS011756
Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, United States            
            Division of Biology, California Institute of Technology, Pasadena, CA 91125, United States            
            Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States            
            Cited By :170            
            Export Date: 7 April 2021            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; Dept. of Neurology, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; carrier protein, 80700-39-6; glutamate decarboxylase, 9024-58-2; Carrier Proteins; GABA permease, 69913-01-5; GABA Plasma Membrane Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters; Receptors, GABA-A; Receptors, GABA-B; Slc6a1 protein, mouse            
            Funding details: National Institute of Mental Health, NIMH, P50MH049176, R01MH061468            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA009121, R01DA010509, R01DA014947            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS011756, R01NS030549
Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, United States            
            Division of Biology, California Institute of Technology, Pasadena, CA 91125, United States            
            Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States            
            Cited By :170            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; Dept. of Neurology, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; carrier protein, 80700-39-6; glutamate decarboxylase, 9024-58-2; Carrier Proteins; GABA permease, 69913-01-5; GABA Plasma Membrane Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters; Receptors, GABA-A; Receptors, GABA-B; Slc6a1 protein, mouse            
            Funding details: National Institute of Mental Health, NIMH, P50MH049176, R01MH061468            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA009121, R01DA010509, R01DA014947            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS011756, R01NS030549
Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095, United States            
            Division of Biology, California Institute of Technology, Pasadena, CA 91125, United States            
            Dept. of Neurology, David Geffen Sch. of Med. at UCLA, RNRC 3-155, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States            
            Cited By :170            
            Export Date: 20 April 2021            
            CODEN: JONEA            
            Correspondence Address: Mody, I.; Dept. of Neurology, 710 Westwood Plaza, Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; carrier protein, 80700-39-6; glutamate decarboxylase, 9024-58-2; Carrier Proteins; GABA permease, 69913-01-5; GABA Plasma Membrane Transport Proteins; Membrane Proteins; Membrane Transport Proteins; Organic Anion Transporters; Receptors, GABA-A; Receptors, GABA-B; Slc6a1 protein, mouse            
            Funding details: National Institute of Mental Health, NIMH, P50MH049176, R01MH061468            
            Funding details: National Institute on Drug Abuse, NIDA, R01DA009121, R01DA010509, R01DA014947            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS011756, R01NS030549
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Jinno, S
AU  - Kosaka, T
TI  - Patterns of expression of neuropeptides in GABAergic nonprincipal neurons in the mouse hippocampus: Quantitative analysis with optical disector
JF  - JOURNAL OF COMPARATIVE NEUROLOGY
J2  - J COMP NEUROL
VL  - 461
PY  - 2003
IS  - 3
SP  - 333
EP  - 349
PG  - 17
SN  - 0021-9967
DO  - 10.1002/cne.10700
UR  - https://m2.mtmt.hu/api/publication/27029615
ID  - 27029615
N1  - Cited By :45            
            Export Date: 21 August 2019            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
Cited By :45            
            Export Date: 23 August 2019            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
Cited By :46            
            Export Date: 20 May 2020            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
Cited By :46            
            Export Date: 24 May 2020            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
Cited By :46            
            Export Date: 25 May 2020            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
Cited By :49            
            Export Date: 23 March 2021            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
Cited By :49            
            Export Date: 6 April 2021            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
Cited By :49            
            Export Date: 13 April 2021            
            CODEN: JCNEA            
            Correspondence Address: Jinno, S.; Department of Anatomy, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; email: sjnno@med.kyushu-u.ac.jp            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; cholecystokinin, 9011-97-6, 93443-27-7; neuropeptide Y, 82785-45-3, 83589-17-7; somatostatin, 38916-34-6, 51110-01-1; vasoactive intestinal polypeptide, 37221-79-7; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Neuropeptide Y; Neuropeptides; Somatostatin, 51110-01-1; Vasoactive Intestinal Peptide, 37221-79-7
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Maccaferri, G
AU  - Lacaille, JC
TI  - Interneuron Diversity series: Hippocampal interneuron classifications - making things as simple as possible, not simpler
JF  - TRENDS IN NEUROSCIENCES
J2  - TRENDS NEUROSCI
VL  - 26
PY  - 2003
IS  - 10
SP  - 564
EP  - 571
PG  - 8
SN  - 0166-2236
DO  - 10.1016/j.tins.2003.08.002
UR  - https://m2.mtmt.hu/api/publication/25007158
ID  - 25007158
N1  - Megjegyzés-21894631
Z9: 80
\n Cited By :131 \n Export Date: 13 November 2018 \n CODEN: TNSCD \n Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu \n Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2 \n Funding details: National Institute of Mental Health, NIMH, MH067561 \n Funding details: Canadian Institutes of Health Research, CIHR \n Funding details: Canada Research Chairs \n Funding details: Fonds de Recherche du Québec - Santé, FRQS \n Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :135            
            Export Date: 17 August 2019            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, MH067561            
            Funding details: Canadian Institutes of Health Research            
            Funding details: Canada Research Chairs            
            Funding details: Fonds de Recherche du Québec - Santé            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :135            
            Export Date: 21 August 2019            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, MH067561            
            Funding details: Canadian Institutes of Health Research            
            Funding details: Canada Research Chairs            
            Funding details: Fonds de Recherche du Québec - Santé            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :136            
            Export Date: 6 March 2020            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, MH067561            
            Funding details: Canadian Institutes of Health Research            
            Funding details: Canada Research Chairs            
            Funding details: Fonds de Recherche du Québec - Santé            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :136            
            Export Date: 12 March 2020            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :137            
            Export Date: 24 April 2020            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :137            
            Export Date: 20 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :138            
            Export Date: 24 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :138            
            Export Date: 25 May 2020            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, Department of Physiology, Northwestern University, Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :144            
            Export Date: 23 March 2021            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, , Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :144            
            Export Date: 31 March 2021            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, , Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :144            
            Export Date: 1 April 2021            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, , Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :144            
            Export Date: 6 April 2021            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, , Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :144            
            Export Date: 13 April 2021            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, , Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
Cited By :144            
            Export Date: 20 April 2021            
            CODEN: TNSCD            
            Correspondence Address: Maccaferri, G.; Feinberg School of Medicine, , Chicago, IL 60611, United States; email: g-maccaferri@northwestern.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH067561            
            Funding details: Canadian Institutes of Health Research, CIHR            
            Funding details: Fonds de Recherche du Québec - Santé, FRQS            
            Funding text 1: We thank Chris J. McBain, Tamas F. Freund and an anonymous reviewer for their constructive comments and insights on the manuscript during the reviewing process. Our research is supported by the National Institute of Mental Health (grant MH067561 to G.M.), the Canadian Institutes of Health Research and the Fonds de la Recherche en Santé du Québec (J.C.L.). J.C.L. is the recipient of a Canada Research Chair in Cellular and Molecular Neurophysiology.
AB  - The nervous system is made up of many specific types of neuron intricately intertwined to form complex networks. Identifying and defining the characteristic features of the many different neuronal types is essential for achieving a cellular understanding of complex activity from perception to cognition. So far, cortical GABAergic interneurons have represented the epitome of cellular diversity in the CNS. Despite the desperate need for effective classification criteria allowing a common language among neuroscientists, interneurons still evoke memories of Babel. Several approaches are now available to overcome the challenges and problems associated with the various classification systems used so far.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Aradi, I
AU  - Soltesz, Ivan
TI  - Modulation of network behaviour by changes in variance in interneuronal properties
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 538
PY  - 2002
IS  - 1
SP  - 227
EP  - 251
PG  - 25
SN  - 0022-3751
DO  - 10.1113/jphysiol.2001.013054
UR  - https://m2.mtmt.hu/api/publication/2941545
ID  - 2941545
AB  - Interneurones are important regulators of neuronal networks. The conventional approach to interneurones is to focus on the mean values of various parameters. Here we tested the hypothesis that changes in the variance of interneuronal properties (e.g. in the degree of scattering of parameter values of individual cells around the population mean) may modify the behaviour of networks. Biophysically based multicompartmental models of principal cells and interneurones showed that changes in the variance in the electrophysiological and anatomical properties of interneurones significantly alter the input-output functions, rhythmicity and synchrony of principal cells, even if the mean values were unchanged. In most cases, increased heterogeneity in interneurones resulted in stronger inhibition of principal cell firing; however, there were parameter ranges where increased interneuronal variance decreased the inhibition of principal cells. Electrophysiological recordings showed that the variance in the resting membrane potential of CA1 stratum oriens interneurones persistently increased following experimental complex febrile seizures in developing rats, without a change in the mean resting membrane potential, indicating that lasting alterations in interneuronal heterogeneity can take place in real neuronal systems. These computational and experimental data demonstrate that modifications in interneuronal population variance influence the behaviour of neuronal networks, and suggest a physiological role for interneuronal diversity. Furthermore, the results indicate that interneuronal heterogeneity can change in neurological diseases, and raise the possibility that neuromodulators may act by regulating the variance of key parameters in interneuronal populations.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Cope, DW
AU  - Maccaferri, G
AU  - Marton, LF
AU  - Roberts, JD
AU  - Cobden, PM
AU  - Somogyi, Péter Pál
TI  - Cholecystokinin-immunopositive basket and Schaffer collateral-associated interneurones target different domains of pyramidal cells in the CA1 area of the rat hippocampus.
JF  - NEUROSCIENCE
J2  - NEUROSCIENCE
VL  - 109
PY  - 2002
IS  - 1
SP  - 63
EP  - 80
PG  - 18
SN  - 0306-4522
DO  - 10.1016/S0306-4522(01)00440-7
UR  - https://m2.mtmt.hu/api/publication/2138527
ID  - 2138527
N1  - MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :102            
            Export Date: 21 August 2019            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :104            
            Export Date: 6 March 2020            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :104            
            Export Date: 12 March 2020            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :105            
            Export Date: 19 April 2020            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :105            
            Export Date: 20 May 2020            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :105            
            Export Date: 24 May 2020            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :105            
            Export Date: 25 May 2020            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :105            
            Export Date: 28 May 2020            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :107            
            Export Date: 9 March 2021            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :108            
            Export Date: 22 March 2021            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :108            
            Export Date: 23 March 2021            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :108            
            Export Date: 1 April 2021            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :108            
            Export Date: 6 April 2021            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :108            
            Export Date: 13 April 2021            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
MRC Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322, United States            
            Cited By :111            
            Export Date: 7 September 2021            
            Chemicals/CAS: biocytin, 576-19-2; calbindin; Calcium-Binding Protein, Vitamin D-Dependent; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
AB  - Two types of GABAergic interneurone are known to express cholecystokinin-related peptides in the isocortex: basket cells, which preferentially innervate the somata and proximal dendrites of pyramidal cells; and double bouquet cells, which innervate distal dendrites and dendritic spines. In the hippocampus, cholecystokinin immunoreactivity has only been reported in basket cells. However, at least eight distinct GABAergic interneurone types terminate in the dendritic domain of CA1 pyramidal cells, some of them with as yet undetermined neurochemical characteristics. In order to establish whether more than one population of cholecystokinin-expressing interneurone exist in the hippocampus, we have performed whole-cell current clamp recordings from interneurones located in the stratum radiatum of the hippocampal CA1 region of developing rats. Recorded neurones were filled with biocytin to reveal their axonal targets, and were tested for the presence of pro-cholecystokinin immunoreactivity. The results show that two populations of cholecystokinin-immunoreactive interneurones exist in the CA1 area (n=15 positive cells). Cholecystokinin-positive basket cells (53%) preferentially innervate stratum pyramidale and adjacent strata oriens and radiatum. A second population of cholecystokinin-positive cells, previously described as Schaffer collateral-associated interneurones [Vida et al. (1998) J. Physiol. 506, 755-773], have axons that ramify almost exclusively in strata radiatum and oriens, overlapping with the Schaffer collateral/commissural pathway originating from CA3 pyramidal cells. Two of seven of the Schaffer collateral-associated cells were also immunopositive for calbindin. Soma position and orientation in stratum radiatum, the number and orientation of dendrites, and the passive and active membrane properties of the two cell populations are only slightly different. In addition, in stratum radiatum and its border with lacunosum of perfusion-fixed hippocampi, 31.6+/-3.8% (adult) or 26.8+/-2.9% (postnatal day 17-20) of cholecystokinin-positive cells were also immunoreactive for calbindin. Therefore, at least two populations of pro-cholecystokinin-immunopositive interneurones, basket and Schaffer collateral-associated cells, exist in the CA1 area of the hippocampus, and are probably homologous to cholecystokinin-immunopositive basket and double bouquet cells in the isocortex. It is not known if the GABAergic terminals of double bouquet cells are co-aligned with specific glutamatergic inputs. However, in the hippocampal CA1 area, it is clear that the terminals of Schaffer collateral-associated cells are co-stratified with the glutamatergic input from the CA3 area, with as yet unknown functional consequences. The division of the postsynaptic neuronal surface by two classes of GABAergic cell expressing cholecystokinin in both the hippocampus and isocortex provides further evidence for the uniform synaptic organisation of the cerebral cortex.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Fischer, Y
AU  - Wittner, Lucia
AU  - Freund, Tamás
AU  - Gähwiler, BH
TI  - Simultaneous activation of gamma and theta network oscillations in rat hippocampal slice cultures
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 539
PY  - 2002
SP  - 857
EP  - 868
PG  - 12
SN  - 0022-3751
DO  - 10.1113/jphysiol.2001.013050
UR  - https://m2.mtmt.hu/api/publication/109159
ID  - 109159
N1  - Brain Research Institute, University of Zurich, CH-8057 Zurich, Switzerland            
            Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Brain Research Institute, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland            
            Cited By :39            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Fischer, Y.; Brain Research Institute, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland; email: kfischer@hifo.unizh.ch            
            Chemicals/CAS: Acetylcholine, 51-84-3; Methacholine Chloride, 62-51-1; Muscarinic Agonists; Receptors, Cholinergic
Brain Research Institute, University of Zurich, CH-8057 Zurich, Switzerland            
            Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Brain Research Institute, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland            
            Cited By :39            
            Export Date: 24 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Fischer, Y.; Brain Research Institute, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland; email: kfischer@hifo.unizh.ch            
            Chemicals/CAS: Acetylcholine, 51-84-3; Methacholine Chloride, 62-51-1; Muscarinic Agonists; Receptors, Cholinergic
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Hájos, Norbert
AU  - Freund, Tamás
AU  - Mody, I
TI  - Comparison of single NMDA receptor channels recorded on hippocampal principal cells and oriens/alveus interneurons projecting to stratum lacunosum-moleculare (O-LM cells)
JF  - ACTA BIOLOGICA HUNGARICA (1983-2018)
J2  - ACTA BIOL HUNG
VL  - 53
PY  - 2002
SP  - 465
EP  - 472
PG  - 8
SN  - 0236-5383
DO  - 10.1556/ABiol.53.2002.4.7
UR  - https://m2.mtmt.hu/api/publication/109363
ID  - 109363
N1  - Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, United States            
            Cited By :13            
            Export Date: 18 August 2019            
            CODEN: ABHUE            
            Correspondence Address: Freund, T.F.; Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary; email: freund@koki.hu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Receptors, N-Methyl-D-Aspartate
Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, United States            
            Cited By :13            
            Export Date: 21 August 2019            
            CODEN: ABHUE            
            Correspondence Address: Freund, T.F.; Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary; email: freund@koki.hu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Receptors, N-Methyl-D-Aspartate
Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, United States            
            Cited By :13            
            Export Date: 6 March 2020            
            CODEN: ABHUE            
            Correspondence Address: Freund, T.F.; Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary; email: freund@koki.hu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Receptors, N-Methyl-D-Aspartate
Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, United States            
            Cited By :13            
            Export Date: 20 May 2020            
            CODEN: ABHUE            
            Correspondence Address: Freund, T.F.; Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary; email: freund@koki.hu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Receptors, N-Methyl-D-Aspartate
Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, United States            
            Cited By :13            
            Export Date: 24 May 2020            
            CODEN: ABHUE            
            Correspondence Address: Freund, T.F.; Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary; email: freund@koki.hu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Receptors, N-Methyl-D-Aspartate
Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, United States            
            Cited By :13            
            Export Date: 23 March 2021            
            CODEN: ABHUE            
            Correspondence Address: Freund, T.F.; Dept. of Functional Neuroanatomy, , H-1450 Budapest, Hungary; email: freund@koki.hu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Receptors, N-Methyl-D-Aspartate            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R37NS030549
Dept. of Functional Neuroanatomy, Institute of Experimental Medicine, Hungarian Academy of Sciences, H-1450 Budapest, Hungary            
            Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-1769, United States            
            Cited By :13            
            Export Date: 13 April 2021            
            CODEN: ABHUE            
            Correspondence Address: Freund, T.F.; Dept. of Functional Neuroanatomy, , H-1450 Budapest, Hungary; email: freund@koki.hu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Receptors, N-Methyl-D-Aspartate            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R37NS030549
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Klausberger, T
AU  - Roberts, JD
AU  - Somogyi, Péter Pál
TI  - Cell type- and input-specific differences in the number and subtypes of synaptic GABA(A) receptors in the hippocampus.
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 22
PY  - 2002
IS  - 7
SP  - 2513
EP  - 2521
PG  - 9
SN  - 0270-6474
DO  - 10.1523/jneurosci.22-07-02513.2002
UR  - https://m2.mtmt.hu/api/publication/2138092
ID  - 2138092
N1  - Megjegyzés-22871898
Megjegyzés-21894676
Z9: 99
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :176            
            Export Date: 12 March 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :178            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :178            
            Export Date: 21 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :178            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 30 December 2020            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 1 January 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 19 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 1 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 7 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :179            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
Medical Research Council, Department of Pharmacology, Oxford University, Oxford OX1 3TH, United Kingdom            
            Medical Research Council, Oxford University, Department of Pharmacology, Mansfield Road, Oxford OX1 3TH, United Kingdom            
            Cited By :181            
            Export Date: 7 September 2021            
            CODEN: JNRSD            
            Correspondence Address: Klausberger, T.; Medical Research Council, Mansfield Road, Oxford OX1 3TH, United Kingdom; email: thomas.klausberger@pharm.ox.ac.uk            
            Chemicals/CAS: parvalbumin, 56094-12-3, 83667-75-8; Protein Subunits; Receptors, GABA-A
AB  - Networks of parvalbumin (PV)-expressing basket cells are implicated in synchronizing cortical neurons at various frequencies, through GABA(A) receptor-mediated synaptic action. These cells are interconnected by GABAergic synapses and gap junctions, and converge with a different class of cholecystokinin-expressing, PV-negative basket cells onto pyramidal cells. To define the molecular specializations in the synapses of the two basket cell populations, we used quantitative electron microscopic immunogold localization of GABA(A) receptors. Synapses formed by PV-positive basket cells on the somata of pyramidal cells had several-fold higher density of alpha1 subunit-containing receptors than synapses made by PV-negative basket cells, most of which were immunonegative. The density of the beta2/3 subunits was similar in the two populations of synapse, indicating similar overall receptor density. Synapses interconnecting parvalbumin-expressing basket cells contained a 3.6 times higher overall density of GABA(A) receptor (beta2/3 subunits) and 3.2 times higher density of alpha1 subunit labeling compared with synapses formed by boutons of PV-positive basket cells on pyramidal cells. Thus, PV-positive basket cells mainly act through alpha1 subunit-containing GABA(A) receptors, but the receptor density depends on the postsynaptic cell type. These observations, together with previously reported enrichment of the alpha2 subunit-containing receptors in synapses made by PV-negative basket cells, indicate that the number and subtypes of GABA(A) receptors present in different synapse populations are regulated by both presynaptic and postsynaptic influences. The high number of GABA(A) receptors in synapses on basket cells might contribute to the precisely timed phasing of basket cell activity.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Pawelzik, H
AU  - Hughes, DI
AU  - Thomson, AM
TI  - Physiological and morphological diversity of immunocytochemically defined parvalbumin- and cholecystokinin-positive interneurones in CA1 of the adult rat hippocampus
JF  - JOURNAL OF COMPARATIVE NEUROLOGY
J2  - J COMP NEUROL
VL  - 443
PY  - 2002
IS  - 4
SP  - 346
EP  - 367
PG  - 22
SN  - 0021-9967
DO  - 10.1002/cne.10118
UR  - https://m2.mtmt.hu/api/publication/27029593
ID  - 27029593
N1  - Cited By :178            
            Export Date: 21 August 2019            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins
Cited By :183            
            Export Date: 6 March 2020            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins
Cited By :185            
            Export Date: 20 May 2020            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins
Cited By :185            
            Export Date: 24 May 2020            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins
Cited By :185            
            Export Date: 25 May 2020            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins
Cited By :185            
            Export Date: 28 May 2020            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins
Cited By :192            
            Export Date: 23 March 2021            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins            
            Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK041301
Cited By :193            
            Export Date: 1 April 2021            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins            
            Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK041301
Cited By :193            
            Export Date: 6 April 2021            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins            
            Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK041301
Cited By :193            
            Export Date: 7 April 2021            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins            
            Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK041301
Cited By :193            
            Export Date: 13 April 2021            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins            
            Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK041301
Cited By :193            
            Export Date: 20 April 2021            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins            
            Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK041301
Cited By :196            
            Export Date: 7 September 2021            
            Chemicals/CAS: Cholecystokinin, 9011-97-6; Parvalbumins            
            Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, P30DK041301
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Perkins, KL
TI  - GABA application to hippocampal CA3 or CA1 stratum lacunosum-moleculare excites an interneuron network
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 87
PY  - 2002
IS  - 3
SP  - 1404
EP  - 1414
PG  - 11
SN  - 0022-3077
DO  - 10.1152/jn.00430.2001
UR  - https://m2.mtmt.hu/api/publication/23269608
ID  - 23269608
N1  - Cited By :11            
            Export Date: 21 August 2019            
            CODEN: JONEA            
            Correspondence Address: Perkins, K.L.; SUNY HSCB, Box 29, 450 Clarkson Ave., Brooklyn, NY 11203, United States; email: kperkins@downstate.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; calcium ion, 14127-61-8; magnesium ion, 22537-22-0
Cited By :11            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Perkins, K.L.; SUNY HSCB, Box 29, 450 Clarkson Ave., Brooklyn, NY 11203, United States; email: kperkins@downstate.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; calcium ion, 14127-61-8; magnesium ion, 22537-22-0
Cited By :11            
            Export Date: 24 May 2020            
            CODEN: JONEA            
            Correspondence Address: Perkins, K.L.; SUNY HSCB, Box 29, 450 Clarkson Ave., Brooklyn, NY 11203, United States; email: kperkins@downstate.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; calcium ion, 14127-61-8; magnesium ion, 22537-22-0
Cited By :11            
            Export Date: 23 March 2021            
            CODEN: JONEA            
            Correspondence Address: Perkins, K.L.; SUNY HSCB, 450 Clarkson Ave., Brooklyn, NY 11203, United States; email: kperkins@downstate.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; calcium ion, 14127-61-8; magnesium ion, 22537-22-0
Cited By :11            
            Export Date: 6 April 2021            
            CODEN: JONEA            
            Correspondence Address: Perkins, K.L.; SUNY HSCB, 450 Clarkson Ave., Brooklyn, NY 11203, United States; email: kperkins@downstate.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; calcium ion, 14127-61-8; magnesium ion, 22537-22-0
Cited By :11            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Perkins, K.L.; SUNY HSCB, 450 Clarkson Ave., Brooklyn, NY 11203, United States; email: kperkins@downstate.edu            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; calcium ion, 14127-61-8; magnesium ion, 22537-22-0
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Wu, CP
AU  - Shen, H
AU  - Luk, WP
AU  - Zhang, L
TI  - A fundamental oscillatory state of isolated rodent hippocampus
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 540
PY  - 2002
IS  - 2
SP  - 509
EP  - 527
PG  - 19
SN  - 0022-3751
DO  - 10.1113/jphysiol.2001.013441
UR  - https://m2.mtmt.hu/api/publication/21503064
ID  - 21503064
N1  - Cited By :77            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Zhang, L.; Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ont. M5T 2S8, Canada; email: liangz@uhnres.utoronto.ca            
            Chemicals/CAS: Muscarinic Agonists; Potassium, 7440-09-7
Cited By :77            
            Export Date: 25 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Zhang, L.; Toronto Western Hospital, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ont. M5T 2S8, Canada; email: liangz@uhnres.utoronto.ca            
            Chemicals/CAS: Muscarinic Agonists; Potassium, 7440-09-7
Cited By :81            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Zhang, L.; Toronto Western Hospital, 399 Bathurst Street, Toronto, Ont. M5T 2S8, Canada; email: liangz@uhnres.utoronto.ca            
            Chemicals/CAS: Muscarinic Agonists; Potassium, 7440-09-7
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Alkondon, M
AU  - Albuquerque, EX
TI  - Nicotinic acetylcholine receptor alpha 7 and alpha 4 beta 2 subtypes differentially control GABAergic input to CA1 neurons in rat hippocampus
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 86
PY  - 2001
IS  - 6
SP  - 3043
EP  - 3055
PG  - 13
SN  - 0022-3077
DO  - 10.1152/jn.2001.86.6.3043
UR  - https://m2.mtmt.hu/api/publication/27029581
ID  - 27029581
N1  - Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :186            
            Export Date: 21 August 2019            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, Univ. of Maryland Sch. of Med., 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: alpha(4)beta(4) nicotinic receptor; alpha-bungarotoxin receptor; Choline, 62-49-7; gamma-Aminobutyric Acid, 56-12-2; Neurotoxins; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Receptors, Nicotinic
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :191            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, Univ. of Maryland Sch. of Med., 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: alpha(4)beta(4) nicotinic receptor; alpha-bungarotoxin receptor; Choline, 62-49-7; gamma-Aminobutyric Acid, 56-12-2; Neurotoxins; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Receptors, Nicotinic
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :191            
            Export Date: 24 May 2020            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, Univ. of Maryland Sch. of Med., 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: alpha(4)beta(4) nicotinic receptor; alpha-bungarotoxin receptor; Choline, 62-49-7; gamma-Aminobutyric Acid, 56-12-2; Neurotoxins; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Receptors, Nicotinic
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :191            
            Export Date: 25 May 2020            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, Univ. of Maryland Sch. of Med., 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: alpha(4)beta(4) nicotinic receptor; alpha-bungarotoxin receptor; Choline, 62-49-7; gamma-Aminobutyric Acid, 56-12-2; Neurotoxins; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents; Receptors, Nicotinic
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :198            
            Export Date: 23 March 2021            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: acetylcholine, 51-84-3, 60-31-1, 66-23-9; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025296            
            Funding details: National Institute of Environmental Health Sciences, NIEHS, R01ES005730
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :199            
            Export Date: 6 April 2021            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: acetylcholine, 51-84-3, 60-31-1, 66-23-9; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025296            
            Funding details: National Institute of Environmental Health Sciences, NIEHS, R01ES005730
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :199            
            Export Date: 7 April 2021            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: acetylcholine, 51-84-3, 60-31-1, 66-23-9; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025296            
            Funding details: National Institute of Environmental Health Sciences, NIEHS, R01ES005730
Department of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, Baltimore, MD 21201, United States            
            Departamento de Farmacologia Básica e Clínica, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21944, Brazil            
            Dept. of Pharmacology and Experimental Therapeutics, University of Maryland, School of Medicine, 655 W. Baltimore St., Baltimore, MD 21201, United States            
            Cited By :199            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacology, 655 W. Baltimore St., Baltimore, MD 21201, United States; email: ealbuque@umaryland.edu            
            Chemicals/CAS: acetylcholine, 51-84-3, 60-31-1, 66-23-9; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025296            
            Funding details: National Institute of Environmental Health Sciences, NIEHS, R01ES005730
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bartos, M
AU  - Vida, I
AU  - Frotscher, M
AU  - Geiger, JRP
AU  - Jonas, P
TI  - Rapid signaling at inhibitory synapses in a dentate gyrus interneuron network
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 21
PY  - 2001
IS  - 8
SP  - 2687
EP  - 2698
PG  - 12
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.21-08-02687.2001
UR  - https://m2.mtmt.hu/api/publication/27029571
ID  - 27029571
N1  - Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :193            
            Export Date: 18 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Universität Freiburg, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :193            
            Export Date: 21 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Universität Freiburg, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :196            
            Export Date: 6 March 2020            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Universität Freiburg, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :196            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Universität Freiburg, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :196            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Universität Freiburg, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :196            
            Export Date: 25 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Universität Freiburg, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de            
            Chemicals/CAS: bicuculline methiodide, 40709-69-1; Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :196            
            Export Date: 30 December 2020            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Universität Freiburg, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :196            
            Export Date: 22 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :196            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :197            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :197            
            Export Date: 7 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de
Physiologisches Institut, D-79104 Freiburg, Germany            
            Anatomisches Institut, Albert-Ludwigs-Universität Freiburg, D-79104 Freiburg, Germany            
            Cited By :197            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Jonas, P.; Physiologisches Institut, Hermann-Herder-Strasse 7, D-79104 Freiburg, Germany; email: jonasp@uni-freiburg.de
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Lim, MSF
AU  - Birnir, B
TI  - Heterogeneity of functional GABA(A) receptors in rat dentate gyrus neurons revealed by a change in response to drugs during the whole-cell current time-course
JF  - NEUROPHARMACOLOGY
J2  - NEUROPHARMACOLOGY
VL  - 40
PY  - 2001
IS  - 8
SP  - 1034
EP  - 1043
PG  - 10
SN  - 0028-3908
DO  - 10.1016/S0028-3908(01)00032-6
UR  - https://m2.mtmt.hu/api/publication/25005911
ID  - 25005911
N1  - Cited By :8            
            Export Date: 20 May 2020            
            CODEN: NEPHB            
            Correspondence Address: Birnir, B.; Membrane Biology Program, John Curtin School of Medical Res., Australian National University, Canberra, ACT, Australia; email: bryndis.birnir@mphy.lu.se            
            Chemicals/CAS: Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A; Zinc, 7440-66-6            
            Funding details: Medicinska Forskningsrådet, MFR, Y0924            
            Funding details: Lunds Universitet            
            Funding text 1: We thank the Swedish Medical Research Council (grant no Y0924), the Crafoord Stiftelse, the Segerfalks Stiftelse, A.O. Swärds and U. Eklunds Stiftelse and the Medical Faculty, Lund University, for financial support.
Cited By :8            
            Export Date: 1 January 2021            
            CODEN: NEPHB            
            Correspondence Address: Birnir, B.; Membrane Biology Program, John Curtin School of Medical Res., Australian National University, Canberra, ACT, Australia; email: bryndis.birnir@mphy.lu.se            
            Chemicals/CAS: Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A; Zinc, 7440-66-6            
            Funding details: Medicinska Forskningsrådet, MFR, Y0924            
            Funding details: Lunds Universitet            
            Funding text 1: We thank the Swedish Medical Research Council (grant no Y0924), the Crafoord Stiftelse, the Segerfalks Stiftelse, A.O. Swärds and U. Eklunds Stiftelse and the Medical Faculty, Lund University, for financial support.
Cited By :8            
            Export Date: 13 April 2021            
            CODEN: NEPHB            
            Correspondence Address: Birnir, B.; Membrane Biology Program, , Canberra, ACT, Australia; email: bryndis.birnir@mphy.lu.se            
            Chemicals/CAS: Bicuculline, 485-49-4; GABA Antagonists; Receptors, GABA-A; Zinc, 7440-66-6            
            Funding details: Lunds Universitet            
            Funding details: Medicinska Forskningsrådet, MFR, Y0924            
            Funding text 1: We thank the Swedish Medical Research Council (grant no Y0924), the Crafoord Stiftelse, the Segerfalks Stiftelse, A.O. Swärds and U. Eklunds Stiftelse and the Medical Faculty, Lund University, for financial support.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Patenaude, C
AU  - Nurse, S
AU  - Lacaille, JC
TI  - Sensitivity of synaptic GABA(A) receptors to allosteric modulators in hippocampal oriens-alveus interneurons
JF  - SYNAPSE
J2  - SYNAPSE
VL  - 41
PY  - 2001
SP  - 29
EP  - 39
PG  - 11
SN  - 0887-4476
DO  - 10.1002/syn.1057
UR  - https://m2.mtmt.hu/api/publication/10049481
ID  - 10049481
N1  - Ctr. de Rech. en Sci. Neurologiques, Département de Physiologie, Université de Montréal, Montréal, Que., Canada            
            Département de Physiologie, Faculté de Médecine, C.P. 6128, succ. Centre-ville, Montréal, Que., Canada            
            Cited By :15            
            Export Date: 18 October 2022            
            CODEN: SYNAE            
            Correspondence Address: Lacaille, J.-C.; Département de Physiologie, succ. Centre-ville, Montréal, Qué. H3C 3J7, Canada; email: lacailj@ere.umontreal.ca            
            Chemicals/CAS: Benzodiazepines; Diuretics; Furosemide, 54-31-9; Pregnanolone, 128-20-1; Receptors, GABA-A; Zinc, 7440-66-6            
            Manufacturers: RBI, United States; Sigma, United States
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Traub, RD
AU  - Kopell, N
AU  - Bibbig, A
AU  - Buhl, EH
AU  - LeBeau, FEN
AU  - Whittington, MA
TI  - Gap junctions between interneuron dendrites can enhance synchrony of gamma oscillations in distributed networks
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 21
PY  - 2001
IS  - 23
SP  - 9478
EP  - 9486
PG  - 9
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.21-23-09478.2001
UR  - https://m2.mtmt.hu/api/publication/27029580
ID  - 27029580
N1  - Cited By :270            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Traub, R.D.; Department of Physiology, State Univ. New York Hlth. Sci. Ctr., Brooklyn, NY 11203, United States; email: rtraub@netmail.hscbklyn.edu            
            Chemicals/CAS: 3,5-dihydroxyphenylglycine, 146255-66-5; Carbenoxolone, 5697-56-3; Glutamic Acid, 56-86-0; Glycine, 56-40-6; Potassium, 7440-09-7; Receptors, GABA-A; Resorcinols
Cited By :270            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Traub, R.D.; Department of Physiology, State Univ. New York Hlth. Sci. Ctr., Brooklyn, NY 11203, United States; email: rtraub@netmail.hscbklyn.edu            
            Chemicals/CAS: 3,5-dihydroxyphenylglycine, 146255-66-5; Carbenoxolone, 5697-56-3; Glutamic Acid, 56-86-0; Glycine, 56-40-6; Potassium, 7440-09-7; Receptors, GABA-A; Resorcinols
Cited By :276            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Traub, R.D.; Department of Physiology, , Brooklyn, NY 11203, United States; email: rtraub@netmail.hscbklyn.edu            
            Chemicals/CAS: carbachol, 462-58-8, 51-83-2            
            Funding details: National Institute of Mental Health, NIMH, R01MH047150
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Hájos, Norbert
AU  - Nusser, Zoltán
AU  - Rancz, Ede
AU  - Freund, Tamás
AU  - Mody, I
TI  - Cell type- and synapse-specific variability in synaptic GABA~A receptor occupancy
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 12
PY  - 2000
SP  - 810
EP  - 818
PG  - 9
SN  - 0953-816X
DO  - 10.1046/j.1460-9568.2000.00964.x
UR  - https://m2.mtmt.hu/api/publication/108823
ID  - 108823
N1  - Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary            
            Depts. of Neurology and Physiology, UCLA School of Medicine, 710 Westwood Plz., Los Angeles, CA 90095-1769, United States            
            Institute of Experimental Medicine, Budapest, Hungary            
            Cited By :121            
            Export Date: 22 June 2023            
            CODEN: EJONE            
            Correspondence Address: Mody, I.; Department of Neurology, 710 Westwood Plz., Los Angeles, CA 90095-1769, United States; email: mody@ucla.edu            
            Chemicals/CAS: Bicuculline, 485-49-4; Excitatory Amino Acid Antagonists; GABA Antagonists; Hypnotics and Sedatives; Kynurenic Acid, 492-27-3; Pyridines; Receptors, GABA-A; Tetrodotoxin, 4368-28-9; zolpidem, 82626-48-0            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS030549
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Hutcheon, B
AU  - Morley, P
AU  - Poulter, MO
TI  - Developmental change in GABA(A) receptor desensitization kinetics and its role in synapse function in rat cortical neurons
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 522
PY  - 2000
IS  - 1
SP  - 3
EP  - 17
PG  - 15
SN  - 0022-3751
DO  - 10.1111/j.1469-7793.2000.t01-5-00003.xm
UR  - https://m2.mtmt.hu/api/publication/25005928
ID  - 25005928
N1  - Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ont. K1A 0R6, Canada            
            Lab. of Molecular Neuropharmacology, Institute for Biological Sciences, National Research Council of Canada, Montreal Road Campus, Ottawa, Ont. K1A 0R6, Canada            
            Cited By :69            
            Export Date: 20 May 2020            
            CODEN: JPHYA            
            Correspondence Address: Poulter, M.O.; Lab. Molecular Neuropharmacol., Institute Biological Sciences, National Research Council Canada, Ottawa, Ont. K1A 0R6, Canada; email: mike.poulter@nrc.a            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Aminopyridines; GABA Modulators; Receptors, GABA-A; SB 205384, 160296-13-9; Thiophenes
Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ont. K1A 0R6, Canada            
            Lab. of Molecular Neuropharmacology, Institute for Biological Sciences, National Research Council of Canada, Montreal Road Campus, Ottawa, Ont. K1A 0R6, Canada            
            Cited By :69            
            Export Date: 1 January 2021            
            CODEN: JPHYA            
            Correspondence Address: Poulter, M.O.; Lab. Molecular Neuropharmacol., Institute Biological Sciences, National Research Council Canada, Ottawa, Ont. K1A 0R6, Canada; email: mike.poulter@nrc.a            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Aminopyridines; GABA Modulators; Receptors, GABA-A; SB 205384, 160296-13-9; Thiophenes
Institute for Biological Sciences, National Research Council of Canada, Ottawa, Ont. K1A 0R6, Canada            
            Lab. of Molecular Neuropharmacology, Institute for Biological Sciences, National Research Council of Canada, Montreal Road Campus, Ottawa, Ont. K1A 0R6, Canada            
            Cited By :69            
            Export Date: 13 April 2021            
            CODEN: JPHYA            
            Correspondence Address: Poulter, M.O.; Lab. Molecular Neuropharmacol., , Ottawa, Ont. K1A 0R6, Canada; email: mike.poulter@nrc.a            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; Aminopyridines; GABA Modulators; Receptors, GABA-A; SB 205384, 160296-13-9; Thiophenes
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Maccaferri, G
AU  - Roberts, JD
AU  - Szűcs, Péter
AU  - Cottingham, CA
AU  - Somogyi, Péter Pál
TI  - Cell surface domain specific postsynaptic currents evoked by identified GABAergic neurones in rat hippocampus in vitro.
JF  - JOURNAL OF PHYSIOLOGY-LONDON
J2  - J PHYSIOL-LONDON
VL  - 524
PY  - 2000
IS  - 1
SP  - 91
EP  - 116
PG  - 26
SN  - 0022-3751
DO  - 10.1111/j.1469-7793.2000.t01-3-00091.x
UR  - https://m2.mtmt.hu/api/publication/2138095
ID  - 2138095
N1  - Cited By :259            
            Export Date: 21 August 2019            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
Cited By :261            
            Export Date: 6 March 2020            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
Cited By :262            
            Export Date: 20 May 2020            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
Cited By :262            
            Export Date: 24 May 2020            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
Cited By :262            
            Export Date: 25 May 2020            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
Cited By :270            
            Export Date: 23 March 2021            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
Cited By :271            
            Export Date: 6 April 2021            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
Cited By :271            
            Export Date: 13 April 2021            
            Chemicals/CAS: Bicuculline, 485-49-4; Cholecystokinin, 9011-97-6; gamma-Aminobutyric Acid, 56-12-2; Parvalbumins; Receptors, GABA-A; Somatostatin, 51110-01-1
AB  - 1. Inhibitory postsynaptic currents (IPSCs) evoked in CA1 pyramidal cells (n = 46) by identified interneurones (n = 43) located in str. oriens were recorded in order to compare their functional properties and to determine the effect of synapse location on the apparent IPSC kinetics as recorded using somatic voltage clamp at -70 mV and nearly symmetrical [Cl-]. 2. Five types of visualised presynaptic interneurone, oriens-lacunosum moleculare (O-LMC), basket (BC), axo-axonic (AAC), bistratified (BiC) and oriens-bistratified (O-BiC) cells, were distinguished by immunocytochemistry and/or synapse location using light and electron microscopy. 3. Somatostatin immunoreactive O-LMCs, innervating the most distal dendritic shafts and spines, evoked the smallest amplitude (26 +/- 10 pA, s.e.m., n = 8) and slowest IPSCs (10-90 % rise time, 6.2 +/- 0.6 ms; decay, 20.8 +/- 1.7 ms, n = 8), with no paired-pulse modulation of the second IPSC (93 +/- 4 %) at 100 ms interspike interval. In contrast, parvalbumin-positive AACs evoked larger amplitude (308 +/- 103 pA, n = 7) and kinetically faster (rise time, 0.8 +/- 0.1 ms; decay 11.2 +/- 0.9 ms, n = 7) IPSCs showing paired-pulse depression (to 68 +/- 5 %, n = 6). Parvalbumin- or CCK-positive BCs (n = 9) terminating on soma/dendrites, BiCs (n = 4) and O-BiCs (n = 7) innervating dendrites evoked IPSCs with intermediate kinetic parameters. The properties of IPSCs and sensitivity to bicuculline indicated that they were mediated by GABAA receptors. 4. In three cases, kinetically complex, multiphasic IPSCs, evoked by an action potential in the recorded basket cells, suggested that coupled interneurones, possibly through electrotonic junctions, converged on the same postsynaptic neurone. 5. The population of O-BiCs (4 of 4 somatostatin positive) characterised in this study had horizontal dendrites restricted to str. oriens/alveus and innervated stratum radiatum and oriens. Other BiCs had radial dendrites as described earlier. The parameters of IPSCs evoked by BiCs and O-BiCs showed the largest cell to cell variation, and a single interneurone could evoke both small and slow as well as large and relatively fast IPSCs. 6. The kinetic properties of the somatically recorded postsynaptic current are correlated with the innervated cell surface domain. A significant correlation of rise and decay times for the overall population of unitary IPSCs suggests that electrotonic filtering of distal responses is a major factor for the location and cell type specific differences of unitary IPSCs, but molecular heterogeneity of postsynaptic GABAA receptors may also contribute to the observed kinetic differences. Furthermore, domain specific differences in the short-term plasticity of the postsynaptic response indicate a differentiation of interneurones in activity-dependent responses.
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Oliva, AA
AU  - Jiang, MH
AU  - Lam, T
AU  - Smith, KL
AU  - Swann, JW
TI  - Novel hippocampal interneuronal subtypes identified using transgenic mice that express green fluorescent protein in GABAergic interneurons
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 20
PY  - 2000
IS  - 9
SP  - 3354
EP  - 3368
PG  - 15
SN  - 0270-6474
DO  - 10.1523/JNEUROSCI.20-09-03354.2000
UR  - https://m2.mtmt.hu/api/publication/27029555
ID  - 27029555
N1  - Megjegyzés-21894750
Z9: 188
Megjegyzés-21953440
Z9: 191
WC: Neurosciences
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :366            
            Export Date: 21 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, MC3-6365, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Green Fluorescent Proteins, 147336-22-9; Luminescent Proteins; Somatostatin, 51110-01-1
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :372            
            Export Date: 6 March 2020            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, MC3-6365, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Green Fluorescent Proteins, 147336-22-9; Luminescent Proteins; Somatostatin, 51110-01-1
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :373            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, MC3-6365, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Chemicals/CAS: gamma-Aminobutyric Acid, 56-12-2; Green Fluorescent Proteins, 147336-22-9; Luminescent Proteins; Somatostatin, 51110-01-1
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :373            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, MC3-6365, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, NS034504, NS018309            
            Funding details: National Institutes of Health, NIH            
            Funding details: U.S. Department of Health and Human Services, HHS
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :373            
            Export Date: 25 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, MC3-6365, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, NS034504, NS018309            
            Funding details: National Institutes of Health, NIH            
            Funding details: U.S. Department of Health and Human Services, HHS
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :386            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS018309, R01NS034504, R01NS037171
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :387            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS018309, R01NS034504, R01NS037171
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :388            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS018309, R01NS034504, R01NS037171
Cain Foundation Laboratories, Houston, TX 77030, United States            
            Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, United States            
            Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States            
            Cain Foundation Laboratories, MC 3-6365, 6621 Fannin Street, Houston, TX 77030, United States            
            Cited By :388            
            Export Date: 14 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Swann, J.W.; Cain Foundation Laboratories, 6621 Fannin Street, Houston, TX 77030, United States; email: jswann@bcm.tmc.edu            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS018309, R01NS034504, R01NS037171
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Shew, T
AU  - Yip, S
AU  - Sastry, BR
TI  - Mechanisms involved in tetanus-induced potentiation of fast IPSCs in rat hippocampal CA1 neurons
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 83
PY  - 2000
SP  - 3388
EP  - 3401
PG  - 14
SN  - 0022-3077
DO  - 10.1152/jn.2000.83.6.3388
UR  - https://m2.mtmt.hu/api/publication/10044158
ID  - 10044158
N1  - Cited By :34            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Sastry, B.R.; Neuroscience Research Laboratory, Dept. of Pharmacology/Therapeutics, University of British Columbia, Vancouver, BC V6T 1Z3, Canada            
            Chemicals/CAS: 3 aminopropylbutylphosphinic acid, 145537-81-1; 4 aminobutyric acid, 28805-76-7, 56-12-2; 4 chloromercuribenzoic acid, 59-85-8; baclofen, 1134-47-0; bicuculline, 485-49-4; gaboxadol, 64603-91-4; n ethylmaleimide, 128-53-0; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, 85233-19-8; Cyclic AMP-Dependent Protein Kinases, EC 2.7.1.37; Egtazic Acid, 67-42-5; Enzyme Activators; Receptors, GABA-B; Receptors, Presynaptic
Cited By :35            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Sastry, B.R.; Neuroscience Research Laboratory, , Vancouver, BC V6T 1Z3, Canada            
            Chemicals/CAS: 3 aminopropylbutylphosphinic acid, 123690-78-8, 145537-81-1; 4 aminobutyric acid, 28805-76-7, 56-12-2; 4 chloromercuribenzoic acid, 59-85-8; baclofen, 1134-47-0; bicuculline, 485-49-4; gaboxadol, 64603-91-4, 85118-33-8, 65202-63-3, 815574-58-4; n ethylmaleimide, 128-53-0; 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid, 85233-19-8; Cyclic AMP-Dependent Protein Kinases, EC 2.7.1.37; Egtazic Acid, 67-42-5; Enzyme Activators; Receptors, GABA-B; Receptors, Presynaptic            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS030959
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - White, JA
AU  - Banks, MI
AU  - Pearce, RA
AU  - Kopell, NJ
TI  - Networks of interneurons with fast and slow gamma-aminobutyric acid type A (GABA(A)) kinetics provide substrate for mixed gamma-theta rhythm
JF  - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
J2  - P NATL ACAD SCI USA
VL  - 97
PY  - 2000
IS  - 14
SP  - 8128
EP  - 8133
PG  - 6
SN  - 0027-8424
DO  - 10.1073/pnas.100124097
UR  - https://m2.mtmt.hu/api/publication/25002836
ID  - 25002836
N1  - Funding Agency and Grant Number: NIGMS NIH HHS [R01 GM055719] Funding Source: Medline; NIMH NIH HHS [MH 47150] Funding Source: Medline; NINDS NIH HHS [R29 NS034425, R01 NS034425, NS 34425, R56 NS034425] Funding Source: Medline; PHS HHS [DMS 9631755] Funding Source: Medline
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Ali, AB
AU  - Bannister, AP
AU  - Thomson, AM
TI  - IPSPs elicited in CA1 pyramidal cells by putative basket cells in slices of adult rat hippocampus
JF  - EUROPEAN JOURNAL OF NEUROSCIENCE
J2  - EUR J NEUROSCI
VL  - 11
PY  - 1999
IS  - 5
SP  - 1741
EP  - 1753
PG  - 13
SN  - 0953-816X
DO  - 10.1046/j.1460-9568.1999.00592.x
UR  - https://m2.mtmt.hu/api/publication/27029529
ID  - 27029529
N1  - Cited By :43            
            Export Date: 21 August 2019            
            CODEN: EJONE            
            Correspondence Address: Thomson, A.M.; Department of Physiology, Royal Free Univ. Coll. Medical Sch., Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom; email: alext@rfhsm.ac.uk            
            Chemicals/CAS: Bicuculline, 485-49-4; biocytin, 576-19-2; GABA Antagonists; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
Cited By :43            
            Export Date: 24 May 2020            
            CODEN: EJONE            
            Correspondence Address: Thomson, A.M.; Department of Physiology, Royal Free Univ. Coll. Medical Sch., Royal Free Campus, Rowland Hill Street, London NW3 2PF, United Kingdom; email: alext@rfhsm.ac.uk            
            Chemicals/CAS: Bicuculline, 485-49-4; biocytin, 576-19-2; GABA Antagonists; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
Cited By :44            
            Export Date: 23 March 2021            
            CODEN: EJONE            
            Correspondence Address: Thomson, A.M.; Department of Physiology, Rowland Hill Street, London NW3 2PF, United Kingdom; email: alext@rfhsm.ac.uk            
            Chemicals/CAS: Bicuculline, 485-49-4; biocytin, 576-19-2; GABA Antagonists; gamma-Aminobutyric Acid, 56-12-2; Lysine, 56-87-1
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Alkondon, M
AU  - Pereira, EFR
AU  - Eisenberg, HM
AU  - Albuquerque, EX
TI  - Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 19
PY  - 1999
IS  - 7
SP  - 2693
EP  - 2705
PG  - 13
SN  - 0270-6474
DO  - 10.1523/jneurosci.19-07-02693.1999
UR  - https://m2.mtmt.hu/api/publication/10324320
ID  - 10324320
N1  - Cited By :279            
            Export Date: 21 August 2019            
            CODEN: JNRSD            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacol./Exp. Therapeut., Univ. of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, United States            
            Chemicals/CAS: Bicuculline, 485-49-4; Choline, 62-49-7; GABA Antagonists; gamma-Aminobutyric Acid, 56-12-2; Nicotinic Agonists; Nicotinic Antagonists; Tetrodotoxin, 4368-28-9
Cited By :284            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacol./Exp. Therapeut., Univ. of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, United States            
            Chemicals/CAS: Bicuculline, 485-49-4; Choline, 62-49-7; GABA Antagonists; gamma-Aminobutyric Acid, 56-12-2; Nicotinic Agonists; Nicotinic Antagonists; Tetrodotoxin, 4368-28-9
Cited By :284            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacol./Exp. Therapeut., Univ. of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, United States            
            Chemicals/CAS: Bicuculline, 485-49-4; Choline, 62-49-7; GABA Antagonists; gamma-Aminobutyric Acid, 56-12-2; Nicotinic Agonists; Nicotinic Antagonists; Tetrodotoxin, 4368-28-9
Cited By :284            
            Export Date: 25 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacol./Exp. Therapeut., Univ. of Maryland School of Medicine, 655 West Baltimore Street, Baltimore, MD 21201, United States            
            Chemicals/CAS: Bicuculline, 485-49-4; Choline, 62-49-7; GABA Antagonists; gamma-Aminobutyric Acid, 56-12-2; Nicotinic Agonists; Nicotinic Antagonists; Tetrodotoxin, 4368-28-9
Cited By :287            
            Export Date: 23 March 2021            
            CODEN: JNRSD            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacol./Exp. Therapeut., 655 West Baltimore Street, Baltimore, MD 21201, United States            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; acetylcholine, 51-84-3, 60-31-1, 66-23-9; alpha bungarotoxin, 11032-79-4; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1; dihydro beta erythroidine, 23255-54-1; methyllycaconitine, 21019-30-7, 72629-98-2            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025296
Cited By :289            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacol./Exp. Therapeut., 655 West Baltimore Street, Baltimore, MD 21201, United States            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; acetylcholine, 51-84-3, 60-31-1, 66-23-9; alpha bungarotoxin, 11032-79-4; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1; dihydro beta erythroidine, 23255-54-1; methyllycaconitine, 21019-30-7, 72629-98-2            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025296
Cited By :290            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Albuquerque, E.X.; Dept. of Pharmacol./Exp. Therapeut., 655 West Baltimore Street, Baltimore, MD 21201, United States            
            Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; acetylcholine, 51-84-3, 60-31-1, 66-23-9; alpha bungarotoxin, 11032-79-4; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1; dihydro beta erythroidine, 23255-54-1; methyllycaconitine, 21019-30-7, 72629-98-2            
            Funding details: National Institute of Neurological Disorders and Stroke, NINDS, R01NS025296
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Bracci, E
AU  - Vreugdenhil, M
AU  - Hack, SP
AU  - Jefferys, JGR
TI  - On the synchronizing mechanisms of tetanically induced hippocampal oscillations
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 19
PY  - 1999
IS  - 18
SP  - 8104
EP  - 8113
PG  - 10
SN  - 0270-6474
DO  - 10.1523/jneurosci.19-18-08104.1999
UR  - https://m2.mtmt.hu/api/publication/23827173
ID  - 23827173
N1  - Cited By :78            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Jefferys, J.G.R.; Department of Neurophysiology, Division of Neuroscience, University of Birmingham, Birmingham B15 2TT, United Kingdom            
            Chemicals/CAS: 1-amino-1,3-dicarboxycyclopentane, 111900-32-4; 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline, 118876-58-7; Bicuculline, 485-49-4; Cycloleucine, 52-52-8; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Quinoxalines; Receptors, GABA-A
Cited By :78            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Jefferys, J.G.R.; Department of Neurophysiology, Division of Neuroscience, University of Birmingham, Birmingham B15 2TT, United Kingdom            
            Chemicals/CAS: 1-amino-1,3-dicarboxycyclopentane, 111900-32-4; 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline, 118876-58-7; Bicuculline, 485-49-4; Cycloleucine, 52-52-8; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid, 56-12-2; Quinoxalines; Receptors, GABA-A
Cited By :78            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Jefferys, J.G.R.; Department of Neurophysiology, , Birmingham B15 2TT, United Kingdom
Cited By :78            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Jefferys, J.G.R.; Department of Neurophysiology, , Birmingham B15 2TT, United Kingdom
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Chapman, CA
AU  - Lacaille, JC
TI  - Cholinergic induction of theta-frequency oscillations in hippocampal inhibitory interneurons and pacing of pyramidal cell firing
JF  - JOURNAL OF NEUROSCIENCE
J2  - J NEUROSCI
VL  - 19
PY  - 1999
IS  - 19
SP  - 8637
EP  - 8645
PG  - 9
SN  - 0270-6474
DO  - 10.1523/jneurosci.19-19-08637.1999
UR  - https://m2.mtmt.hu/api/publication/27029533
ID  - 27029533
N1  - Cited By :117            
            Export Date: 20 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Lacaille, J.-C.; Departement de Physiologie, Faculte de Medecine, Universite de Montreal, C.P. 6128 Succ. Centreville, Montreal, Que. H3C 3J7, Canada            
            Chemicals/CAS: 2-Amino-5-phosphonovalerate, 76726-92-6; 6-Cyano-7-nitroquinoxaline-2,3-dione, 115066-14-3; Atropine, 51-55-8; Carbachol, 51-83-2; Cholinergic Agonists; Receptors, GABA-A
Cited By :117            
            Export Date: 24 May 2020            
            CODEN: JNRSD            
            Correspondence Address: Lacaille, J.-C.; Departement de Physiologie, Faculte de Medecine, Universite de Montreal, C.P. 6128 Succ. Centreville, Montreal, Que. H3C 3J7, Canada            
            Chemicals/CAS: 2-Amino-5-phosphonovalerate, 76726-92-6; 6-Cyano-7-nitroquinoxaline-2,3-dione, 115066-14-3; Atropine, 51-55-8; Carbachol, 51-83-2; Cholinergic Agonists; Receptors, GABA-A
Cited By :122            
            Export Date: 6 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Lacaille, J.-C.; Departement de Physiologie, C.P. 6128 Succ. Centreville, Montreal, Que. H3C 3J7, Canada            
            Chemicals/CAS: carbachol, 462-58-8, 51-83-2
Cited By :122            
            Export Date: 13 April 2021            
            CODEN: JNRSD            
            Correspondence Address: Lacaille, J.-C.; Departement de Physiologie, C.P. 6128 Succ. Centreville, Montreal, Que. H3C 3J7, Canada            
            Chemicals/CAS: carbachol, 462-58-8, 51-83-2
LA  - English
DB  - MTMT
ER  - 

TY  - JOUR
AU  - Chapman, CA
AU  - Lacaille, JC
TI  - Intrinsic theta-frequency membrane potential oscillations in hippocampal CA1 interneurons of stratum lacunosum-moleculare
JF  - JOURNAL OF NEUROPHYSIOLOGY
J2  - J NEUROPHYSIOL
VL  - 81
PY  - 1999
IS  - 3
SP  - 1296
EP  - 1307
PG  - 12
SN  - 0022-3077
DO  - 10.1152/jn.1999.81.3.1296
UR  - https://m2.mtmt.hu/api/publication/25003827
ID  - 25003827
N1  - Cited By :112            
            Export Date: 20 May 2020            
            CODEN: JONEA            
            Correspondence Address: Lacaille, J.-C.; Departement de Physiologie, Faculte de Medecine, Universite de Montreal, C.P. 6128 Succ. Centre-ville, Montreal, Que. H3C 3J7, Canada            
            Chemicals/CAS: calcium, 7440-70-2, 14092-94-5; sodium, 7440-23-5
Cited By :112            
            Export Date: 6 April 2021            
            CODEN: JONEA            
            Correspondence Address: Lacaille, J.-C.; Departement de Physiologie, C.P. 6128 Succ. Centre-ville, Montreal, Que. H3C 3J7, Canada            
            Chemicals/CAS: calcium, 7440-70-2, 14092-94-5; sodium, 7440-23-5
Cited By :112            
            Export Date: 13 April 2021            
            CODEN: JONEA            
            Correspondence Address: Lacaille, J.-C.; Departement de Physiologie, C.P. 6128 Succ. Centre-ville, Montreal, Que. H3C 3J7, Canada            
            Chemicals/CAS: calcium, 7440-70-2, 14092-94-5; sodium, 7440-23-5
LA  - English
DB  - MTMT
ER  -